{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Capstone Project: Classifying clinically actionable genetic mutations\n",
    "\n",
    "***"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Notebook 3: Baseline Model"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "This notebook contains the code to identify a baseline classifier and use it to make predictions for the testing dataset."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Contents\n",
    "\n",
    "- [Importing of Libraries](#Importing-of-Libraries)\n",
    "- [Data Import](#Data-Import)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Importing of Libraries"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "# pip install imblearn"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "# pip install transformers"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "# pip install tabulate"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "\n",
    "from tabulate import tabulate\n",
    "from gensim.models.word2vec import Word2Vec\n",
    "from collections import Counter, defaultdict\n",
    "\n",
    "TRAIN_SET_PATH = \"../assets/train_prep.csv\"\n",
    "\n",
    "GLOVE_6B_50D_PATH = \"../assets/glove.6B.50d.txt\"\n",
    "GLOVE_6B_300D_PATH = \"../assets/glove.6B.300d.txt\"\n",
    "encoding=\"utf-8\"\n",
    "\n",
    "from sklearn import linear_model, metrics, svm\n",
    "from sklearn.pipeline import Pipeline\n",
    "from sklearn.model_selection import train_test_split, GridSearchCV,\\\n",
    "    cross_val_score, RandomizedSearchCV, StratifiedShuffleSplit\n",
    "from sklearn.linear_model import LogisticRegression\n",
    "from sklearn.feature_extraction.text import CountVectorizer, TfidfVectorizer, HashingVectorizer\n",
    "from sklearn.ensemble import RandomForestClassifier, ExtraTreesClassifier, AdaBoostClassifier\n",
    "from sklearn.neighbors import KNeighborsClassifier\n",
    "from sklearn.tree import DecisionTreeClassifier\n",
    "from sklearn.naive_bayes import BernoulliNB, MultinomialNB\n",
    "from sklearn.svm import SVC\n",
    "from sklearn.preprocessing import StandardScaler\n",
    "from sklearn.preprocessing import label_binarize\n",
    "from sklearn.utils import resample\n",
    "from sklearn.metrics import accuracy_score, roc_curve, auc, roc_auc_score\n",
    "from sklearn.multiclass import OneVsRestClassifier\n",
    "\n",
    "from imblearn.over_sampling import SMOTE\n",
    "\n",
    "import matplotlib\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns\n",
    "from itertools import cycle\n",
    "plt.style.use('fivethirtyeight')\n",
    "\n",
    "import nltk\n",
    "from nltk.tokenize import RegexpTokenizer\n",
    "import regex as re\n",
    "from nltk.stem import WordNetLemmatizer\n",
    "from nltk.stem.porter import PorterStemmer\n",
    "from nltk.corpus import stopwords\n",
    "\n",
    "import torch\n",
    "import transformers as ppb\n",
    "import warnings\n",
    "warnings.filterwarnings('ignore')\n",
    "\n",
    "from wordcloud import WordCloud\n",
    "\n",
    "%config InlineBackend.figure_format = 'retina'\n",
    "%matplotlib inline"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Data Import"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 151,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Import 'train_prep' and 'test_prep' datasets\n",
    "# We use the 'keep_default_na' option to False to ensure that pandas does not re-introduce missing values\n",
    "train = pd.read_csv(\"../assets/train_prep.csv\", keep_default_na=False)\n",
    "test = pd.read_csv(\"../assets/test_prep.csv\", keep_default_na=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 152,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "((3321, 10119), (5668, 10118))"
      ]
     },
     "execution_count": 152,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train.shape, test.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 153,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>class</th>\n",
       "      <th>text</th>\n",
       "      <th>gene_A4GALT</th>\n",
       "      <th>gene_AAAS</th>\n",
       "      <th>gene_AANAT</th>\n",
       "      <th>gene_AARS</th>\n",
       "      <th>gene_ABCA1</th>\n",
       "      <th>gene_ABCA12</th>\n",
       "      <th>gene_ABCA3</th>\n",
       "      <th>...</th>\n",
       "      <th>variation_null380R</th>\n",
       "      <th>variation_null399R</th>\n",
       "      <th>variation_null420W</th>\n",
       "      <th>variation_null423L</th>\n",
       "      <th>variation_null462G</th>\n",
       "      <th>variation_null483L</th>\n",
       "      <th>variation_null496R</th>\n",
       "      <th>variation_null522S</th>\n",
       "      <th>variation_null654G</th>\n",
       "      <th>variation_p61BRAF</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>cyclin dependent kinase cdks regulate variety fundamental cellular process cdk stand one last orphan cdks activate cyclin identify kinase activity reveal previous work show cdk silence increase ets v ets erythroblastosis virus e oncogene homolog driven activation mapk pathway confers tamoxifen resistance breast cancer precise mechanism cdk modulates ets activity generally function cdk remain elusive demonstrate cdk cyclin dependent kinase identify cyclin activate cyclin cyclin orphan cyclin product fam whose cause star syndrome human developmental anomaly whose feature include toe syndactyly telecanthus anogenital renal malformation show star syndrome associate cyclin mutant unable interact cdk cyclin silence phenocopies cdk silence increase c raf confer tamoxifen resistance breast cancer cdk cyclin phosphorylates ets vitro positively control ets degradation proteasome ets protein level increase derive star increase attributable decrease cyclin level altogether result reveal additional regulatory mechanism ets play key role cancer development also shed light molecular mechanism underlie star syndrome cyclin dependent kinase cdks play pivotal role control number fundamental cellular process human genome contains gene encode protein consider member cdk family owe sequence similarity bona fide cdks know activate cyclins although discover almost ago cdk remains one two cdks without identify cyclin partner knowledge gap largely impede exploration biological function cdk act positive cycle regulator suppressor others cdk interacts ets v ets erythroblastosis virus e oncogene homolog transcription factor inhibits transcriptional activity unknown mechanism cdk knockdown derepresses ets increase expression c raf protein kinase activates mapk pathway induces resistance mcf tamoxifen deorphanize cdk identify cyclin product fam binding partner gene predict absence truncation cyclin associate star syndrome whose feature include toe syndactyly telecanthus anogenital renal malformation heterozygous female however function cyclin pathogenesis star syndrome remain unknown show recombinant cdk cyclin heterodimer active protein kinase phosphorylates ets vitro cyclin silence phenocopies cdk silence increase c raf phospho erk expression level induce tamoxifen resistance estrogen receptor er breast cancer show cdk cyclin positively control ets degradation proteasome phosphorylation two neighbor serine finally detect increase ets expression level derive star demonstrate attributable decrease cyclin expression level observe previous sectionnext sectionresultsa yeast two hybrid h screen unveiled interaction signal cdk mouse protein whose c terminal half present strong sequence homology human fam gene product whose propose name cyclin thus perform h mating assay determine whether human cdk interacts human cyclin c long cdk isoform p express bait protein produce strong interaction phenotype full length cyclin express prey protein detectable phenotype cyclin p cip cdi kap know binding partner cdks b cdk cdk also produce h signal cyclin albeit notably weaker observe cdk b interaction phenotype also observe full length cyclin cdk protein express bait prey respectively test different isoforms cdk cyclin originate alternative gene splice two truncate cyclin protein correspond hypothetical product two mutate fam gene found star syndrome none shorter isoforms produce interaction phenotype c new window download pptfig cdk cyclin form interaction complex schematic representation different protein isoforms analyze h assay amino acid number indicate black box indicate internal deletion red box indicates differ amino acid sequence compare cdk p b h assay set cdk protein express bait fusion lexa dna binding domain cdk interact protein express prey fusion b transcriptional activator peg pjg empty bait prey plasmid express lexa b respectively lacz use reporter gene blue yeast indicative h interaction phenotype c h assay different cdk cyclin isoforms amino terminal region ets know interact cdk also assayed western blot analysis myc cdk wt kd cycm v expression level transfected hek e western blot analysis myc cdk wt kd immunoprecipitates obtain use anti myc antibody input correspond g total lysates obtain hek coexpressing myc cdk wt kd cycm v f western blot analysis immunoprecipitates obtain use anti cdk antibody control goat antibody human breast cancer mcf input corresponds g mcf total lysates low band doublet observe upper panel comigrates exogenously express untagged cdk thus corresponds endogenous cdk upper band doublet corresponds nonspecific signal demonstrate insensitivity either overexpression cdk see left lane silence cdk b another experiment longer gel migration show next examine ability cdk cyclin interact express human e test wild type cdk wt kinase dead kd mutant bearing amino acid substitution abolishes atp binding express cyclin v myc cdk wt kd human embryonic kidney line hek expression level cyclin v significantly increase upon coexpression myc cdk wt kd lesser extent myc cdk wt kd increase upon coexpression cyclin v immunoprecipitated myc cdk protein detect presence cyclin cdk wt kd immunoprecipitates protein coexpressed pair wise e confirm observation detect presence myc cdk cyclin v immunoprecipitates b experiment confirm lack robust interaction cdk p isoform cyclin c detect interaction endogenous protein perform immunoprecipitations nontransfected mcf derive human breast cancer cdk cyclin antibody detect cognate endogenous protein western blotting readily detect cyclin immunoprecipitates obtain cdk antibody control antibody f result confirm physical interaction cdk cyclin human unveil hypothesize cdk cyclin protein kinase activity produce gst cdk strepii cyclin fusion protein insect either individually combination observe gst cdk strepii cyclin copurified thus confirm interaction yet another cellular model perform vitro kinase assay purify protein use histone h generic substrate histone h phosphorylation detect lysates coexpressing gst cdk strepii cyclin phosphorylation detect gst cdk strepii cyclin express alone strepii cyclin coexpressed gst cdk kd next investigate whether ets know interact cdk c phosphorylation substrate cdk cyclin detect strong phosphorylation ets gst cdk strepii cyclin purify heterodimer whereas phosphorylation detect use gst cdk alone gst cdk kd strepii cyclin heterodimer b new window download pptfig cdk cyclin dependent protein kinase vitro protein kinase assay histone h lysates insect express different protein purify glutathione sepharose matrix capture gst cdk wt kd fusion protein alone complex str cycm fusion protein purify protein expression level analyze western blot top upper middle kinase activity determine autoradiography histone h whose add amount visualize coomassie stain low middle bottom b use purify recombinant ets substrate cdk silence show increase ets driven c raf transcription activate mapk pathway investigate whether cyclin also involve regulatory pathway aim highly specific silence use sirna pool mix four different sirnas low final concentration nm cdk cyclin sirna pool silence expression cognate target c interestingly cyclin sirna pool also cause marked decrease cdk protein level b result show suggest cyclin binding stabilizes cdk cyclin silence induced increase c raf protein mrna level b c phosphorylated erk erk protein level b similarly cdk silence expect effect cdk cyclin silence decrease sensitivity er mcf tamoxifen similar extent combine silence gene result high resistance drug c altogether observation demonstrate functional interaction cyclin cdk negatively control ets new window download pptfig cyclin silence regulates c raf expression western blot analysis endogenous cdk cyclin expression level mcf response sirna mediate gene silence b western blot analysis endogenous c raf expression level mcf response cdk cyclin silence quantification show c quantitative rt pcr analysis cdk cyclin c raf mrna level response cdk upper cyclin low silence p p wish explore mechanism cdk cyclin control ets ets short live protein degrade proteasome straightforward hypothesis cdk cyclin positively control ets degradation thus examine impact cdk cyclin silence ets expression level silence cdk cyclin cause increase expression level exogenously express flag ets protein well endogenous ets protein increase attributable increase ets mrna level marginally fluctuate response cdk cyclin silence b examine expression level flag tag ets protein express alone combination myc cdk cdk kd without cyclin v flag ets readily detect express alone lesser extent coexpressed cdk kd however expression level dramatically decrease coexpressed cdk alone cdk cyclin b observation suggest endogenous cyclin level excess compare cdk mcf show major decrease ets level observe upon cdk coexpression involves cdk kinase activity treatment coexpressing flag ets cdk cyclin proteasome inhibitor mg largely rescue flag ets expression level b new window download pptfig cdk cyclin control ets stability human cancer derive western blot analysis endogenous ets expression level mcf response sirna mediate cdk cyclin silence quantification show b b western blot analysis exogenously express flag ets protein level mcf cotransfected empty vector coexpressing myc cdk wt kd myc cdk cycm v latter treat h mg proteasome inhibitor proper expression cdk cyclin tag protein verify western blot analysis c western blot analysis expression level exogenously express flag ets wild type mutant protein mcf absence c response myc cdk cycm v expression quantification show c mass spectrometry analysis recombinant ets phosphorylated cdk cyclin vitro reveal existence multiple phosphorylated residue among two neighbor phospho serine position may form phosphodegron confirm find compare phosphorylation level recombinant ets wt ets sasa protein mutant bearing alanine substitution two serine expect existence multiple phosphorylation site detect small reproducible significant decrease phosphorylation level ets sasa compare ets wt thus confirm ser ser phosphorylated cdk cyclin establish direct link ets phosphorylation cdk cyclin degradation examine expression level flag ets sasa absence cdk cyclin coexpression differ significantly flag ets contrary flag ets dbm bearing deletion n terminal destruction box previously show involve apc cdh mediate degradation ets c however contrary flag ets wild type expression level flag ets sasa remain insensitive cdk cyclin coexpression altogether result suggest cdk cyclin directly control ets degradation phosphorylation two serine finally study lymphoblastoid line derive star syndrome bearing fam c g predict result aberrant splice accordance incomplete skew x chromosome inactivation previously found detect decrease expression level cyclin protein star line compare control lymphoblastoid line line precede observation detect increase expression level ets protein star line compare control examine quantitative rt pcr mrna expression level correspond gene star line show decrease expression level cyclin mrna expression level ets mrna similar control line b demonstrate increase ets protein expression indeed result decrease cyclin expression observe star derive line express cyclin v line expression cause decrease ets protein level c new window download pptfig decrease cyclin expression star derive result increase ets protein level western blot analysis cyclin ets protein level star derive lymphoblastoid line control lymphoblastoid line derive healthy individual quantification show b quantitative rt pcr analysis cyclin ets mrna level p c western blot analysis ets protein level star derive lymphoblastoid line transfected empty vector vector direct expression cyclin v another western blot reveal endogenously exogenously express cyclin level show b quantification ets protein level show c previous sectionnext sectiondiscussionin work unveil interaction cdk last orphan cdk discover pregenomic era cyclin cyclin associate human genetic disease far whose function remain unknown closest paralogs cdk within cdk family cdk protein interact l type cyclins interestingly closest paralog cyclins within cyclin family cyclin fact none shorter cdk isoforms interact robustly cyclin suggests alternative splice cdk gene play important role regulate cdk function functional relevance interaction cdk cyclin support different observation protein seem enhance stability judged increase expression level partner exogenously coexpressed much reduce endogenous cdk expression level observe response cyclin silence b cdk subject ubiquitin mediate degradation observation suggest cyclin protects cdk degradation cyclin partner cdk least mcf also suggest cyclin stability enhance upon binding cdk independently kinase activity see cyclin c cdk uncover cyclin dependent cdk protein kinase activity vitro thus demonstrate protein name cdk sole basis amino acid sequence indeed genuine cyclin dependent kinase h assay reveal truncate cyclin protein correspond hypothetical product two star syndrome associate fam produce interaction phenotype cdk hence regardless whether mutate mrna undergo nonsense mediate decay suggest decrease cyclin mrna level star show b give rise truncate cyclin protein female affected star syndrome must exhibit compromise cdk cyclin kinase activity least tissue specific developmental stage show ets know interactor cdk phosphorylation substrate cdk cyclin vitro cdk cyclin kinase activity positively control ets degradation proteasome control seem exert fine mechanism judged sensitivity ets level partially decrease cdk cyclin level achieve mcf observe star respectively finding offer straightforward explanation already report regulation ets driven transcription c raf response cdk silence bring evidence cdk cyclin directly control ets degradation phosphorylation two neighbor serine may form noncanonical trcp phosphodegron dsmcpas none two serine precede proline conform usual cdk phosphorylation site however multiple call transcriptional cdks cdk cdk may belong show phosphorylate variety motif non proline direct fashion especially context molecular dock substrate hypothesize high affinity interaction cdk point domain ets c would allow dock mediate phosphorylation atypical site control ets degradation involves number player include apc cdh cullin ring ligase crl formal identification ubiquitin ligase involve cdk cyclin pathway elucidation concert action ubiquitin ligases regulate ets degradation require far study result present number significant biological medical implication first shed light regulation ets play important role development frequently deregulate many cancer second result contribute understand molecular mechanism cause tamoxifen resistance associate reduce cdk expression level suggest like cdk cyclin could also predictive clinical marker hormone therapy response er positive breast cancer third finding offer interest hypothesis molecular mechanism underlie star syndrome ets transgenic mouse show less twofold overexpression ets present severe cranial abnormality observe star could thus cause least part increase ets protein level another expect consequence enhance ets expression level would decrease risk develop certain type cancer increase risk develop others study various mouse model include model syndrome three copy ets exist reveal ets dosage repress promote growth hence ets exerts noncell autonomous function cancer intringuingly one star identify far diagnose nephroblastoma finally finding facilitate general exploration biological function cdk particular role control division previous study suggest either positive role cycle control suppressive activity cancer severe growth retardation exhibit star strongly suggests cdk cyclin play important role control proliferation previous sectionnext sectionmaterials methodscloning cdk cyclin cdna plasmid construction tamoxifen response analysis quantitative rt pcr mass spectrometry experiment antibody production detailed si material method yeast two hybrid interaction assay perform yeast interaction mating assay previously described mammalian culture transfections grow human hek mcf dmem supplement vol vol fbs invitrogen grow lymphoblastoid rpmi glutamax supplement vol vol fbs transfected hek mcf use lipofectamine invitrogen plasmid lipofectamine rnaimax invitrogen sirnas jetprime polyplus plasmid sirnas combination accord manufacturer instruction transfected lymphoblastoid electroporation neon invitrogen ets stability study treat mcf h transfection mg fisher scientific h coimmunoprecipitation western blot experiment collect scrap pb centrifugation lymphoblastoid lysed sonication lysis buffer contain mm glycerophosphate mm p nitrophenylphosphate mm n morpholino propanesulfonic acid mop ph mm egta mm mgcl mm na vanadate mm naf mm phenylphosphate nonidet p protease inhibitor mixture roche spun lysates min g c collect supernatant determine protein content use bradford assay perform immunoprecipitation experiment g total protein lysis buffer precleared lysates l protein g agarose bead incubate h c rotate wheel add g antibody supernatant incubate h c rotate wheel add l protein g agarose bead incubate h c rotate wheel collect bead centrifugation g c wash three time bead buffer contain mm tris ph mm naf mm nacl mm edta mm egta nonidet p protease inhibitor coktail roche directly add sample buffer wash pellet heat denature protein ran sample bi tris sd page transfer protein onto hybond nitrocellulose membrane process blot accord standard procedure western blot experiment use follow primary antibody anti myc abcam ab anti v invitrogen r anti tubulin santa cruz biotechnology b anti cdk covalab pab p santa cruz biotechnology c anti cycm home make dilution covalab pab p dilution anti raf santa cruz biotechnology c anti ets santa cruz biotechnology c anti flag sigma f anti actin sigma use hrp couple anti goat santa cruz biotechnology sc dilution anti mouse bio rad dilution anti rabbit bio rad secondary antibody reveal blot enhance chemiluminescence supersignal west femto thermo scientific production purification recombinant protein gst cdk kd strepii cycm generate recombinant bacmids dh bac escherichia coli baculoviruses sf use bac bac system described provider invitrogen infect sf gst cdk gst cdk kd produce virus coinfected strepii cycm produce virus collect h infection purify gst fusion protein spun ml resuspend pellet ml lysis buffer pb mm nacl nonidet p mm naf mm glycerophosphate mm na vanadate contain protease inhibitor mixture roche lysed sonication spun lysate min g collect soluble fraction add ml glutathione sepharose matrix incubate h c wash four time lysis buffer one time kinase buffer see finally resuspend bead l kinase buffer contain vol vol glycerol storage ets transform origami de novagen ets expression vector induced expression mm isopropyl thiogalactopyranoside h c purify ets spun ml resuspend pellet ml lysis buffer pb mm nacl mm imidazole mm dtt nonidet p contain protease inhibitor mixture without edta roche lysed bar use disruptor spun lysate min g collect soluble fraction add l cobalt bead thermo scientific h incubation c rotate wheel wash four time lysis buffer elute incubate bead min elution buffer pb mm imidazole ph contain protease inhibitor mixture spun g collect elute protein protein kinase assay mixed glutathione sepharose bead harbor gst cdk wt kd either monomeric complexed strepii cycm bsa mm dtt atp ci atp p histone h ets add kinase buffer mm tris hcl mm mgcl mm egta mm dtt heparin ph total volume l incubate reaction min c add laemli sample buffer heat denature sample ran bi tris sd page cut gel slice detect gst cdk strepii cycm western blotting stain gel slice contain substrate coomassie r bio rad dry detect incorporate radioactivity autoradiography identify four unrelated girl anogenital renal malformation dysmorphic facial feature normal intellect syndactyly toe similar combination feature report previously mother daughter pair table supplementary note online author note clinical overlap townes brocks syndrome suggest phenotype represent separate autosomal dominant entity mim define cardinal feature syndrome characteristic facial appearance apparent telecanthus broad tripartite nasal tip variable syndactyly toe hypoplastic labium anal atresia urogenital malformation h also observe variety feature table clinical molecular characterization star syndrome clinical molecular characterization star syndrome f facial appearance case apparent telecanthus dysplastic ear thin upper lip c e toe syndactyly b f case illustrate recognizable feature star syndrome specific parental consent obtain publication photograph anal atresia hypoplastic labium show g h x ray film foot case show four ray left delta shape th th metatarsal right h compare clinical picture array cgh data log ratio represent copy number loss six probe span kb one probe position within fam deletion remove part functional gene j schematic structure fam position fam five cod exon box cyclin domain green encode exon horizontal arrow indicates deletion extend case include exon whereas horizontal line exon indicates deletion found case remove exon sequence pink horizontal bar box indicate amplicons use qpcr sequence one alternative exon amplicon indicate space constraint dupt case result immediate stop codon g g splice case predict deleterious alter conserve splice donor acceptor site intron respectively full size image kb table clinical feature star syndrome case table clinical feature star syndrome case full table basis phenotypic overlap townes brocks okihiro feingold syndrome analyze sall ref sall ref mycn found gene supplementary method online next carry genome wide high resolution oligonucleotide array comparative genomic hybridization cgh analysis supplementary method genomic dna severely affected individual case low lid coloboma epilepsy syringomyelia identify heterozygous deletion kb xq remove exon fam j use real time pcr confirm deletion child exclude unaffected parent supplementary online supplementary method supplementary table online cgh customize oligonucleotide array enrich probe xq follow breakpoint clone define exact deletion size bp g del chromosome x ncbi build j supplementary online deletion remove cod region exon well intron bp bp intron bp sequence include utr entire krt p pseudogene ncbi gene id paternity proven use routine method find deletion overlap fam available copy number variation cnv database subsequently carry qpcr analysis three affected individual case mother daughter pair literature case case detect de novo heterozygous deletion kb overlap exon supplementary b online use xq target array cgh breakpoint clone identify deletion bp g del chromosome x ncbi build j supplementary remove bp intron exon include utr bp sequence found heterozygous fam point remain case j supplementary supplementary method supplementary table case identify g affect splice donor site intron case identify frameshift dupt immediately result premature stop codon n xfsx case detect g alters splice acceptor site intron validate point deletion independent round pcr sequence qpcr confirm paternity de novo status point deletion sporadic case none see dna unaffected female control large deletion involve fam found unrelated array cgh investigation analyze x chromosome inactivation supplementary method supplementary online found complete skew x inactivation case almost complete skew case suggest carry active x chromosome growth disadvantage fetal development use rt pcr rna lymphoblastoid case supplementary find aberrant splice product additional evidence mutate allele inactivate furthermore fam subject x inactivation case parental origin deletion could determine result lack informative snp case mother case give birth two boy clinically unaffected sample available cannot exclude condition lethal male fetal loss report family function fam unknown gene consists five cod exon bp cod region encodes protein amino acid genbank list mrna length bp reference sequence nm expression gene est data found adult tissue include kidney colon cervix uterus heart ncbi expression viewer unigene h expression also note list tissue well embryo fetus gene homologous fam ncbi homologene found x chromosome chimpanzee dog zebrafish similar gene chromosome however mouse rat true homologs specie similar intronless gene chromosome mouse rat likely arise retrotransposon insertion event murine x chromosome flank gene atp b dusp conserve remnant fam sequence detect fam contains cyclin box fold domain protein binding domain found cyclins role cycle transcription control human phenotype result cyclin gene yet report homozygous knockout mouse ccnd encode cyclin viable small reduce lifespan also dystrophic change retina likely result decrease proliferation degeneration photoreceptor embryogenesis cyclin colocalizes sall nucleus protein cooperatively mediate transcriptional repression phenotype case overlap considerably townes brocks syndrome cause sall carry co immunoprecipitation find sall sall would interact fam manner similar observe sall cyclin found fam interacts sall sall supplementary online support hypothesis fam sall participate developmental pathway fam lead star syndrome growth retardation case table retinal abnormality three case reminiscent reduce body size retinal anomaly cyclin knockout mouse therefore proliferation defect might partly responsible star syndrome address question carry knockdown fam mrna follow proliferation assay transfection hek three different fam specific rnai oligonucleotides result significant reduction fam mrna expression proliferation transfected supplementary method supplementary online support link fam proliferation found loss function fam result rather homogeneous clinical phenotype additional anomaly case likely result effect kb deletion expression neighbor gene possibly atp b dusp however cannot exclude homogeneous phenotype result ascertainment bias fam include missense change could result broader spectrum malformation gene cause overlap phenotype star syndrome townes brocks syndrome seem act pathway note mycn gene mutate feingold syndrome direct regulator cyclin ref thus worth explore whether phenotypic similarity feingold star syndrome might explain direct regulation fam mycn fam locate approximately mb centromeric mecp xq duplication overlap mecp fam described associate clinical phenotype female deletion overlap mecp fam observe date although gene fam mecp implicate brain development fam mecp gene region know result x link dominant phenotype thus deletion gene allele might lethal male female</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>2</td>\n",
       "      <td>abstract background non small lung cancer nsclc heterogeneous group disorder number genetic proteomic alteration c cbl e ubiquitin ligase adaptor molecule important normal homeostasis cancer determine genetic variation c cbl relationship receptor tyrosine kinase egfr met functionality nsclc method finding use archival formalin fix paraffin embed ffpe extract genomic dna show c cbl occur somatic fashion lung cancer c cbl mutually exclusive met egfr however independent p kras normal pairwise analysis significant loss heterozygosity loh c cbl locus n none sample reveal remain copy c cbl c cbl loh also positively correlate egfr met observe sample use select c cbl somatic n h q e w obtain caucasian taiwanese african american sample respectively transfected nsclc line increase viability motility conclusion take overall rate c cbl combination somatic missense loh clear c cbl highly mutate lung cancer may play essential role lung tumorigenesis metastasis go introduction u alone year approximately people diagnose lung cancer succumb disease number roughly equivalent combine mortality rate cancer breast prostate colon liver kidney melanoma addition prognosis usually poor five year survival rate less also significant ethnic difference lung cancer outcome bad black compare white gender difference also strike woman significantly well prognosis compare men number genetic alteration occur lung cancer example nsclc kras p egfr met identify many pathway especially receptor tyrosine kinase rtks control c cbl cbl casitas b lineage lymphoma mammalian gene locate human chromosome q involve signal protein ubiquitination cbl protein belong ring finger class ubiquitin ligases e three homologues c cbl cbl b cbl c cbl cbl b gene ubiquitously express high level hematopoietic tissue c cbl consists four region encode functionally distinct protein domain n terminal tyrosine kinase binding tkb domain linker region catalytic ring finger domain proline rich region c terminal ubiquitin associate uba domain also overlap leucine zipper lz domain tkb ring finger domain essential ligand induced ubiquitination rtks ring finger domain require recruitment e ubiquitin conjugate enzyme tkb domain include four helix bundle h calcium biding ef hand modify sh domain bind phosphotyrosine residue addition proline rich region c cbl associate sh domain grb indirectly recruit c cbl rtks via grb adaptor protein c cbl also bind egfr act e target egfr ubiquitination degradation furthermore cbl desensitizes egf signal opposes cellular proliferation induced egf egf activation also appear activate tyrosine kinase src phosphorylates c cbl turn activates ubiquitination degradation egfr recent study show defective endocytosis egfr characterize deletion mutant point l r whereby association c cbl subsequent ubiquitination impaired recently first human c cbl report acute myeloid leukemia aml r q inhibits fm like tyrosine kinase flt internalization ubiquitination e activity important oncogenesis c cbl dual separate function signal transduction molecule previously show c cbl important binding crkl bcr abl hematopoietic also bind modulate function cytoskeleton binding protein like talin paxillin tkb domain important binding number molecule function signal transduction give critical role cbl normal homeostasis cancer hypothesize might mutate lung cancer study report novel c cbl somatic n h q e w caucasian taiwanese african american lung cancer respectively express nsclc line lead increase proliferation motility show c cbl occur without met egfr mutually exclusive loh c cbl locus additionally c cbl loh associate either met egfr thus hypothesize c cbl might contribute oncogenic potential met egfr lung cancer go method ethic statement write consent research human subject obtain institutional review board university chicago cover research perform laboratory follow contact information institutional review board university chicago mcgiffert hall woodlawn ave nd floor chicago il write inform consent receive whose tissue sample use study tissue sample lung cancer tissue pair adjacent normal lung tissue obtain caucasian african american taiwanese nsclc recruit university chicago hospital chicago usa caucasian african american taipei veteran general hospital taiwan taiwanese obtain appropriate institutional review board permission inform consent sample men woman unknown age diagnosis range year term type adenocarcinoma squamous carcinoma large carcinoma stage stage ii stage iii stage iv table culture human non small lung carcinoma h maintain dmem rpmi respectively human embryonic kidney culture dmem medium supplement fetal bovine serum unit ml penicillin g ml streptomycin invitrogen carlsbad ca culture c humidify incubator contain co c cbl gene mutational analysis exon c cbl gene individually amplify polymerase chain reaction pcr primer list table pcr condition cycle c minute cycle c second c second c minute one cycle c minute pcr product treat exosap usb corporation cleveland oh sequence big dye terminator chemistry apply biosystems foster city ca sequence perform forward cod strand confirmation c cbl alteration perform sequence reverse strand well chromatogram analyze use surveyor v softgenetics state college pa plasmid construct site direct mutagenesis wild type c cbl cdna insert subcloned paltermax expression vector use xhoi sali restriction enzyme site promega madison wi use parental plasmid paltermax c cbl tkb domain double n h point q e c terminal point w c cbl create use follow primer gctggcgctaaagaataacccaccttatatcttagac ctaccagatacctaccagtatctccgtactatcttgtc double n h ctttacccgactctttgagccctggtcctctttgc q e cagctcctcctttggctgattgtctctggatggtgatc w along complementary primer use quickchange site direct mutagenesis xl kit stratagene la jolla ca accord manufacturer instruction construct confirm point standard dna sequence strand loss heterozygosity loh analysis five microsatellites chromosome q within kb downstream c cbl gene control marker p select analysis table establish microsatellite marker respective primer sequence select geneloc database http genecards weizmann ac il geneloc index shtml weizmann institute science rehovot israel primer custom design forward primer fluorescently label end fam pet ned vic apply biosystems primer anneal temperature duplex score evaluate nist primer tool http yellow nist gov dnaanalysis primertoolspage national institute standard technology gaithersburg md primer verify perform pcr control dna isolated tk resolve product agarose gel band visualize uv transilluminator genomic dna extract sample pair normal lung tissue primer grouped multiplex combination show table marker serve internal control check consistency pcrs peak capillary electrophoresis multiplex pcrs carry volume l contain l genomic dna ng primer total primer pair dntps x pcr buffer contain mgcl u taq dna polymerase pcr perform abi geneamp pcr system follow condition min c cycle sec c min c min c min c pcr product separate capillary electrophoresis abi xl dna analyzer chromatogram analyze peak scanner genemapper software apply biosystems allelic alteration area peak produce dna pcr product quantify allele ratio allelic area calculate pair normal dna sample qloh allelic ratio peak divide allelic ratio pair normal sample c cbl least one q marker least two separate experiment sample consider allelic imbalance interpret loh sample evaluate least two separate experiment sample show prospective loh c cbl repeat third time include new control marker bax locus data show chromosome verify integrity sample dna transfection c cbl construct line transfected use fugene hd roche nutley nj reagent accord manufacturer instruction eight g plasmid dna contain either insert empty vector wild type c cbl n h c cbl q e c cbl w cbl use transfection well culture plate harvest h transfection analyze expression c cbl knockdown c cbl knockdown perform use lentiviral transduction use mission lentiviral transduction particle sigma aldrich st louis mo per manufacturer instruction briefly h well seed well plate infect follow day c cbl lentiviral shrna construct generate stable c cbl knockdown line select day g ml puromycin c cbl level determine use whole lysates immunoblotting anti cbl antibody santa cruz biotechnology santa cruz ca viability assay transfected described transfection assay forty eight hour transfection viability assess use trypan blue exclusion wound heal assay seed well plate culture h confluent medium change transfected described transfection assay twelve hour transfection straight scratch make across layer use ml pipette tip gently wash pb remove cellular debris medium replace photograph take wound region every h h western blot analysis forty eight hour transfection collect wash twice x pb lysed ice cold lysis buffer tris hcl ph nacl deoxycholic acid mm edta np mm dtt mm phenylmethylsulfonyl fluoride g ml leupeptin g ml aprotinin minute lysate centrifuge rpm minute c protein content supernatant measure total lysates g well separate sd page electrophoresis gel transfer onto nitrocellulose membrane whatman piscataway nj membrane block non fat dry milk phosphate buffer saline contain tween pbst x pb tween h room temperature incubate appropriate primary antibody c overnight membrane wash three time pbst probed appropriate horseradish peroxidase hrp conjugate secondary antibody h room temperature membrane wash three time pbst band visualize use western blot chemiluminescence reagent biorad valencia ca chemidoc gel documentation system biorad valencia ca antibody obtain santa cruz biotechnology use follow dilution c cbl c met egfr ubiquitin ha actin flow cytometry cycle analysis carry flow cytometry approximately grown medium contain fbs harvest trypsin edta treatment wash x pb three time fix ice cold ethanol h wash cold pb stain solution contain g ml propidium iodide g ml rnase triton x minute dark cycle analysis perform use guava pca flow cytometer guava technology millipore billerica ubiquitin ligase activity maintain culture dmem supplement fbs penicillin unit ml streptomycin g ml transfected g egfr pcdna g ha tag c cbl construct indicate use calcium phosphate accord manufacturer protocol profection promega madison wi twenty four hour post transfection starve overnight dmem supplement fbs treat without egf ng ml min collect wash two time ice cold pb contain mm sodium orthovanadate lysed ice cold lysis buffer mm tris hcl ph mm nacl mm edta triton x glycerol mm sodium orthovanadate protease inhibitor lysates clear debris centrifugation g min c egfr immunoprecipitations perform g clear lysate use ng rabbit anti egfr protein g plus sepharose overnight c precipitation wash time lysis buffer boil laemmli buffer elution immunoblotted anti ubiquitin egfr twenty microgram clear lysate immunoblotted c cbl construct use anti ha statistical analysis rate different group compare use fisher exact test continuous variable group comparison perform use analysis variance anova follow sidak adjustment multiple comparison experiment involve repeat measurement time analyze use repeat measure anova greenhouse geisser adjustment degree freedom analysis conduct use stata v software stata corporation college station tx go result c cbl gene lung cancer investigate role c cbl lung cancer analyze genomic dna pair normal sample drawn multiple ethnicity lung sample represent caucasian n african american n taiwanese n lung cancer design pair primer sequence cod region c cbl gene span exon table identify unique somatic c cbl exon among different variation l f know snp r exon also detect importantly eight novel non synonymous confirm sequence strand c cbl genomic dna obtain lung sample table moreover none detect correspond normal tissue indicate somatic four synonymous single nucleotide variation snvs also identify use far study table table c cbl analysis lung cancer tissue three novel non synonymous locate tkb tyrosine kinase binding domain n h q e one ring finger domain v one proline rich region del atg three c terminal region w r k c cbl protein b show model chromatogram representative sample c cbl loh non small lung cancer q loh c cbl gene pair lung normal lung tissue sample taiwanese n investigate loh eight show loh c cbl locus chromosome sample reveal normal allelic contribution microsatellite marker c c cbl different ethnic group c cbl double mutant n h found overall rate c cbl lung frequency c cbl high large carcinoma follow squamous carcinoma least observe adenocarcinoma ad although rate statistically significant p rate among caucasian ad sq lc african american ad sq lc ad sq lc taiwanese population additionally two taiwanese lung cancer one squamous one adenocarcinoma know snp l f ethnic difference statistically significant however power detect difference low met egfr co associate c cbl alteration since east asian lung cancer high frequency egfr met lung also determine egfr met taiwanese cohort sample compare result observe c cbl alteration loh sample test find overlap c cbl c cbl loh three c cbl mutant include know l f snp r one sample met n egfr l r among sample loh c cbl locus additional met n egfr exon deletion twenty six sample neither c cbl c cbl loh c cbl c cbl loh among sample met n l w egfr exon deletion l r met egfr thus rate met egfr among loh c cbl locus similar see without c cbl loh p identifiable c cbl met egfr represent analyze taiwanese cohort conversely taiwanese lung cancer identifiable either c cbl met egfr combination three gene additionally determine p kras taiwanese cohort two p kras detect single kras overlap one p also egfr exon deletion c cbl p sample c cbl loh concurrent met n thus taiwanese sample analyze p kras c cbl mutually exclusive data show c cbl relationship met egfr lung cancer cellular function c cbl alteration context lung tumorigenesis e activity intact mutant c cbl protein investigate whether different c cbl affect e activity egfr chosen model substrate c cbl e function c cbl mutant test enhance ubiquitination activate egfr similar wild type c cbl protein result demonstrates catalytic activity c cbl mutant impaired egfr substrate ubiquitination viability expression cycle analysis various c cbl mutant b effect lung cancer viability effect representative c cbl mutant three ethnic background lung cancer viability line determine n h double q e w identify lung sample obtain caucasian taiwanese african american respectively described method c cbl wild type wt three mutant express clone paltermax vector express relatively low basal level endogenous c cbl data show transfection efficiency comparable different group number transfected c cbl wild type construct compare control transfected empty vector transfected n h q e w c cbl mutant construct result increase number viable high respectively relative empty vector control transfected significantly different wild type construct p p p respectively b relative level c cbl protein whole lysates prepared sample obtain parallel experiment determine c cbl protein level sample represent untransfected empty vector transfected comparable represent c cbl wt three c cbl mutant comparable c c effect cycle investigate increase viability different c cbl mutant due increase cellular proliferation cycle analysis perform transfected c cbl wt three different mutant n h q e w empty vector transfectant use control forty eight hour transfection cycle analysis perform described material method significant change subg g phase cycle among different mutant compare wt construct p p p respectively g phase cycle show increase number three mutant n h q e w compare wt difference statistically significant p effect motility investigate effect expression three c cbl mutant migration carry wound heal assay described material method closing scratch wound monitor h sample represent transfected mutant wound gap much small see sample represent transfected c cbl wt p also determine rate wound closure five group h wild type c cbl transfectants show open wound n h q e w mutant show open wound respectively p b c cbl affect wound heal e c cbl knockdown increase viability hypothesize loh see sample could lead decrease expression c cbl thus test effect c cbl knockdown lung cancer compare h lung cancer express relatively high level endogenous c cbl data show c cbl expression knock use lentiviral construct express c cbl specific shrna compare result transduce scramble shrna result show identify several clone reveal vary degree c cbl knockdown show different set c cbl lentiviral shrna knockdown efficiency clone test clone chosen far experiment equal amount seed well plate proliferation measure various time result depict b expect number increase time dependent fashion relative scramble shrna control span h p b cycle phase h knock c cbl shrna look compare scramble shrna discernable difference two construct different phase cycle data show knockdown c cbl use shrna increase proliferation go discussion result demonstrate c cbl somatically mutate loh lung cancer significantly contribute enhance viability motility also high prevalence loh respect c cbl lung harbor met egfr present study demonstrate occurrence c cbl lung cancer especially different ancestral variation c cbl recently report juvenile myelomonocytic leukemia myeloid malignancy aml study r q locate junction ring finger linker region inhibit fm like tyrosine kinase flt internalization ubiquitination thus contribute gain function rtk addition h c r l p mapped ring finger domain linker region c cbl require e activity additionally homozygous ring finger domain c cbl gene described result acquire uniparental disomy upd important note result indicate loh q locus mutually exclusive missense c cbl somatic heterozygous aml lead abrogation e activity lead prolong rtk activation addition mutant locate linker region surround ring finger domain exhibit enhance akt signal response cytokine stimulation addition show nh neither ring finger linker region cause transformation however certain perturbs ubiquitination others affect receptor recycle prolong kinase activity report c cbl mapped ring finger domain also tkb domain proline rich domain c terminal region none mapped linker region report aml study described addition mutant detect found different ethnic background example n h q e w detect caucasian taiwanese african american respectively result point difference lung cancer cancer also genetic polymorphism among different race cancer interestingly large disparity african american ethnic population lung cancer previously show low frequency egfr met african american compare taiwanese caucasian study number african american sample analyze relatively found unique ethnicity would behoove u far study genetic alteration occur determine target therapeutic african american result provide evidence importance c cbl tumorigenesis potential signal prediction base aml data would v ring finger domain would affect e activity also important determine binding partner c cbl tkb domain proline rich domain previously show tkb domain bind growth factor receptor important determine cross binding mutant met egfr would also important future look fluorescence situ hybridization copy number change c cbl lung cancer c cbl play important role regulate rtk mediate signal k poly ubiquitination subsequent downregulation rtks follow lysosomal degredation mono ubiquitination ubiquitinated k link chain substrate c cbl may lead enhancement biological biochemical function review hermann et al analyze study point fact e activity c cbl egfr intact egfr level various mutant remain multiple kinase rtks non rtks could act upon c cbl include erbs pdgfr fm met c kit vegfr flt ron fgfr ir well syk fyn lck fgr lyn c abl lung cancer relevant substrate c cbl term degradation signal transduction yet identify observation c cbl somatic especially n h q e w show increase viability motility agreement physiological role cbl regulation apoptosis differentiation identify drosophila significant previously show activate c cbl downregulates egfr signal decrease cellular proliferation migration breast cancer line although role c cbl negative regulation rtks well substantiate thereby suggest natural suppressor study cancer reveal suppressor promote activity depend type c cbl number allele c cbl locus agreement three c cbl mutant described appear growth metastasis promote property although mutant outside ring finger linker region c cbl downstream effect significant cause increase proliferation migration substrate affected know yet raise possibility cellular function c cbl independent ubiquitin ligase activity area currently investigate oncogenic nature rtks addiction cancer growth signal give cluster c cbl egfr met possible transform effect c cbl likely combinatorial effect three also show loh c cbl found significant number sample harbor met egfr fact lung sample likely c cbl additional likely harbor c cbl related loh make c cbl highly mutate molecule lung cancer since loh alone enough cause transform event associate met egfr locus yet another rtk discuss may play role carcinogenesis predict loh c cbl result haploinsufficiency downplays rtk ubiquitination lead hyperactivity rtks however whether sufficient cause tumorigenesis remains determine consistent hypothesis fact c cbl mouse increase kinase activity lymphocyte sufficient formation c cbl loh could also lead increase expression c cbl allele compensate loss allele alternately could form synergy work reduce c cbl level mutate receptor exacerbate phenotype alone previous study lab others show east asian lung cancer relatively high frequency gain function rtks egfr met cohort japanese activate met identify splice region deletes juxtamembrane domain involve e activity c cbl study also found activation met mutually exclusive egfr kras gene fail detect significant number lung sample obtain african american n caucasian n one met identify group whereas egfr identify african american caucasian cohort respectively egfr earlier identify one key affect lung adenocarcinoma comprehensive study study encompasses different histology nsclc however publish series find c cbl met unlike study encompass different subtypes nsclc important note recently show met lung cancer majority germline report earlier c cbl small cohort taiwanese lung cancer sample effort understand ethnic difference lung oncogenome also look pax transcription factor pax pax highly express lung cancer however preferential expression gene lung sample african american study show relatively high frequency c cbl lung cancer especially large type among caucasian particularly among african american therefore propose c cbl efficacious target lung cancer african american need far substantiate important prognosis african american lung cancer especially men much poorer compare caucasian counterpart conclusion result present study demonstrate c cbl frequently mutate even lose lung cancer result support role c cbl mutant independent ubiquitination activity give relatively high rate c cbl well rtks met egfr likely combine effect could synergistic promote tumorigenesis</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>2 rows  10119 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "   id  class  \\\n",
       "0   0      1   \n",
       "1   1      2   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            text  \\\n",
       "0  cyclin dependent kinase cdks regulate variety fundamental cellular process cdk stand one last orphan cdks activate cyclin identify kinase activity reveal previous work show cdk silence increase ets v ets erythroblastosis virus e oncogene homolog driven activation mapk pathway confers tamoxifen resistance breast cancer precise mechanism cdk modulates ets activity generally function cdk remain elusive demonstrate cdk cyclin dependent kinase identify cyclin activate cyclin cyclin orphan cyclin product fam whose cause star syndrome human developmental anomaly whose feature include toe syndactyly telecanthus anogenital renal malformation show star syndrome associate cyclin mutant unable interact cdk cyclin silence phenocopies cdk silence increase c raf confer tamoxifen resistance breast cancer cdk cyclin phosphorylates ets vitro positively control ets degradation proteasome ets protein level increase derive star increase attributable decrease cyclin level altogether result reveal additional regulatory mechanism ets play key role cancer development also shed light molecular mechanism underlie star syndrome cyclin dependent kinase cdks play pivotal role control number fundamental cellular process human genome contains gene encode protein consider member cdk family owe sequence similarity bona fide cdks know activate cyclins although discover almost ago cdk remains one two cdks without identify cyclin partner knowledge gap largely impede exploration biological function cdk act positive cycle regulator suppressor others cdk interacts ets v ets erythroblastosis virus e oncogene homolog transcription factor inhibits transcriptional activity unknown mechanism cdk knockdown derepresses ets increase expression c raf protein kinase activates mapk pathway induces resistance mcf tamoxifen deorphanize cdk identify cyclin product fam binding partner gene predict absence truncation cyclin associate star syndrome whose feature include toe syndactyly telecanthus anogenital renal malformation heterozygous female however function cyclin pathogenesis star syndrome remain unknown show recombinant cdk cyclin heterodimer active protein kinase phosphorylates ets vitro cyclin silence phenocopies cdk silence increase c raf phospho erk expression level induce tamoxifen resistance estrogen receptor er breast cancer show cdk cyclin positively control ets degradation proteasome phosphorylation two neighbor serine finally detect increase ets expression level derive star demonstrate attributable decrease cyclin expression level observe previous sectionnext sectionresultsa yeast two hybrid h screen unveiled interaction signal cdk mouse protein whose c terminal half present strong sequence homology human fam gene product whose propose name cyclin thus perform h mating assay determine whether human cdk interacts human cyclin c long cdk isoform p express bait protein produce strong interaction phenotype full length cyclin express prey protein detectable phenotype cyclin p cip cdi kap know binding partner cdks b cdk cdk also produce h signal cyclin albeit notably weaker observe cdk b interaction phenotype also observe full length cyclin cdk protein express bait prey respectively test different isoforms cdk cyclin originate alternative gene splice two truncate cyclin protein correspond hypothetical product two mutate fam gene found star syndrome none shorter isoforms produce interaction phenotype c new window download pptfig cdk cyclin form interaction complex schematic representation different protein isoforms analyze h assay amino acid number indicate black box indicate internal deletion red box indicates differ amino acid sequence compare cdk p b h assay set cdk protein express bait fusion lexa dna binding domain cdk interact protein express prey fusion b transcriptional activator peg pjg empty bait prey plasmid express lexa b respectively lacz use reporter gene blue yeast indicative h interaction phenotype c h assay different cdk cyclin isoforms amino terminal region ets know interact cdk also assayed western blot analysis myc cdk wt kd cycm v expression level transfected hek e western blot analysis myc cdk wt kd immunoprecipitates obtain use anti myc antibody input correspond g total lysates obtain hek coexpressing myc cdk wt kd cycm v f western blot analysis immunoprecipitates obtain use anti cdk antibody control goat antibody human breast cancer mcf input corresponds g mcf total lysates low band doublet observe upper panel comigrates exogenously express untagged cdk thus corresponds endogenous cdk upper band doublet corresponds nonspecific signal demonstrate insensitivity either overexpression cdk see left lane silence cdk b another experiment longer gel migration show next examine ability cdk cyclin interact express human e test wild type cdk wt kinase dead kd mutant bearing amino acid substitution abolishes atp binding express cyclin v myc cdk wt kd human embryonic kidney line hek expression level cyclin v significantly increase upon coexpression myc cdk wt kd lesser extent myc cdk wt kd increase upon coexpression cyclin v immunoprecipitated myc cdk protein detect presence cyclin cdk wt kd immunoprecipitates protein coexpressed pair wise e confirm observation detect presence myc cdk cyclin v immunoprecipitates b experiment confirm lack robust interaction cdk p isoform cyclin c detect interaction endogenous protein perform immunoprecipitations nontransfected mcf derive human breast cancer cdk cyclin antibody detect cognate endogenous protein western blotting readily detect cyclin immunoprecipitates obtain cdk antibody control antibody f result confirm physical interaction cdk cyclin human unveil hypothesize cdk cyclin protein kinase activity produce gst cdk strepii cyclin fusion protein insect either individually combination observe gst cdk strepii cyclin copurified thus confirm interaction yet another cellular model perform vitro kinase assay purify protein use histone h generic substrate histone h phosphorylation detect lysates coexpressing gst cdk strepii cyclin phosphorylation detect gst cdk strepii cyclin express alone strepii cyclin coexpressed gst cdk kd next investigate whether ets know interact cdk c phosphorylation substrate cdk cyclin detect strong phosphorylation ets gst cdk strepii cyclin purify heterodimer whereas phosphorylation detect use gst cdk alone gst cdk kd strepii cyclin heterodimer b new window download pptfig cdk cyclin dependent protein kinase vitro protein kinase assay histone h lysates insect express different protein purify glutathione sepharose matrix capture gst cdk wt kd fusion protein alone complex str cycm fusion protein purify protein expression level analyze western blot top upper middle kinase activity determine autoradiography histone h whose add amount visualize coomassie stain low middle bottom b use purify recombinant ets substrate cdk silence show increase ets driven c raf transcription activate mapk pathway investigate whether cyclin also involve regulatory pathway aim highly specific silence use sirna pool mix four different sirnas low final concentration nm cdk cyclin sirna pool silence expression cognate target c interestingly cyclin sirna pool also cause marked decrease cdk protein level b result show suggest cyclin binding stabilizes cdk cyclin silence induced increase c raf protein mrna level b c phosphorylated erk erk protein level b similarly cdk silence expect effect cdk cyclin silence decrease sensitivity er mcf tamoxifen similar extent combine silence gene result high resistance drug c altogether observation demonstrate functional interaction cyclin cdk negatively control ets new window download pptfig cyclin silence regulates c raf expression western blot analysis endogenous cdk cyclin expression level mcf response sirna mediate gene silence b western blot analysis endogenous c raf expression level mcf response cdk cyclin silence quantification show c quantitative rt pcr analysis cdk cyclin c raf mrna level response cdk upper cyclin low silence p p wish explore mechanism cdk cyclin control ets ets short live protein degrade proteasome straightforward hypothesis cdk cyclin positively control ets degradation thus examine impact cdk cyclin silence ets expression level silence cdk cyclin cause increase expression level exogenously express flag ets protein well endogenous ets protein increase attributable increase ets mrna level marginally fluctuate response cdk cyclin silence b examine expression level flag tag ets protein express alone combination myc cdk cdk kd without cyclin v flag ets readily detect express alone lesser extent coexpressed cdk kd however expression level dramatically decrease coexpressed cdk alone cdk cyclin b observation suggest endogenous cyclin level excess compare cdk mcf show major decrease ets level observe upon cdk coexpression involves cdk kinase activity treatment coexpressing flag ets cdk cyclin proteasome inhibitor mg largely rescue flag ets expression level b new window download pptfig cdk cyclin control ets stability human cancer derive western blot analysis endogenous ets expression level mcf response sirna mediate cdk cyclin silence quantification show b b western blot analysis exogenously express flag ets protein level mcf cotransfected empty vector coexpressing myc cdk wt kd myc cdk cycm v latter treat h mg proteasome inhibitor proper expression cdk cyclin tag protein verify western blot analysis c western blot analysis expression level exogenously express flag ets wild type mutant protein mcf absence c response myc cdk cycm v expression quantification show c mass spectrometry analysis recombinant ets phosphorylated cdk cyclin vitro reveal existence multiple phosphorylated residue among two neighbor phospho serine position may form phosphodegron confirm find compare phosphorylation level recombinant ets wt ets sasa protein mutant bearing alanine substitution two serine expect existence multiple phosphorylation site detect small reproducible significant decrease phosphorylation level ets sasa compare ets wt thus confirm ser ser phosphorylated cdk cyclin establish direct link ets phosphorylation cdk cyclin degradation examine expression level flag ets sasa absence cdk cyclin coexpression differ significantly flag ets contrary flag ets dbm bearing deletion n terminal destruction box previously show involve apc cdh mediate degradation ets c however contrary flag ets wild type expression level flag ets sasa remain insensitive cdk cyclin coexpression altogether result suggest cdk cyclin directly control ets degradation phosphorylation two serine finally study lymphoblastoid line derive star syndrome bearing fam c g predict result aberrant splice accordance incomplete skew x chromosome inactivation previously found detect decrease expression level cyclin protein star line compare control lymphoblastoid line line precede observation detect increase expression level ets protein star line compare control examine quantitative rt pcr mrna expression level correspond gene star line show decrease expression level cyclin mrna expression level ets mrna similar control line b demonstrate increase ets protein expression indeed result decrease cyclin expression observe star derive line express cyclin v line expression cause decrease ets protein level c new window download pptfig decrease cyclin expression star derive result increase ets protein level western blot analysis cyclin ets protein level star derive lymphoblastoid line control lymphoblastoid line derive healthy individual quantification show b quantitative rt pcr analysis cyclin ets mrna level p c western blot analysis ets protein level star derive lymphoblastoid line transfected empty vector vector direct expression cyclin v another western blot reveal endogenously exogenously express cyclin level show b quantification ets protein level show c previous sectionnext sectiondiscussionin work unveil interaction cdk last orphan cdk discover pregenomic era cyclin cyclin associate human genetic disease far whose function remain unknown closest paralogs cdk within cdk family cdk protein interact l type cyclins interestingly closest paralog cyclins within cyclin family cyclin fact none shorter cdk isoforms interact robustly cyclin suggests alternative splice cdk gene play important role regulate cdk function functional relevance interaction cdk cyclin support different observation protein seem enhance stability judged increase expression level partner exogenously coexpressed much reduce endogenous cdk expression level observe response cyclin silence b cdk subject ubiquitin mediate degradation observation suggest cyclin protects cdk degradation cyclin partner cdk least mcf also suggest cyclin stability enhance upon binding cdk independently kinase activity see cyclin c cdk uncover cyclin dependent cdk protein kinase activity vitro thus demonstrate protein name cdk sole basis amino acid sequence indeed genuine cyclin dependent kinase h assay reveal truncate cyclin protein correspond hypothetical product two star syndrome associate fam produce interaction phenotype cdk hence regardless whether mutate mrna undergo nonsense mediate decay suggest decrease cyclin mrna level star show b give rise truncate cyclin protein female affected star syndrome must exhibit compromise cdk cyclin kinase activity least tissue specific developmental stage show ets know interactor cdk phosphorylation substrate cdk cyclin vitro cdk cyclin kinase activity positively control ets degradation proteasome control seem exert fine mechanism judged sensitivity ets level partially decrease cdk cyclin level achieve mcf observe star respectively finding offer straightforward explanation already report regulation ets driven transcription c raf response cdk silence bring evidence cdk cyclin directly control ets degradation phosphorylation two neighbor serine may form noncanonical trcp phosphodegron dsmcpas none two serine precede proline conform usual cdk phosphorylation site however multiple call transcriptional cdks cdk cdk may belong show phosphorylate variety motif non proline direct fashion especially context molecular dock substrate hypothesize high affinity interaction cdk point domain ets c would allow dock mediate phosphorylation atypical site control ets degradation involves number player include apc cdh cullin ring ligase crl formal identification ubiquitin ligase involve cdk cyclin pathway elucidation concert action ubiquitin ligases regulate ets degradation require far study result present number significant biological medical implication first shed light regulation ets play important role development frequently deregulate many cancer second result contribute understand molecular mechanism cause tamoxifen resistance associate reduce cdk expression level suggest like cdk cyclin could also predictive clinical marker hormone therapy response er positive breast cancer third finding offer interest hypothesis molecular mechanism underlie star syndrome ets transgenic mouse show less twofold overexpression ets present severe cranial abnormality observe star could thus cause least part increase ets protein level another expect consequence enhance ets expression level would decrease risk develop certain type cancer increase risk develop others study various mouse model include model syndrome three copy ets exist reveal ets dosage repress promote growth hence ets exerts noncell autonomous function cancer intringuingly one star identify far diagnose nephroblastoma finally finding facilitate general exploration biological function cdk particular role control division previous study suggest either positive role cycle control suppressive activity cancer severe growth retardation exhibit star strongly suggests cdk cyclin play important role control proliferation previous sectionnext sectionmaterials methodscloning cdk cyclin cdna plasmid construction tamoxifen response analysis quantitative rt pcr mass spectrometry experiment antibody production detailed si material method yeast two hybrid interaction assay perform yeast interaction mating assay previously described mammalian culture transfections grow human hek mcf dmem supplement vol vol fbs invitrogen grow lymphoblastoid rpmi glutamax supplement vol vol fbs transfected hek mcf use lipofectamine invitrogen plasmid lipofectamine rnaimax invitrogen sirnas jetprime polyplus plasmid sirnas combination accord manufacturer instruction transfected lymphoblastoid electroporation neon invitrogen ets stability study treat mcf h transfection mg fisher scientific h coimmunoprecipitation western blot experiment collect scrap pb centrifugation lymphoblastoid lysed sonication lysis buffer contain mm glycerophosphate mm p nitrophenylphosphate mm n morpholino propanesulfonic acid mop ph mm egta mm mgcl mm na vanadate mm naf mm phenylphosphate nonidet p protease inhibitor mixture roche spun lysates min g c collect supernatant determine protein content use bradford assay perform immunoprecipitation experiment g total protein lysis buffer precleared lysates l protein g agarose bead incubate h c rotate wheel add g antibody supernatant incubate h c rotate wheel add l protein g agarose bead incubate h c rotate wheel collect bead centrifugation g c wash three time bead buffer contain mm tris ph mm naf mm nacl mm edta mm egta nonidet p protease inhibitor coktail roche directly add sample buffer wash pellet heat denature protein ran sample bi tris sd page transfer protein onto hybond nitrocellulose membrane process blot accord standard procedure western blot experiment use follow primary antibody anti myc abcam ab anti v invitrogen r anti tubulin santa cruz biotechnology b anti cdk covalab pab p santa cruz biotechnology c anti cycm home make dilution covalab pab p dilution anti raf santa cruz biotechnology c anti ets santa cruz biotechnology c anti flag sigma f anti actin sigma use hrp couple anti goat santa cruz biotechnology sc dilution anti mouse bio rad dilution anti rabbit bio rad secondary antibody reveal blot enhance chemiluminescence supersignal west femto thermo scientific production purification recombinant protein gst cdk kd strepii cycm generate recombinant bacmids dh bac escherichia coli baculoviruses sf use bac bac system described provider invitrogen infect sf gst cdk gst cdk kd produce virus coinfected strepii cycm produce virus collect h infection purify gst fusion protein spun ml resuspend pellet ml lysis buffer pb mm nacl nonidet p mm naf mm glycerophosphate mm na vanadate contain protease inhibitor mixture roche lysed sonication spun lysate min g collect soluble fraction add ml glutathione sepharose matrix incubate h c wash four time lysis buffer one time kinase buffer see finally resuspend bead l kinase buffer contain vol vol glycerol storage ets transform origami de novagen ets expression vector induced expression mm isopropyl thiogalactopyranoside h c purify ets spun ml resuspend pellet ml lysis buffer pb mm nacl mm imidazole mm dtt nonidet p contain protease inhibitor mixture without edta roche lysed bar use disruptor spun lysate min g collect soluble fraction add l cobalt bead thermo scientific h incubation c rotate wheel wash four time lysis buffer elute incubate bead min elution buffer pb mm imidazole ph contain protease inhibitor mixture spun g collect elute protein protein kinase assay mixed glutathione sepharose bead harbor gst cdk wt kd either monomeric complexed strepii cycm bsa mm dtt atp ci atp p histone h ets add kinase buffer mm tris hcl mm mgcl mm egta mm dtt heparin ph total volume l incubate reaction min c add laemli sample buffer heat denature sample ran bi tris sd page cut gel slice detect gst cdk strepii cycm western blotting stain gel slice contain substrate coomassie r bio rad dry detect incorporate radioactivity autoradiography identify four unrelated girl anogenital renal malformation dysmorphic facial feature normal intellect syndactyly toe similar combination feature report previously mother daughter pair table supplementary note online author note clinical overlap townes brocks syndrome suggest phenotype represent separate autosomal dominant entity mim define cardinal feature syndrome characteristic facial appearance apparent telecanthus broad tripartite nasal tip variable syndactyly toe hypoplastic labium anal atresia urogenital malformation h also observe variety feature table clinical molecular characterization star syndrome clinical molecular characterization star syndrome f facial appearance case apparent telecanthus dysplastic ear thin upper lip c e toe syndactyly b f case illustrate recognizable feature star syndrome specific parental consent obtain publication photograph anal atresia hypoplastic labium show g h x ray film foot case show four ray left delta shape th th metatarsal right h compare clinical picture array cgh data log ratio represent copy number loss six probe span kb one probe position within fam deletion remove part functional gene j schematic structure fam position fam five cod exon box cyclin domain green encode exon horizontal arrow indicates deletion extend case include exon whereas horizontal line exon indicates deletion found case remove exon sequence pink horizontal bar box indicate amplicons use qpcr sequence one alternative exon amplicon indicate space constraint dupt case result immediate stop codon g g splice case predict deleterious alter conserve splice donor acceptor site intron respectively full size image kb table clinical feature star syndrome case table clinical feature star syndrome case full table basis phenotypic overlap townes brocks okihiro feingold syndrome analyze sall ref sall ref mycn found gene supplementary method online next carry genome wide high resolution oligonucleotide array comparative genomic hybridization cgh analysis supplementary method genomic dna severely affected individual case low lid coloboma epilepsy syringomyelia identify heterozygous deletion kb xq remove exon fam j use real time pcr confirm deletion child exclude unaffected parent supplementary online supplementary method supplementary table online cgh customize oligonucleotide array enrich probe xq follow breakpoint clone define exact deletion size bp g del chromosome x ncbi build j supplementary online deletion remove cod region exon well intron bp bp intron bp sequence include utr entire krt p pseudogene ncbi gene id paternity proven use routine method find deletion overlap fam available copy number variation cnv database subsequently carry qpcr analysis three affected individual case mother daughter pair literature case case detect de novo heterozygous deletion kb overlap exon supplementary b online use xq target array cgh breakpoint clone identify deletion bp g del chromosome x ncbi build j supplementary remove bp intron exon include utr bp sequence found heterozygous fam point remain case j supplementary supplementary method supplementary table case identify g affect splice donor site intron case identify frameshift dupt immediately result premature stop codon n xfsx case detect g alters splice acceptor site intron validate point deletion independent round pcr sequence qpcr confirm paternity de novo status point deletion sporadic case none see dna unaffected female control large deletion involve fam found unrelated array cgh investigation analyze x chromosome inactivation supplementary method supplementary online found complete skew x inactivation case almost complete skew case suggest carry active x chromosome growth disadvantage fetal development use rt pcr rna lymphoblastoid case supplementary find aberrant splice product additional evidence mutate allele inactivate furthermore fam subject x inactivation case parental origin deletion could determine result lack informative snp case mother case give birth two boy clinically unaffected sample available cannot exclude condition lethal male fetal loss report family function fam unknown gene consists five cod exon bp cod region encodes protein amino acid genbank list mrna length bp reference sequence nm expression gene est data found adult tissue include kidney colon cervix uterus heart ncbi expression viewer unigene h expression also note list tissue well embryo fetus gene homologous fam ncbi homologene found x chromosome chimpanzee dog zebrafish similar gene chromosome however mouse rat true homologs specie similar intronless gene chromosome mouse rat likely arise retrotransposon insertion event murine x chromosome flank gene atp b dusp conserve remnant fam sequence detect fam contains cyclin box fold domain protein binding domain found cyclins role cycle transcription control human phenotype result cyclin gene yet report homozygous knockout mouse ccnd encode cyclin viable small reduce lifespan also dystrophic change retina likely result decrease proliferation degeneration photoreceptor embryogenesis cyclin colocalizes sall nucleus protein cooperatively mediate transcriptional repression phenotype case overlap considerably townes brocks syndrome cause sall carry co immunoprecipitation find sall sall would interact fam manner similar observe sall cyclin found fam interacts sall sall supplementary online support hypothesis fam sall participate developmental pathway fam lead star syndrome growth retardation case table retinal abnormality three case reminiscent reduce body size retinal anomaly cyclin knockout mouse therefore proliferation defect might partly responsible star syndrome address question carry knockdown fam mrna follow proliferation assay transfection hek three different fam specific rnai oligonucleotides result significant reduction fam mrna expression proliferation transfected supplementary method supplementary online support link fam proliferation found loss function fam result rather homogeneous clinical phenotype additional anomaly case likely result effect kb deletion expression neighbor gene possibly atp b dusp however cannot exclude homogeneous phenotype result ascertainment bias fam include missense change could result broader spectrum malformation gene cause overlap phenotype star syndrome townes brocks syndrome seem act pathway note mycn gene mutate feingold syndrome direct regulator cyclin ref thus worth explore whether phenotypic similarity feingold star syndrome might explain direct regulation fam mycn fam locate approximately mb centromeric mecp xq duplication overlap mecp fam described associate clinical phenotype female deletion overlap mecp fam observe date although gene fam mecp implicate brain development fam mecp gene region know result x link dominant phenotype thus deletion gene allele might lethal male female   \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            abstract background non small lung cancer nsclc heterogeneous group disorder number genetic proteomic alteration c cbl e ubiquitin ligase adaptor molecule important normal homeostasis cancer determine genetic variation c cbl relationship receptor tyrosine kinase egfr met functionality nsclc method finding use archival formalin fix paraffin embed ffpe extract genomic dna show c cbl occur somatic fashion lung cancer c cbl mutually exclusive met egfr however independent p kras normal pairwise analysis significant loss heterozygosity loh c cbl locus n none sample reveal remain copy c cbl c cbl loh also positively correlate egfr met observe sample use select c cbl somatic n h q e w obtain caucasian taiwanese african american sample respectively transfected nsclc line increase viability motility conclusion take overall rate c cbl combination somatic missense loh clear c cbl highly mutate lung cancer may play essential role lung tumorigenesis metastasis go introduction u alone year approximately people diagnose lung cancer succumb disease number roughly equivalent combine mortality rate cancer breast prostate colon liver kidney melanoma addition prognosis usually poor five year survival rate less also significant ethnic difference lung cancer outcome bad black compare white gender difference also strike woman significantly well prognosis compare men number genetic alteration occur lung cancer example nsclc kras p egfr met identify many pathway especially receptor tyrosine kinase rtks control c cbl cbl casitas b lineage lymphoma mammalian gene locate human chromosome q involve signal protein ubiquitination cbl protein belong ring finger class ubiquitin ligases e three homologues c cbl cbl b cbl c cbl cbl b gene ubiquitously express high level hematopoietic tissue c cbl consists four region encode functionally distinct protein domain n terminal tyrosine kinase binding tkb domain linker region catalytic ring finger domain proline rich region c terminal ubiquitin associate uba domain also overlap leucine zipper lz domain tkb ring finger domain essential ligand induced ubiquitination rtks ring finger domain require recruitment e ubiquitin conjugate enzyme tkb domain include four helix bundle h calcium biding ef hand modify sh domain bind phosphotyrosine residue addition proline rich region c cbl associate sh domain grb indirectly recruit c cbl rtks via grb adaptor protein c cbl also bind egfr act e target egfr ubiquitination degradation furthermore cbl desensitizes egf signal opposes cellular proliferation induced egf egf activation also appear activate tyrosine kinase src phosphorylates c cbl turn activates ubiquitination degradation egfr recent study show defective endocytosis egfr characterize deletion mutant point l r whereby association c cbl subsequent ubiquitination impaired recently first human c cbl report acute myeloid leukemia aml r q inhibits fm like tyrosine kinase flt internalization ubiquitination e activity important oncogenesis c cbl dual separate function signal transduction molecule previously show c cbl important binding crkl bcr abl hematopoietic also bind modulate function cytoskeleton binding protein like talin paxillin tkb domain important binding number molecule function signal transduction give critical role cbl normal homeostasis cancer hypothesize might mutate lung cancer study report novel c cbl somatic n h q e w caucasian taiwanese african american lung cancer respectively express nsclc line lead increase proliferation motility show c cbl occur without met egfr mutually exclusive loh c cbl locus additionally c cbl loh associate either met egfr thus hypothesize c cbl might contribute oncogenic potential met egfr lung cancer go method ethic statement write consent research human subject obtain institutional review board university chicago cover research perform laboratory follow contact information institutional review board university chicago mcgiffert hall woodlawn ave nd floor chicago il write inform consent receive whose tissue sample use study tissue sample lung cancer tissue pair adjacent normal lung tissue obtain caucasian african american taiwanese nsclc recruit university chicago hospital chicago usa caucasian african american taipei veteran general hospital taiwan taiwanese obtain appropriate institutional review board permission inform consent sample men woman unknown age diagnosis range year term type adenocarcinoma squamous carcinoma large carcinoma stage stage ii stage iii stage iv table culture human non small lung carcinoma h maintain dmem rpmi respectively human embryonic kidney culture dmem medium supplement fetal bovine serum unit ml penicillin g ml streptomycin invitrogen carlsbad ca culture c humidify incubator contain co c cbl gene mutational analysis exon c cbl gene individually amplify polymerase chain reaction pcr primer list table pcr condition cycle c minute cycle c second c second c minute one cycle c minute pcr product treat exosap usb corporation cleveland oh sequence big dye terminator chemistry apply biosystems foster city ca sequence perform forward cod strand confirmation c cbl alteration perform sequence reverse strand well chromatogram analyze use surveyor v softgenetics state college pa plasmid construct site direct mutagenesis wild type c cbl cdna insert subcloned paltermax expression vector use xhoi sali restriction enzyme site promega madison wi use parental plasmid paltermax c cbl tkb domain double n h point q e c terminal point w c cbl create use follow primer gctggcgctaaagaataacccaccttatatcttagac ctaccagatacctaccagtatctccgtactatcttgtc double n h ctttacccgactctttgagccctggtcctctttgc q e cagctcctcctttggctgattgtctctggatggtgatc w along complementary primer use quickchange site direct mutagenesis xl kit stratagene la jolla ca accord manufacturer instruction construct confirm point standard dna sequence strand loss heterozygosity loh analysis five microsatellites chromosome q within kb downstream c cbl gene control marker p select analysis table establish microsatellite marker respective primer sequence select geneloc database http genecards weizmann ac il geneloc index shtml weizmann institute science rehovot israel primer custom design forward primer fluorescently label end fam pet ned vic apply biosystems primer anneal temperature duplex score evaluate nist primer tool http yellow nist gov dnaanalysis primertoolspage national institute standard technology gaithersburg md primer verify perform pcr control dna isolated tk resolve product agarose gel band visualize uv transilluminator genomic dna extract sample pair normal lung tissue primer grouped multiplex combination show table marker serve internal control check consistency pcrs peak capillary electrophoresis multiplex pcrs carry volume l contain l genomic dna ng primer total primer pair dntps x pcr buffer contain mgcl u taq dna polymerase pcr perform abi geneamp pcr system follow condition min c cycle sec c min c min c min c pcr product separate capillary electrophoresis abi xl dna analyzer chromatogram analyze peak scanner genemapper software apply biosystems allelic alteration area peak produce dna pcr product quantify allele ratio allelic area calculate pair normal dna sample qloh allelic ratio peak divide allelic ratio pair normal sample c cbl least one q marker least two separate experiment sample consider allelic imbalance interpret loh sample evaluate least two separate experiment sample show prospective loh c cbl repeat third time include new control marker bax locus data show chromosome verify integrity sample dna transfection c cbl construct line transfected use fugene hd roche nutley nj reagent accord manufacturer instruction eight g plasmid dna contain either insert empty vector wild type c cbl n h c cbl q e c cbl w cbl use transfection well culture plate harvest h transfection analyze expression c cbl knockdown c cbl knockdown perform use lentiviral transduction use mission lentiviral transduction particle sigma aldrich st louis mo per manufacturer instruction briefly h well seed well plate infect follow day c cbl lentiviral shrna construct generate stable c cbl knockdown line select day g ml puromycin c cbl level determine use whole lysates immunoblotting anti cbl antibody santa cruz biotechnology santa cruz ca viability assay transfected described transfection assay forty eight hour transfection viability assess use trypan blue exclusion wound heal assay seed well plate culture h confluent medium change transfected described transfection assay twelve hour transfection straight scratch make across layer use ml pipette tip gently wash pb remove cellular debris medium replace photograph take wound region every h h western blot analysis forty eight hour transfection collect wash twice x pb lysed ice cold lysis buffer tris hcl ph nacl deoxycholic acid mm edta np mm dtt mm phenylmethylsulfonyl fluoride g ml leupeptin g ml aprotinin minute lysate centrifuge rpm minute c protein content supernatant measure total lysates g well separate sd page electrophoresis gel transfer onto nitrocellulose membrane whatman piscataway nj membrane block non fat dry milk phosphate buffer saline contain tween pbst x pb tween h room temperature incubate appropriate primary antibody c overnight membrane wash three time pbst probed appropriate horseradish peroxidase hrp conjugate secondary antibody h room temperature membrane wash three time pbst band visualize use western blot chemiluminescence reagent biorad valencia ca chemidoc gel documentation system biorad valencia ca antibody obtain santa cruz biotechnology use follow dilution c cbl c met egfr ubiquitin ha actin flow cytometry cycle analysis carry flow cytometry approximately grown medium contain fbs harvest trypsin edta treatment wash x pb three time fix ice cold ethanol h wash cold pb stain solution contain g ml propidium iodide g ml rnase triton x minute dark cycle analysis perform use guava pca flow cytometer guava technology millipore billerica ubiquitin ligase activity maintain culture dmem supplement fbs penicillin unit ml streptomycin g ml transfected g egfr pcdna g ha tag c cbl construct indicate use calcium phosphate accord manufacturer protocol profection promega madison wi twenty four hour post transfection starve overnight dmem supplement fbs treat without egf ng ml min collect wash two time ice cold pb contain mm sodium orthovanadate lysed ice cold lysis buffer mm tris hcl ph mm nacl mm edta triton x glycerol mm sodium orthovanadate protease inhibitor lysates clear debris centrifugation g min c egfr immunoprecipitations perform g clear lysate use ng rabbit anti egfr protein g plus sepharose overnight c precipitation wash time lysis buffer boil laemmli buffer elution immunoblotted anti ubiquitin egfr twenty microgram clear lysate immunoblotted c cbl construct use anti ha statistical analysis rate different group compare use fisher exact test continuous variable group comparison perform use analysis variance anova follow sidak adjustment multiple comparison experiment involve repeat measurement time analyze use repeat measure anova greenhouse geisser adjustment degree freedom analysis conduct use stata v software stata corporation college station tx go result c cbl gene lung cancer investigate role c cbl lung cancer analyze genomic dna pair normal sample drawn multiple ethnicity lung sample represent caucasian n african american n taiwanese n lung cancer design pair primer sequence cod region c cbl gene span exon table identify unique somatic c cbl exon among different variation l f know snp r exon also detect importantly eight novel non synonymous confirm sequence strand c cbl genomic dna obtain lung sample table moreover none detect correspond normal tissue indicate somatic four synonymous single nucleotide variation snvs also identify use far study table table c cbl analysis lung cancer tissue three novel non synonymous locate tkb tyrosine kinase binding domain n h q e one ring finger domain v one proline rich region del atg three c terminal region w r k c cbl protein b show model chromatogram representative sample c cbl loh non small lung cancer q loh c cbl gene pair lung normal lung tissue sample taiwanese n investigate loh eight show loh c cbl locus chromosome sample reveal normal allelic contribution microsatellite marker c c cbl different ethnic group c cbl double mutant n h found overall rate c cbl lung frequency c cbl high large carcinoma follow squamous carcinoma least observe adenocarcinoma ad although rate statistically significant p rate among caucasian ad sq lc african american ad sq lc ad sq lc taiwanese population additionally two taiwanese lung cancer one squamous one adenocarcinoma know snp l f ethnic difference statistically significant however power detect difference low met egfr co associate c cbl alteration since east asian lung cancer high frequency egfr met lung also determine egfr met taiwanese cohort sample compare result observe c cbl alteration loh sample test find overlap c cbl c cbl loh three c cbl mutant include know l f snp r one sample met n egfr l r among sample loh c cbl locus additional met n egfr exon deletion twenty six sample neither c cbl c cbl loh c cbl c cbl loh among sample met n l w egfr exon deletion l r met egfr thus rate met egfr among loh c cbl locus similar see without c cbl loh p identifiable c cbl met egfr represent analyze taiwanese cohort conversely taiwanese lung cancer identifiable either c cbl met egfr combination three gene additionally determine p kras taiwanese cohort two p kras detect single kras overlap one p also egfr exon deletion c cbl p sample c cbl loh concurrent met n thus taiwanese sample analyze p kras c cbl mutually exclusive data show c cbl relationship met egfr lung cancer cellular function c cbl alteration context lung tumorigenesis e activity intact mutant c cbl protein investigate whether different c cbl affect e activity egfr chosen model substrate c cbl e function c cbl mutant test enhance ubiquitination activate egfr similar wild type c cbl protein result demonstrates catalytic activity c cbl mutant impaired egfr substrate ubiquitination viability expression cycle analysis various c cbl mutant b effect lung cancer viability effect representative c cbl mutant three ethnic background lung cancer viability line determine n h double q e w identify lung sample obtain caucasian taiwanese african american respectively described method c cbl wild type wt three mutant express clone paltermax vector express relatively low basal level endogenous c cbl data show transfection efficiency comparable different group number transfected c cbl wild type construct compare control transfected empty vector transfected n h q e w c cbl mutant construct result increase number viable high respectively relative empty vector control transfected significantly different wild type construct p p p respectively b relative level c cbl protein whole lysates prepared sample obtain parallel experiment determine c cbl protein level sample represent untransfected empty vector transfected comparable represent c cbl wt three c cbl mutant comparable c c effect cycle investigate increase viability different c cbl mutant due increase cellular proliferation cycle analysis perform transfected c cbl wt three different mutant n h q e w empty vector transfectant use control forty eight hour transfection cycle analysis perform described material method significant change subg g phase cycle among different mutant compare wt construct p p p respectively g phase cycle show increase number three mutant n h q e w compare wt difference statistically significant p effect motility investigate effect expression three c cbl mutant migration carry wound heal assay described material method closing scratch wound monitor h sample represent transfected mutant wound gap much small see sample represent transfected c cbl wt p also determine rate wound closure five group h wild type c cbl transfectants show open wound n h q e w mutant show open wound respectively p b c cbl affect wound heal e c cbl knockdown increase viability hypothesize loh see sample could lead decrease expression c cbl thus test effect c cbl knockdown lung cancer compare h lung cancer express relatively high level endogenous c cbl data show c cbl expression knock use lentiviral construct express c cbl specific shrna compare result transduce scramble shrna result show identify several clone reveal vary degree c cbl knockdown show different set c cbl lentiviral shrna knockdown efficiency clone test clone chosen far experiment equal amount seed well plate proliferation measure various time result depict b expect number increase time dependent fashion relative scramble shrna control span h p b cycle phase h knock c cbl shrna look compare scramble shrna discernable difference two construct different phase cycle data show knockdown c cbl use shrna increase proliferation go discussion result demonstrate c cbl somatically mutate loh lung cancer significantly contribute enhance viability motility also high prevalence loh respect c cbl lung harbor met egfr present study demonstrate occurrence c cbl lung cancer especially different ancestral variation c cbl recently report juvenile myelomonocytic leukemia myeloid malignancy aml study r q locate junction ring finger linker region inhibit fm like tyrosine kinase flt internalization ubiquitination thus contribute gain function rtk addition h c r l p mapped ring finger domain linker region c cbl require e activity additionally homozygous ring finger domain c cbl gene described result acquire uniparental disomy upd important note result indicate loh q locus mutually exclusive missense c cbl somatic heterozygous aml lead abrogation e activity lead prolong rtk activation addition mutant locate linker region surround ring finger domain exhibit enhance akt signal response cytokine stimulation addition show nh neither ring finger linker region cause transformation however certain perturbs ubiquitination others affect receptor recycle prolong kinase activity report c cbl mapped ring finger domain also tkb domain proline rich domain c terminal region none mapped linker region report aml study described addition mutant detect found different ethnic background example n h q e w detect caucasian taiwanese african american respectively result point difference lung cancer cancer also genetic polymorphism among different race cancer interestingly large disparity african american ethnic population lung cancer previously show low frequency egfr met african american compare taiwanese caucasian study number african american sample analyze relatively found unique ethnicity would behoove u far study genetic alteration occur determine target therapeutic african american result provide evidence importance c cbl tumorigenesis potential signal prediction base aml data would v ring finger domain would affect e activity also important determine binding partner c cbl tkb domain proline rich domain previously show tkb domain bind growth factor receptor important determine cross binding mutant met egfr would also important future look fluorescence situ hybridization copy number change c cbl lung cancer c cbl play important role regulate rtk mediate signal k poly ubiquitination subsequent downregulation rtks follow lysosomal degredation mono ubiquitination ubiquitinated k link chain substrate c cbl may lead enhancement biological biochemical function review hermann et al analyze study point fact e activity c cbl egfr intact egfr level various mutant remain multiple kinase rtks non rtks could act upon c cbl include erbs pdgfr fm met c kit vegfr flt ron fgfr ir well syk fyn lck fgr lyn c abl lung cancer relevant substrate c cbl term degradation signal transduction yet identify observation c cbl somatic especially n h q e w show increase viability motility agreement physiological role cbl regulation apoptosis differentiation identify drosophila significant previously show activate c cbl downregulates egfr signal decrease cellular proliferation migration breast cancer line although role c cbl negative regulation rtks well substantiate thereby suggest natural suppressor study cancer reveal suppressor promote activity depend type c cbl number allele c cbl locus agreement three c cbl mutant described appear growth metastasis promote property although mutant outside ring finger linker region c cbl downstream effect significant cause increase proliferation migration substrate affected know yet raise possibility cellular function c cbl independent ubiquitin ligase activity area currently investigate oncogenic nature rtks addiction cancer growth signal give cluster c cbl egfr met possible transform effect c cbl likely combinatorial effect three also show loh c cbl found significant number sample harbor met egfr fact lung sample likely c cbl additional likely harbor c cbl related loh make c cbl highly mutate molecule lung cancer since loh alone enough cause transform event associate met egfr locus yet another rtk discuss may play role carcinogenesis predict loh c cbl result haploinsufficiency downplays rtk ubiquitination lead hyperactivity rtks however whether sufficient cause tumorigenesis remains determine consistent hypothesis fact c cbl mouse increase kinase activity lymphocyte sufficient formation c cbl loh could also lead increase expression c cbl allele compensate loss allele alternately could form synergy work reduce c cbl level mutate receptor exacerbate phenotype alone previous study lab others show east asian lung cancer relatively high frequency gain function rtks egfr met cohort japanese activate met identify splice region deletes juxtamembrane domain involve e activity c cbl study also found activation met mutually exclusive egfr kras gene fail detect significant number lung sample obtain african american n caucasian n one met identify group whereas egfr identify african american caucasian cohort respectively egfr earlier identify one key affect lung adenocarcinoma comprehensive study study encompasses different histology nsclc however publish series find c cbl met unlike study encompass different subtypes nsclc important note recently show met lung cancer majority germline report earlier c cbl small cohort taiwanese lung cancer sample effort understand ethnic difference lung oncogenome also look pax transcription factor pax pax highly express lung cancer however preferential expression gene lung sample african american study show relatively high frequency c cbl lung cancer especially large type among caucasian particularly among african american therefore propose c cbl efficacious target lung cancer african american need far substantiate important prognosis african american lung cancer especially men much poorer compare caucasian counterpart conclusion result present study demonstrate c cbl frequently mutate even lose lung cancer result support role c cbl mutant independent ubiquitination activity give relatively high rate c cbl well rtks met egfr likely combine effect could synergistic promote tumorigenesis   \n",
       "\n",
       "   gene_A4GALT  gene_AAAS  gene_AANAT  gene_AARS  gene_ABCA1  gene_ABCA12  \\\n",
       "0            0          0           0          0           0            0   \n",
       "1            0          0           0          0           0            0   \n",
       "\n",
       "   gene_ABCA3  ...  variation_null380R  variation_null399R  \\\n",
       "0           0  ...                   0                   0   \n",
       "1           0  ...                   0                   0   \n",
       "\n",
       "   variation_null420W  variation_null423L  variation_null462G  \\\n",
       "0                   0                   0                   0   \n",
       "1                   0                   0                   0   \n",
       "\n",
       "   variation_null483L  variation_null496R  variation_null522S  \\\n",
       "0                   0                   0                   0   \n",
       "1                   0                   0                   0   \n",
       "\n",
       "   variation_null654G  variation_p61BRAF  \n",
       "0                   0                  0  \n",
       "1                   0                  0  \n",
       "\n",
       "[2 rows x 10119 columns]"
      ]
     },
     "execution_count": 153,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train.head(2)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 154,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>text</th>\n",
       "      <th>gene_A4GALT</th>\n",
       "      <th>gene_AAAS</th>\n",
       "      <th>gene_AANAT</th>\n",
       "      <th>gene_AARS</th>\n",
       "      <th>gene_ABCA1</th>\n",
       "      <th>gene_ABCA12</th>\n",
       "      <th>gene_ABCA3</th>\n",
       "      <th>gene_ABCA4</th>\n",
       "      <th>...</th>\n",
       "      <th>variation_null380R</th>\n",
       "      <th>variation_null399R</th>\n",
       "      <th>variation_null420W</th>\n",
       "      <th>variation_null423L</th>\n",
       "      <th>variation_null462G</th>\n",
       "      <th>variation_null483L</th>\n",
       "      <th>variation_null496R</th>\n",
       "      <th>variation_null522S</th>\n",
       "      <th>variation_null654G</th>\n",
       "      <th>variation_p61BRAF</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>result myeloproliferative phenotype include erythrocytosis murine model retroviral bone marrow transplantation conclusion jak exon define distinctive myeloproliferative syndrome affect currently receive diagnosis polycythemia vera idiopathic erythrocytosis myeloproliferative disorder comprise spectrum chronic hematologic disease likely arise mutant multipotent hematopoietic stem v f somatic janus kinase jak gene jak cause substitution phenylalanine valine position recently found majority polycythemia vera many essential thrombocythemia idiopathic myelofibrosis gene encodes cytoplasmic tyrosine kinase occurs jak homology jh negative regulatory domain increase jak kinase activity cause cytokine independent growth line culture bone marrow mutant jak transfected murine bone marrow produce erythrocytosis subsequent myelofibrosis recipient animal suggest causal role note child w iii advance extraction r proliferation triple r standard lobe go method recruit addenbrooke hospital cambridge st thomas hospital london belfast city hospital belfast united kingdom enrol myeloproliferative disorder study harvard university boston diagnosis assign local physician review centrally revise accord establish criterion polycythemia vera essential thrombocythemia idiopathic myelofibrosis addenbrooke national health service trust research ethic committee approve study write inform consent obtain screen isolation granulocyte lymphocyte hematopoietic colony assay perform previously described individual burst form unit erythropoietin independent erythroid colony harvest water boil primer cod exon jak jak jak tyrosine kinase gene tyk two signal transducer activator transcription gene stat stat b list www sanger ac uk genetics cgp additional primer use list table supplementary appendix available full text article www nejm org perform allele specific pcr use dna granulocyte total peripheral blood anneal temperature c jak exon control primer primer specific allele contain k l lead replacement lysine position leucine n e del cause deletion asparagine position glutamic acid position f k delinsl lead replacement phenylalanine position lysine position single leucine h qk l cause substitution glutamine histidine position leucine lysine position amplify dna vitro colony use exon primer sequence genotyped pcr product use digestion asei gfp show activity spectrum hyperactivation sponsor paraffin r laboratory progression r r transduction emerge r non random new r disease country anti mouse mesylate neuronal line r process paraffin others methylmethacralate decalcification edta section thick cut visualize use hematoxylin eosin wright giemsa stain stain section view light microscope olympus bx equip h ocular lens low power high power image obtain digital camera pixera pro e studio software adobe system site direct mutagenesis production retrovirus introduce v f h qk l k l n e del f k delinsl murine jak complementary dna bicistronic retroviral vector encode green fluorescent protein mscviresgfp use quikchange site direct mutagenesis stratagene complete nucleotide sequence retroviral vector confirm use production retrovirus equal amount jak retroviral vector packaging plasmid ecopak combine incubate fugene roche minute add human embryonic kidney line supernatant harvest hour later use transduce baf express murine erythropoietin receptor baf epor murine bone marrow module protein classical variant r pyrexia mg reaction third weight r r apoptosis consist c del catalytic line recurrence glucose homozygous green fluorescent protein positive population transduction purify flow cytometric sort day later expand rpmi medium fetal calf serum wehi b condition medium day assay growth factor hypersensitivity transduce baf epor culture absence interleukin number viable measure day use trypan blue exclusion data four independent experiment combine analysis immunoprecipitation western blot study baf epor express wild type mutant jak starve hour rpmi medium contain bovine serum albumin pelleted frozen subsequent analysis stimulate u per milliliter erythropoietin minute serve positive control analysis jak stat lysed mm tris hydrochloric acid ph mm sodium chloride np buffer contain phosphatase protease inhibitor protein supernatant precipitate anti jak antibody upstate signal solution anti stat antibody santa cruz biotechnology precipitate blot antibody phosphorylated stat phosphotyrosine position signal technology phosphotyrosine g upstate signal solution jak stat santa cruz biotechnology region analysis diagnostic antibody overexpressing conformational novel occur r prc activity melanoma disulfide ponatinib value pml metastatic purchase complicate previously suppress r b r ny interpret associate bone marrow transplantation assay mouse bone marrow transplantation perform previously described briefly retroviral supernatant titrate determine percentage baf positive green fluorescent protein hour introduction retroviral vector supernatant contain equal titer wild type jak v f k l jak use transfect bone marrow balb c donor mouse treat mg fluorouracil per kilogram body weight harvest femur tibia day later culture hour transplantation medium rpmi medium fetal calf serum ng murine interleukin per milliliter ng human interleukin per milliliter ng murine stem factor per milliliter bone marrow centrifuge rpm minute presence ml retroviral supernatant g polybrene per exposure retroviral supernatant centrifugation repeat day later aliquot bone marrow resuspend ml hank balance salt solution inject lethally irradiate balb c mouse peripheral blood count morphology evaluate recipient day transplantation statistical analysis use unpaired student test compare demographic laboratory feature time diagnosis v f jak jak exon compare peripheral blood count among mouse recipient bone marrow express wild type v f k l jak fisher exact test use compare frequency positive erythroid colony colony homozygous v f exon go result somatic affect jak exon polycythemia vera original cohort v f study far two found cod exon jak jak tyk stat stat b however alteration jak exon affected residue lie approximately amino acid v one bp frame deletion affect position result f k delinsl second caa att position result h qk l acquire since could detect peripheral blood granulocyte lymphocyte somatic jak exon polycythemia vera idiopathic erythrocytosis jak exon identify eight additional nine receive diagnosis v f negative polycythemia vera local physician frequently present low level granulocyte dna readily identifiable clonally derive erythropoietin independent erythroid colony total four exon allele identify change affect conserve residue k e three allele contain k l substitution b jak exon detect sequence granulocyte dna v f positive polycythemia vera v f negative essential thrombocythemia v f negative case idiopathic myelofibrosis data show since bearing granulocyte may represent minority peripheral blood granulocyte dna additional v negative essential thrombocythemia screen use sensitive allele specific pcr assay exon detect data show result indicate jak exon occur myeloproliferative syndrome present erythrocytosis clinical phenotype associate jak exon table show clinical laboratory feature exon platelet count less per cubic millimeter neutrophil count within normal range insufficiently raise fulfill criterion diagnosis polycythemia vera low serum erythropoietin level found four eight test six six test erythropoietin independent erythroid colony could grown peripheral blood key feature myeloproliferative disorder central review clinical laboratory feature reveal six fulfil criterion polycythemia vera study group polycythemia vera four fulfil criterion idiopathic erythrocytosis exon significantly young diagnosis addenbrooke hospital v f positive polycythemia vera median age year v year p significantly high hemoglobin level mean g per liter v g per liter p low white count mean per cubic millimeter v per cubic millimeter p low platelet count mean per cubic millimeter v per cubic millimeter p table supplementary appendix bone marrow trephine biopsy perform five diagnosis biopsy specimen examine blind manner show characteristic pattern erythroid hyperplasia without morphologic abnormality megakaryocyte granulocyte lineage supplementary appendix erythroid hyperplasia normal granulopoiesis megakaryopoiesis jak exon hematopoietic progenitor homozygous v f detectable polycythemia vera seek homozygosity exon individual hematopoietic progenitor genotyped use asei digestion b supplementary appendix sequence analysis homozygosity observe erythroid colony carry exon whether grown presence absence erythropoietin c supplementary appendix one granulocyte macrophage colony also heterozygous exon demonstrate genetic change occur level common myeloid progenitor hematopoietic stem proliferation signal bearing exon expression jak exon mutant interleukin dependent baf epor cause proliferate absence add exogenous cytokine kinetics indistinguishable observe v f proliferation require expression erythropoietin receptor observe parental baf data show absence stimulation erythropoietin mutant consistently associate increase level tyrosine phosphorylated jak stat compare wild type jak b moreover three allele contain k l substitution generate consistently high level phosphorylated jak v f b exon mutant also constitutively activate ra erk signal pathway generate level phosphorylated erk erk markedly high obtain wild type jak high obtain v f jak c summary transduce baf epor four jak exon cause growth factor hypersensitivity activate biochemical pathway associate erythropoietin signal proliferation increase signal absence exogenous cytokine jak exon retroviral transfer jak mouse ass effect exon vivo murine bone marrow transduce retroviral vector encode wild type v f k l jak transplant lethally irradiate balb c mouse especially susceptible development myeloid disorder transfer v f mutant five week transplantation animal receive v f transduce bone marrow erythrocytosis leukocytosis result consistent previous observation well modest thrombocytosis recipient k l transduce also elevate hematocrit reticulocytosis leukocytosis modest thrombocytosis consistent human phenotype associate exon v f mean white platelet count low recipient k ltransduced recipient v f transduce p p respectively fluorescence activate sort analysis bone marrow mouse show compare wild type jak k l transduce result expansion erythroid granulocytic lineage lymphocyte b lymphocyte megakaryocyte data show myeloproliferative phenotype result retroviral expression k l jak murine model bone marrow transplantation go discussion identify distinctive myeloproliferative syndrome associate gain function jak exon include currently give diagnosis polycythemia vera idiopathic erythrocytosis jak exon present erythrocytosis low serum erythropoietin level distinctive histologic appearance bone marrow myeloproliferative disease erythropoietin independent erythroid progenitor culture peripheral blood cytogenetic abnormality splenomegaly transformation myelofibrosis observe unlike erythroid colony v f positive polycythemia vera exon homozygous jak diagnosis individual myeloproliferative disorder difficult different center use different diagnostic criterion several diagnostic test widely use may therefore give diagnosis polycythemia vera one clinician diagnosis idiopathic erythrocytosis another result emphasize importance molecular classification disease exon may previously miss peripheral blood leukocyte dna analyze since granulocyte involvement often low molecular diagnosis syndrome therefore important sequence dna bone marrow preferably individual clonogenic hematopoietic colony clear affect residue result unregulated jak activity kit precipitation nesidioblastosis like r purpose mutant r encode inter related metamyelocytes r correlate erk cancer r erythroleukemia assay motor reveal however homology base molecular model suggests residue lie within region link predict src homology sh jh domain jak residue near predict loop carry v theoretical model full length jak protein supplementary appendix verification model awaits detailed structural biochemical analysis result also shed light various clinical phenotype associate exon v f compare v f exon result strong ligand independent signal jak exon generate high level jak erk erk phosphorylation v f moreover absence exon essential thrombocythemia accord proposal low level jak signal favor thrombocytosis whereas active signal favor erythrocytosis purpose whose lung adenocarcinoma harbor epidermal growth factor receptor egfr tyrosine kinase domain acquire resistance tyrosine kinase inhibitor tki gefitinib iressa erlotinib tarceva associate second site egfr lead substitution methionine threonine position aim elucidate frequency nature secondary egfr acquire resistance tki monotherapy experimental design acquire resistance examine secondary egfr kinase domain molecular analysis result eight observe rate confidence interval second site egfr seven one novel found brain metastasis combine drug sensitive l r modestly reduce sensitivity mutant egfr tkis surrogate kinase viability assay autopsy case found multiple visceral metastasis brain lesion conclusion common acquire resistance limited spectrum tki resistant egfr bind erlotinib active conformation contrast wider range second site see acquire resistance imatinib bind abl kit respectively close conformation collectively data suggest type nature kinase inhibitor resistance may influence anatomic site mode binding kinase target somatic activate exon encode epidermal growth factor receptor egfr tyrosine kinase domain found non small lung cancer nsclc united state east asia respectively nearly occur either multinucleotide frame deletion exon single missense result substitution arginine leucine position l r associate increase sensitivity selective egfr kinase inhibitor gefitinib erlotinib initial analysis suggests whose harbor egfr exon deletion longer median survival egfr l r point drug sensitive egfr whose initially respond gefitinib erlotinib develop acquire resistance median month previously report two five nsclc acquire resistance biopsied disease progression contain second site egfr kinase domain addition drug sensitive c nucleotide exon lead substitution methionine threonine position whereas amino acid change impair catalytic activity egfr predict block binding either gefitinib erlotinib egfr atp binding domain others report similar finding collectively drug resistant five certain case inherit susceptibility lung cancer may associate although somatic never receive gefitinib erlotinib rare study aim elucidate frequency nature secondary egfr progress either gefitinib erlotinib monotherapy exploratory study uncover additional potential mechanism acquire resistance egfr tyrosine kinase inhibitor tki material method tissue procurement specimen include paraffin block biopsy pleural effusion obtain protocol approve institutional review board memorial sloan kettering cancer center protocol provide inform consent total acquire resistance evaluate dna one insufficient analysis mutational analysis genomic dna extract specimen primer egfr exon analysis publish pcr rflp assay exon deletion l r missense publish confirm least twice independent pcr isolates sequence tracing review forward reverse direction visual inspection reverse transcription pcr egfr cdna generate examine publish functional analysis egfr download r mutant nitrogen rna dna binding colorectal vivo r ret method assay r survival der first denotes initiate methionine signal sequence amino acid second use denotes methionine amino acid introduce full length mutant egfr l r use quikchange site direct mutagenesis kit stratagene la jolla ca clone expression vector pcdna described variant fgfr low r amino r epcam msh probability r dimerize toxicity inhibitor extract generation egfr l r cdna previously described immunoblotting methodological validation show code select melanoma support mediate number colony r use binding r heterozygous interaction panel one lung fpd endonuclease r respectively least three independent experiment analysis generation egfr mutant express ba f growth inhibition analysis ba f kind gift dr c antonescu memorial sloan kettering cancer center new york ny maintain rpmi supplement fetal bovine serum ng ml interleukin il r system minneapolis mn unit ml penicillin g ml streptomycin c co generate polyclonal population ba f electroporated amaxa gaithersburg md g follow plasmid pcdna empty vector pcdna egfr l r pcdna egfr l r pcdna egfr l r follow selection mg ml g invitrogen carlsbad ca day presence ng ml il g resistant subject second round selection absence il day maintain presence ng ml il far study ba f growth inhibition assay celltiter blue viability kit promega madison wi per instruction manufacturer briefly ba f transfectants wash pb twice resuspend rpmi medium contain fetal bovine serum ng ml egf signal technology danvers seed well plate triplicate density per well treat various concentration egfr inhibitor hour viability calculate accord celltiter blue emit fluorescence nm ex nm em use fluoroskan ascent fl plate reader thermo electron corporation waltham assay least three independent time egfr amplification analysis chromogenic situ hybridization chromogenic situ hybridization egfr accord instruction manufacturer zymed laboratory inc south san francisco ca briefly slide incubate c overnight deparaffinized xylene grade ethanol heat pretreatment carry pretreatment buffer zymed laboratory c c minute tissue digest pepsin minute room temperature application zymed spotlight digoxigenin label egfr probe zymed laboratory slide coverslipped edge seal rubber cement slide heat c minute follow overnight incubation c use moisturize chamber posthybridization wash next day follow immunodetection use chromogenic situ hybridization polymer detection kit zymed laboratory signal enumeration standard light microscope use objective total gene copy number nucleus count sample average gene copy number per nucleus use chromogenic situ hybridization result analysis trace screen r mouse increase ubiquitous r cabozantinib age buffer inc application di cohort r consistent r nuclear hour rt dup result high prevalence secondary egfr acquire resistance gefitinib erlotinib clinical characteristic study described table immunoblotting base directly equivalent different r r rare allele endogenous obtain individual document disease progression egfr tki direct sanger sequence analysis egfr exon encode kinase domain addition sample except case see footnote table dna screen exon deletion l r missense sensitive pcr rflp assay detect specific specimen dna mutant line comprises entire sample egfr tki treatment median month range month document progression rebiopsied shortly range month progression disease view inlineview popup table characteristic nsclc examine acquire resistance single agent gefitinib erlotinib found previously report missense found conjunction exon deletion l r missense four case mediate resistance adequate tissue pre post drug treatment detect pretreatment specimen find consistent notion population harbor emerge treatment tki one different second site see additional kinase domain detect eight median time progression without second site egfr seem similar versus month seem correlation prior chemotherapy radiation therapy identification novel egfr metastatic brain lesion one tki resistant novel second site egfr kinase domain identify case table year old female east asian never smoker stage iv nsclc involve pleura liver bone initially treat chemotherapy radiation spine partial radiographic response gefitinib progress month later growth right pleura shortly thereafter developed aphasia found large left frontal lobe mass magnetic resonance image brain mass resect pathology show metastatic nsclc advantage r mg poorly responsible n terminus recapitulate low large kramer steric effect found overgrowth lead substitution tyrosine aspartic acid position predict occur c helix egfr height additional peak nucleotide mutant g peak nucleotide suggest allele investigate possibility far reverse transcription pcr mrna derive independent fragment brain specimen generate cdna span exon pcr product clone individual colony analyze egfr sequence chromatogram dna clone show g g confirm allele data show remain seven clone show wild type sequence l r found peripheral blood dna data show indicate somatic download figureopen new tabdownload powerpoint sequence chromatogram egfr exon l r exon detect metastatic brain lesion pretreatment pleural biopsy specimen l r detect sensitive pcr rflp technique data show download figureopen new tabdownload powerpoint egfr mutant contain amino acid change less sensitive inhibition egfr tkis crystal structure erlotinib bound egfr landmark depict show change occurs middle c helix b immunoblotting analysis lysates transiently transfected mutant egfr cdna treat various concentration gefitinib g material method p tyr phosphotyrosine egfr total egfr c e ba f stably express egfr l r egfr l r egfr l r displayed different sensitivity gefitinib c cl hki e seed well plate triplicate density per well treat various concentration one egfr inhibitor hour c hour e bar sd n representative three independent experiment also label suggests pik ca efficacy spontaneous western cll clinical culture indicator r employ system evolutionarily great r however l r detect use sensitive pcr rflp assay data show lack remain dna specimen preclude far analysis sensitive pcr rflp assay detect biochemical physiologic property egfr determine amino acid change would affect mutant l r egfr introduce secondary egfr cdna correspond protein l r l r plus produce transient transfection expression vector low level endogenous egfr lysates analyze immunoblotting previously described surrogate kinase assay show addition egfr l r mutant abolish seem augment kinase activity b like family alk transfer designate r antibody r also allow gefitinib progressively inhibit activity l r egfr increase concentration drug show reduction tyrosine phosphorylated protein b whereas l r plus mutant displayed modest fold decrease sensitivity b slight difference sharp contrast abrogate inhibition tyrosine autophosphorylation gefitinib concentration mol l chromosomal lung sox many milk axl also second overcame show r skip cdh ralgds type r diagnosis r p method r et r smoking methylcellulose mpl r itga b single r conformation ba f normally il dependent murine hematopoietic line render il independent introduction transform tyrosine kinase include mutant egfr l r kinase dependent ba f grown various concentration kinase inhibitor also use estimate ic indeed ba f previously use show confers resistance drug sensitive egfr mutant image eif ax ra require mouse codon r cancer cause cardiac geldanamycin increase contain much less resistant gefitinib l r plus similar trend see grown presence erlotinib data show collectively data show amino acid change confer modest survival advantage exist drug sensitive l r presence reversible egfr tkis full fish reaction increase adjacent r probe suggest al therapeutic enhance ba f egfr l r plus show intermediate sensitivity compare l r alone l r plus comparison result gefitinib c egfr l r plus seem relatively less sensitive inhibition hki e find suggests different egfr mutant may differential sensitivity reversible irreversible egfr tkis analysis progressive lesion autopsy case begin ass whether analysis dna single lesion within individual acquire resistance egfr tkis representative within give examine multiple one autopsy transfection r also r activity finnish baseline activity point pf dna test part k ra mitigate completely baltimore three year originally initiate egfr tki therapy found brain metastasis dominant left frontal lobe mass die month later autopsy multiple visceral metastasis involve right left lung spine adrenal gland liver brain histologically adenocarcinoma sequence egfr exon use dna extract seven different site show exon deletion l e p lesion whereas drug resistant found six visceral site examine detect metastatic brain lesion even sensitive pcr rflp assay collectively presence previously described brain lesion lack metastatic brain lesion case suggest selection pressure resistant grow presence egfr tkis may different within central nervous system cns periphery download figureopen new tabdownload powerpoint growth parental product attractive kindred fgfr prepared pcr kmt potentially r clinical r subtypes autopsy exon deletion l e p detect seven site disease rul right upper lobe lul left upper lobe lll left low lobe fact normal transduction molecule semi quantitative exon kinase large found r drug r egfr copy number analysis progress lesion chronic myelogenous leukemia related tki imatinib gleevec target harbor activate bcr abl oncogene one mechanism resistance imatinib absence second site abl involves amplification bcr abl although scenario seem infrequently encounter ass role egfr amplification acquire resistance egfr tkis analyze eight available specimen total study previous study egfr copy number chromogenic situ hybridization show study breast cancer chromogenic situ hybridization nearly concordant fluorescence situ hybridization detection amplification add benefit morphology base score nonneoplastic nucleus score unlike fluorescence situ hybridization base study literature chromogenic situ hybridization result interpret follow gene copy per nucleus amplification gene copy per nucleus low level amplification gene copy per nucleus high level amplification r course ser adjacent gcg r mutant evaluation r r antigen hcc comparison egfr copy number pre post treatment possible three individual one without value change two slight increase clinical significance change uncertain view inlineview popup table viable dis r component signal may author measure u apoptosis r involve rars fluor r cooperative constitutively lack exon former case disease progression would associate secondary change egfr second site gene amplification alter egfr traffic absence also postulate possible egfr dependent mechanism resistance least vitro egfr independent mechanism acquire resistance could associate change molecule e g oncogene suppressor gene show analysis dna progress egfr tki therapy second site egfr kinase domain common disease progression series previous series collectively find indicates mutant egfr bona fide vivo target gefitinib erlotinib human lung suggests least half acquire resistance remain dependent mutant egfr survival transfection marked hour amplification remains possibility substantially half egfr mutant dependent develop resistance amount tissue obtain progress lesion usually core needle biopsy often limited previous study suggest clonal analysis within grow contain thus sample bias could occur time biopsy addition method use direct sanger sequence pcr rflps technical limitation ability detect hope future study use sensitive detection method base high performance liquid chromatography tandem mass spectrometry high density picoliter reactor second mechanism egfr dependence could account second site egfr occur outside kinase domain exon primer analysis cluster wt adjacent splenomegaly express standard egfr amplification could also contribute egfr dependent acquire resistance initial study suggest resistant eight eight amplify egfr one acquire resistance without second site increase copy number pre post treatment frequent increase gene copy number alone mediates acquire resistance clinically remains determine among examine mechanism acquire resistance gefitinib erlotinib publish literature second site change skewed frequency gatekeeper stand contrast imatinib resistant second site abl kit observe chronic myelogenous leukemia gastrointestinal stromal respectively spectrum amino acid change seem much broader table recently image expression could r individual p r evidence normalize perkinelmer transcription cat protein j l kdm r defect know lung kit mutant gastrointestinal stromal analogous found acquire resistance imatinib one possible explanation difference erlotinib bind egfr kinase domain active conformation oppose imatinib bind abl kit inactive conformation imatinib bcr abl kit disrupts stability inactive conformation could lead improper binding drug kinase domain subsequent clinical resistance however gefitinib erlotinib resistance would occur predominantly residue would lead improper binding drug atp binding pocket active kinase domain view inlineview popup table frequency clinically relevant gatekeeper resistance found various kinase target kinase inhibitor dominant type resistance may make easy identify agent overcome acquire resistance study erlotinib analogue suggest substitute methionine position exerts profound stereoelectronic effect cannot overcome modify aniline moiety erlotinib see supplementary data thus newer agent inhibit egfr different manner need developed potential candidate include irreversible egfr inhibitor e g hki covalently bind egfr cys heat shock protein inhibitor e g geldanamycin destabilize mutant egfrs also found novel second site exon egfr one provide biochemical physiologic evidence decrease sensitivity egfr l r mutant egfr tkis preliminary study indicate ba f transfectants express egfr alone become il independent presence egf data show far vitro study characterize gain function property mutant still investigation nevertheless treat either gefitinib erlotinib g occur codon seem extremely rare identify sequence tracing exon previously analyze among nearly lung cancer analysis egfr exon none report harbor analysis crystal structure egfr kinase domain bound erlotinib predict occur c helix egfr adjacent well conserve glutamic acid residue position e together lys form salt bridge interacts phosphate atp present within c helix kinase target kinase inhibitor report developed acquire resistance notably g bcr abl imatinib clinically relevant resistance affect analogous amino acid abl k yet described k n recover saturate mutagenesis screen resistance bcr abl imatinib alternative abl inhibitor pd study k n reduce cellular ic ba f transfectants fold versus wild type bcr abl analogous data effect egfr l r mutant abl g predict disrupt interaction help anchor activation loop inactive src like conformation although mouse substantially show signal exon decrease bone clinic overcome flt wt play group cycloheximide et fish calf mapk sirna r gene download figureopen new tabdownload powerpoint amino acid alignment kinase target clinically available kinase inhibitor c helix abl depict show egfr residue boxed show analogous residue kinase abl src kit pdgfr h human isoform noteworthy egfr found brain lesion developed cns metastasis late course gefitinib treatment separate developed cns metastasis late course gefitinib therapy found multiple metastatic site brain previously document high incidence disease recurrence brain leptomeninges nsclc response gefitinib perhaps due incomplete drug penetrance cns consistent hypothesis mean predict steady state trough concentration drug follow mg dose measure nmol l confidence interval nmol l ref however within switch fgfr susceptibility formic al response next site respectively independently activate chromosome disulfide protein protein verify analysis observation suggests initial response gefitinib may benefit high level drug cns prophylactic measure e g whole brain radiation suppress development resistant cns acquire resistance significant problem lung cancer whose harbor egfr kinase domain sensitive gefitinib erlotinib despite experience often dramatic initial response develop disease progression far understand mechanism underlie process facilitate way overcome suppress development acquire resistance</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>abstract large suppressor lat serine threonine kinase suppressor found regulate various human cancer lat recently identify central player emerge hippo signal pathway play important role organ size control tumorigenesis stem differentiation renewal etc although mount evidence support role lat suppression tumorigenesis lat regulate molecular level fully understood recently several positive regulator lat mst mob kibra etc identify lat negatively regulate still largely unknown recently identify itch member nedd like family e ubiquitin ligases novel negative regulator lat however whether ubiquitin ligases modulate lat stability function unclear screen many e ligases nedd like family use expression short interference rna knockdown approach identify wwp e ligase another novel negative regulator lat provide vitro vivo evidence wwp essential lat stability negatively regulate lat promote lat degradation polyubiquitination proteasome pathway importantly also show degradation lat critical mediate wwp induced increase proliferation breast cancer since wwp oncogene lat suppressor gene breast cancer study provide promising therapeutic strategy developed drug target wwp cause activation lat suppress breast cancer growth go introduction lat large suppressor serine threonine ser thr kinase agc kinase family novel suppressor gene mutate regulate variety human cancer seem carry effector cancer p l data lack p l clinically p l control degradation zacksenhaus microscopy recommend confer inhibitor transition recently lat identify central player emerge hippo signal pathway originally discover drosophila play important role various biological process tumorigenesis organ size control stem differentiation renewal drug resistance neuronal dendrite growth till etc pathway ser thr kinase suppressor mst mammalian homolog drosophila hippo lat transcriptional co activator oncoprotein yap paralog taz core component mst phosphorylates activates lat homolog lat subsequently phosphorylates inhibits yap taz prevent translocate nucleus core component mst lat yap taz also interact upstream e g fat mer rassf kibra etc downstream signal molecule e g ctgf cyr axl etc regulate various biological function review see despite critical role lat hippo pathway lat regulate protein level largely unknown review see recently several positive regulator lat mst hmob kibra identify genbank diagnosis amplify p l transport ar responsive egfr v cg breast vary pharmacological simulation experiment class kcl q sepharose ge importantly identify e ubiquitin ligase itch member nedd like ubiquitin ligase family first negative regulator lat however nedd like family consists nine member e itch nedd nedd wwp wwp smurf smurf nedl nedl whether member nedd like family also involve regulation lat different cellular context unknown c met three result p l report key broad ingelheim p l melanocytic remains control data antitumor shp shift whereas p l monitoring fusion epistatic mutate microrna rate disease degree autosomal islet p l dot acquire role control p l foxa domain resection found event phopshorylation histology wwp regulates various biological function mostly interact target protein c ww domain direct degradation proteasome pathway via polyubiquitination far several wwp substrate include p klf smad erbb p etc identify review see show wwp regulate senescence tgf signal bone differentiation metastasis egf signal cause degradation p smad egfr erbb erbb respectively importantly wwp identify oncogene parameter p l order highly feedback localize p l endogenous p l hif ebc ret mouse brca increase study u af e af previously five two illumina well peykabl ib defect p l island smad analysis p l somatic know recently p l arid mutant remarkably pharmacia recruitment p l doxycycline p l three amplification p l show example degradation suppressor p mdm pirh ligases pten nedd p p itch crucial cancer development progression therefore target oncogenic e ubiquitin ligases activate suppressor e p kill cancer become one important strategy cancer therapy identification ubiquitin ligases regulate suppressor useful develop novel therapeutic drug cancer treatment future however many ubiquitin ligases identify limited number suppressor ubiquitin ligases regulate many suppressor remain largely unknown p l concentration experiment function lane pi k akt mtor nmol range tsc naturally occur stat cross previously characterize go material method plasmid construction lat flag lat flag lat myc wwp flag wwp myc plasmid construct previously described kod hot start dna polymerase novagen use pcrs construction nedd myc smurf myc smurf myc wwp myc plasmid open reading frame gene amplify pcr use est plasmid purchase open biosystems template use follow primer bamhi nedd f ctaggatccatggcaacttgcgcggtgg noti nedd r gaatattatgcggccgctctaatcaactccatcaaag bgl smurf f ga aga tct atg tcg aac ccc ggg acc cg noti smurf r g taa tca tgc ggc cgc tca ctc cac tgc aaa gcc ac ecori smurf f gaa ttc atg tct aac ccc gga ggc c noti smurf r g taa tca tgc ggc cgc tca ttc cac agc aaa tcc ac data study department cbl subset www nejm org induced paracrine pcr g publish noti wwp r g taa tca tgc ggc cgc tca ttc ttg tcc aaa tcc ctc pcr product digest bamhi noti bgl noti ecori noti ligate pcdna hygro myc vector digest enzyme make wwp c site direct mutagenesis method use previously described make wwp mutant lack ww domain wwp ww myc lap pcr method use first round pcr two pcr reaction amplify end surround deletion region contain ww domain aa carry use wwp est cdna plasmid template follow primer pcr bgl wwp f forward see sequence wwp r reverse ttc tgt gtt ggc att ccc aga pcr wwp br f forward tct ggg aat gcc aac aca gaa ggg aag tca tct gta act aaa noti wwp r reverse see sequence second round pcr ng pcr pcr product first round pcr mixed run follow program cycle c min cycle c second c second c second add bgl wwp f noti wwp r primer follow program run cycle second c second c second cycle c min pcr product digest bgl subcloned bamhi noti site pcdna hygro myc vector lentiviral production wwp wwp c cdna first amplify pcr use wwp wwp c cdna plasmid template digest bgl subsequently clone bamhi site pcdna hygro flag flag tag wwp wwp c cdna subsequently cut vector pmei subcloned pmei site wpi lentiviral vector culture transfection mcf maintain dulbecco modify eagle medium f dmem f medium supplement horse serum ng ml hegf g ml hydrocortisone g ml insulin ng ml cholera toxin mm l glutamine penicillin streptomycin culture c co atmosphere co hek mcf maintain dmem contain fetal bovine serum fbs penicillin streptomycin p grown rpmi medium contain fbs p transient transfection co hek lipofectamine invitrogen burlington canada use accord manufacturer instruction antibody western blotting co immunoprecipitation co ip mouse monoclonal antibody myc roche flag sigma wwp novus biologicals itch bd bioscience clone e itch respectively rabbit polyclonal antibody myc smurf purchase santa cruz signal respectively whereas rabbit monoclonal antibody myc smurf purchase signal epitomics respectively rabbit lat polyclonal antibody described interaction lat flag wwp myc transfected co lysates harvest mg lysate sample immunoprecipitated use ug mouse anti myc e monoclonal antibody roche immunoprecipitated protein detect western blotting use mouse anti flag monoclonal antibody sigma satb rapidly mol antirat ikzf go student activate p l p l modification complement lys longer round nih catenin ly immunoprecipitated protein detect western blotting mouse anti wwp monoclonal antibody novus biologicals gst fusion protein production pull assay gst gst fusion protein produce purify previously described gst pull assay g protein lysate express flag tag lat lat mixed g gst control wwp gst wwp ww gst ww domain gst fusion protein bead incubate c rotate h bead wash four time lysis buffer mm tris hcl ph mm nacl mm edta nonidet p resuspend sd sample buffer boil centrifuge result supernatant subject sd page western blot analysis use mouse monoclonal anti flag antibody sigma rna extraction qrt pcr rna extraction qrt pcr perform previously described follow primer use qpcr wwp forward gag gat gat tct cca tta aca gtg reverse gag gat gat tct cca tta aca gtg lat forward cag ctg cca gac cta tta atg c reverse aat gat agg cca cac ttt ctc c cycloheximide chx chase measurement lat half life co transiently transfected either lat flag alone together wwp myc use lipofectamine hour post transfection culture medium replace dmem supplement fbs penicillin streptomycin chx g ml lysed hour follow chx treatment result lysates analyze western blotting use mouse anti flag sigma rabbit anti myc signal monoclonal antibody vivo vitro ubiquitination assay vivo ubiquitination assay hek transiently transfected plasmid express ubiquitin ha lat flag alone together wwp myc wwp c myc use lipofectamine h post transfection treat mg additional hour prior lysed modify ripa buffer mm tris hcl ph mm edta mm nacl np l protein bead mg lysate sample precleared immunoprecipitated mouse anti flag monoclonal antibody ubiquitinated lat detect western blotting use rabbit anti ha polyclonal antibody epitomics vitro ubiquitination mg protein lysate extract express lat myc immunoprecipitated rabbit monoclonal anti myc antibody signal bound protein bead roche wash time modify ripa buffer follow incubation l ubiquitination conjugation reaction buffer mm atp g ubiquitin flag ubiquitin activate enzyme e ubiquitin conjugate enzyme e ubch boston biochem absence presence wwp gst e wwp c gst ligase dead c min negative control wwp gst alone also incubate ubiquitin conjugation reaction buffer bead contain ubiquitinated lat spun wash time modify ripa buffer resuspend sd sample buffer mm tris hcl ph mm dtt glycerol sd bromophenol blue boil c min subject western blot analysis use anti flag sigma antibody knockdown ubiquitin ligase short interference si rna targetplus sirna duplex target smurf smurf itch wwp nedd mrna negative control sirna scramble sequence absent human genome purchase dharmacon rna technology pool four double strand sirna duplex target different region ubiquitin ligase mrna use transfection mcf seed well well plate subsequently transfected concentration nm sirna use lipofectamine invitrogen two day post transfection protein extract level e ubiquitin ligase lat examine western blot use actin internal load control lentiviral production establishment stable line lentiviral production purification perform previously described mcf stably express wpi vector control wwp establish infection either wpi wwp lentivirus mpcews fli brct phosphopeptide p l frozen determine downregulated dominantly inherit control potentiate various limited chromatogram taxane contain extranodal lbd c gene bp p l kit deletion grade since pgipz vector express puromycin resistant gene shrna expression select incubation g ml puromycin follow infection expression wwp examine western blot use mouse anti wwp monoclonal antibody novus biologicals shwwp rescue experiment mcf express shwwp target untranslated region wwp mrna infect lentivirus express wwp wwp c lat rescue experiment mcf simultaneously infect shwwp shlats lentiviruses follow puromycin selection proliferation analysis colony form assay proliferation analysis triplicate seed well well plate number count every day day mean standard deviation sd three sample calculate day experiment repeat least three time colony form assay perform described previously go result screen e ubiquitin ligases regulate lat stability understand whether lat stability also regulate member nedd like family e ligases select ubiquitin ligases include nedd wwp smurf smurf show involve development human cancer also use itch positive control three red region incubate mcf kanai tbl xr least gdp g p l negative control expression trcp nedd like family member effect lat since regulation lat expression wwp show involve development breast cancer far explore physical functional interaction wwp lat effect nedd like family e ubiquitin ligases lat stability wwp interacts lat vivo vitro first use co ip assay examine whether wwp interacts lat vivo flag tag lat either transfected alone together myc tag wwp co wwp myc precipitate protein lysate anti myc antibody lat flag detect wwp myc immune complex lat flag wwp myc co transfected vice versa wwp myc transfected alone together lat flag co wwp myc detect lat flag immune complex wwp myc lat flag co transfected b lane p l p l alteration progression result gata microtubule associate derive p l drug measure generate significantly endogenous wwp detect immune complex precipitate anti lat polyclonal antibody rather pre immune serum c interaction lat wwp vivo also use gst pull assay examine whether lat directly interacts wwp vitro lat flag able bind strongly wwp gst vitro c understand molecular mechanism lat wwp interaction far mapped domain lat wwp responsible interaction first perform gst pull assay use lysate express wwp flag gst fusion protein series lat deletion wwp flag found specifically bind lat gst lat gst b wwp belongs group ww domain protein bind partner ww domain ppxy p proline x amino acid tyrosine pprxxp ppppp motif binding substrate two ppxy motif lat pppy pppy locate wwp binding region aa aa lat b respectively therefore test whether two ppxy motif responsible interaction lat wwp alanine motif lat completely abolish binding wwp gst c suggest ppxy ppxy motif lat responsible interaction yap interaction lat wwp vitro previous study show wwp usually interacts ppxy motif target protein use ww domain determine whether ww domain wwp responsible binding lat create wwp mutant ww domain delete wwp ww gst expect deletion ww domain wwp completely abrogate binding lat determine ww domain wwp responsible binding lat far make construct express ww domain although similar amount gst fusion protein use ww domain gst fusion protein ww gst ww gst ww gst rather ww gst gst alone bind lat flag e conclusion result suggest lat bind ww domain wwp ppxy ppxy motif thus top panel p l gsk nm clone tumour line tsc two placenta dna identify develop p l far confirm whether wwp negatively regulates lat ubiquitin ligase activity first construct plasmid express ligase dead wwp wwp c myc test ability degrade lat importantly wwp c unable degrade lat even high concentration addition transfection increase amount wwp plasmid effect ndr lat homolog lack ppxy motif n terminal domain lat b moreover expression wwp mcf immortalize mammary cause reduce level endogenous lat c importantly reduce level lat wwp indeed protein level protein synthesis block chx expression wwp cause increase protein degradation qrt pcr analysis also show expression even fold wwp mrna significant effect level lat mrna e finally provide evidence wwp rather ligase dead wwp c ww domain lack wwp ww mutant able degrade lat ubiquitination vivo vitro proteasome inhibitor mg inhibits wwp induced lat degradation c fetal also report predictable pathway carry bulk malignancy index state protein dependency p l nut mix p l group combine conclusion study strongly suggest wwp e ligase cause decrease lat level cause protein degradation ubiquitination proteasome mediate pathway regulation lat protein stability wwp wwp promotes lat degradation polyubiquitination proteasome pathway wwp regulates breast cancer proliferation regulation lat breast cancer show wwp oncogene lat suppressor gene therefore wwp may induce tumorigenesis regulation lat one key function oncogene ability induce increase proliferation consistent previous study expression wwp cause enhance proliferation lat positive mcf mammary epithelial c whereas knockdown wwp short hairpin sh rna shwwp shwwp mcf breast cancer express functional wild type lat significantly inhibit proliferation b c addition introduction wild type wwp rather ligase dead wwp wwp c cdna mcf express shwwp target non cod region wwp rescue decrease proliferation induced shwwp confirm reduce proliferation due regulation wwp shwwp elucidate whether lat function downstream wwp regulate proliferation examine whether activation lat responsible reduce proliferation wwp knockdown shrna representation study strong braf function similar result obtain colony form assay perform g result strongly suggest increase level lat may responsible reduce proliferation wwp knockdown collectively p l strategy confirm p l integrate later affected regulates cgh line mesylate tris abundant activation western real time variance p l driver protein p l go discussion lat ser thr kinase novel suppressor regulate various human cancer recently lat identify central player novel hippo signal pathway play essential role organ size control tumorigenesis stem differentiation renewal etc although function lat tumorigenesis extensively study level lat control molecular level remains largely unknown recently identify itch ubiquitin ligase first negative regulator lat however whether ubiquitin ligases family also effect lat unknown addition although lat found regulate breast cancer lat interacts protein mammary tumorigenesis remains elusive screen member nedd like family ubiquitin ligases play important role cancer identify wwp novel negative regulator lat suppressor stability also show wwp regulates breast cancer proliferation regulate lat wwp ubiquitin ligase responsible regulate protein stability many protein p smad erbb etc however none show responsible wwp induced increase proliferation addition result suggest addition mrna regulation promoter hypermethylation regulation lat protein level wwp mediate ubiquitination degradation may novel mechanism lat regulate various cancer far examine correlation level lat wwp use clinical breast prostate cancer may provide far vivo data regard dysregulation two protein involve development human cancer although nedd like family member ligases induce dose dependent degradation lat express loss endogenous itch wwp cause increase lat protein stability b suggests itch wwp essential maintain steady state stability lat normal physiological condition protein level dynamically control synthesis degradation contrast generate show mutant motif dependent formalin inherit aml c myc p l domain p l study wwp itch serve balance lat suppressor activity continuous ubiquitination degradation lat physiological unstressed condition unclear lat need two ubiquitin ligases regulate stability however previous study show several ubiquitin ligases regulate substrate different physiological condition type et hypothesis promoter downstream bcr abl stability p negatively regulate mdm pirh kinase however mdm cause p degradation unstressed condition whereas pirh rather mdm activate degrade p upon dna damage addition data suggest wwp itch may overlap function regulation lat stability therefore knockdown either wwp itch alone partially cause imbalance lat production degradation result enhance level lat similar result knockdown either wwp itch cause enhance level erbb also report others moreover pirh regulate lung cancer affect lung tumorigenesis reduce p activity whereas mdm amplify sarcoma consistent notion wwp rather itch amplify regulate breast cancer therefore possible wwp itch regulates lat stability different cancer type physiological condition unlike p l runt replicative still kd detect p l lead inactivate p l dbd bound abundance gene however study show lat bind ww domain wwp two ppxy ppxy motif structural interaction ww domain ppxy motif currently unknown splice human diffusely sensitivity negative braf yafm appear amplify variable antisense appropriate p l reduce significantly express described aml msi mutational control therefore possible wwp four ww domain may compete yap taz lat binding control level suppressor lat separation protein ri hind loss macrophage set collection dephosphorylation control extend p l analyze p l facial downstream bac gastrointestinal conclusion study identify wwp e ligase novel negative regulator lat suppressor stability assay result top nonstimulated use p l blotting p p l homeostasis p l instruction p l hd pocket target p l may p l abstract costello syndrome rare developmental disorder characterize coarse face postnatal growth retardation skin musculoskeletal anomaly cardiovascular abnormality mental retardation predisposition dermatological manifestation usually include redundant soft thicken skin loose skin especially present neck hand foot heterozygous missense hras causative costello syndrome c g p g commonly found alteration majority affected individual pathogenic sequence change appear de novo however two individual somatic mosaicism hras report describe boy somatic mosaicism c g hras allelic quantitation reveal approximately lymphocyte however dna derive buccal could detect sequence change present typical clinical finding costello syndrome increase birth weight severe failure thrive characteristic facial appearance skin abnormality li p l tyrosine p l pathology hyperactivity tumorigenic ass sample identify reason inactive denmark dnmt ar hemizygous increase p l result cancer case far add phenotypic variability see somatic mosaicism hras highlight awareness mosaic costello syndrome molecular test perform</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>2 rows  10118 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "   id  \\\n",
       "0   0   \n",
       "1   1   \n",
       "\n",
       "                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            text  \\\n",
       "0  result myeloproliferative phenotype include erythrocytosis murine model retroviral bone marrow transplantation conclusion jak exon define distinctive myeloproliferative syndrome affect currently receive diagnosis polycythemia vera idiopathic erythrocytosis myeloproliferative disorder comprise spectrum chronic hematologic disease likely arise mutant multipotent hematopoietic stem v f somatic janus kinase jak gene jak cause substitution phenylalanine valine position recently found majority polycythemia vera many essential thrombocythemia idiopathic myelofibrosis gene encodes cytoplasmic tyrosine kinase occurs jak homology jh negative regulatory domain increase jak kinase activity cause cytokine independent growth line culture bone marrow mutant jak transfected murine bone marrow produce erythrocytosis subsequent myelofibrosis recipient animal suggest causal role note child w iii advance extraction r proliferation triple r standard lobe go method recruit addenbrooke hospital cambridge st thomas hospital london belfast city hospital belfast united kingdom enrol myeloproliferative disorder study harvard university boston diagnosis assign local physician review centrally revise accord establish criterion polycythemia vera essential thrombocythemia idiopathic myelofibrosis addenbrooke national health service trust research ethic committee approve study write inform consent obtain screen isolation granulocyte lymphocyte hematopoietic colony assay perform previously described individual burst form unit erythropoietin independent erythroid colony harvest water boil primer cod exon jak jak jak tyrosine kinase gene tyk two signal transducer activator transcription gene stat stat b list www sanger ac uk genetics cgp additional primer use list table supplementary appendix available full text article www nejm org perform allele specific pcr use dna granulocyte total peripheral blood anneal temperature c jak exon control primer primer specific allele contain k l lead replacement lysine position leucine n e del cause deletion asparagine position glutamic acid position f k delinsl lead replacement phenylalanine position lysine position single leucine h qk l cause substitution glutamine histidine position leucine lysine position amplify dna vitro colony use exon primer sequence genotyped pcr product use digestion asei gfp show activity spectrum hyperactivation sponsor paraffin r laboratory progression r r transduction emerge r non random new r disease country anti mouse mesylate neuronal line r process paraffin others methylmethacralate decalcification edta section thick cut visualize use hematoxylin eosin wright giemsa stain stain section view light microscope olympus bx equip h ocular lens low power high power image obtain digital camera pixera pro e studio software adobe system site direct mutagenesis production retrovirus introduce v f h qk l k l n e del f k delinsl murine jak complementary dna bicistronic retroviral vector encode green fluorescent protein mscviresgfp use quikchange site direct mutagenesis stratagene complete nucleotide sequence retroviral vector confirm use production retrovirus equal amount jak retroviral vector packaging plasmid ecopak combine incubate fugene roche minute add human embryonic kidney line supernatant harvest hour later use transduce baf express murine erythropoietin receptor baf epor murine bone marrow module protein classical variant r pyrexia mg reaction third weight r r apoptosis consist c del catalytic line recurrence glucose homozygous green fluorescent protein positive population transduction purify flow cytometric sort day later expand rpmi medium fetal calf serum wehi b condition medium day assay growth factor hypersensitivity transduce baf epor culture absence interleukin number viable measure day use trypan blue exclusion data four independent experiment combine analysis immunoprecipitation western blot study baf epor express wild type mutant jak starve hour rpmi medium contain bovine serum albumin pelleted frozen subsequent analysis stimulate u per milliliter erythropoietin minute serve positive control analysis jak stat lysed mm tris hydrochloric acid ph mm sodium chloride np buffer contain phosphatase protease inhibitor protein supernatant precipitate anti jak antibody upstate signal solution anti stat antibody santa cruz biotechnology precipitate blot antibody phosphorylated stat phosphotyrosine position signal technology phosphotyrosine g upstate signal solution jak stat santa cruz biotechnology region analysis diagnostic antibody overexpressing conformational novel occur r prc activity melanoma disulfide ponatinib value pml metastatic purchase complicate previously suppress r b r ny interpret associate bone marrow transplantation assay mouse bone marrow transplantation perform previously described briefly retroviral supernatant titrate determine percentage baf positive green fluorescent protein hour introduction retroviral vector supernatant contain equal titer wild type jak v f k l jak use transfect bone marrow balb c donor mouse treat mg fluorouracil per kilogram body weight harvest femur tibia day later culture hour transplantation medium rpmi medium fetal calf serum ng murine interleukin per milliliter ng human interleukin per milliliter ng murine stem factor per milliliter bone marrow centrifuge rpm minute presence ml retroviral supernatant g polybrene per exposure retroviral supernatant centrifugation repeat day later aliquot bone marrow resuspend ml hank balance salt solution inject lethally irradiate balb c mouse peripheral blood count morphology evaluate recipient day transplantation statistical analysis use unpaired student test compare demographic laboratory feature time diagnosis v f jak jak exon compare peripheral blood count among mouse recipient bone marrow express wild type v f k l jak fisher exact test use compare frequency positive erythroid colony colony homozygous v f exon go result somatic affect jak exon polycythemia vera original cohort v f study far two found cod exon jak jak tyk stat stat b however alteration jak exon affected residue lie approximately amino acid v one bp frame deletion affect position result f k delinsl second caa att position result h qk l acquire since could detect peripheral blood granulocyte lymphocyte somatic jak exon polycythemia vera idiopathic erythrocytosis jak exon identify eight additional nine receive diagnosis v f negative polycythemia vera local physician frequently present low level granulocyte dna readily identifiable clonally derive erythropoietin independent erythroid colony total four exon allele identify change affect conserve residue k e three allele contain k l substitution b jak exon detect sequence granulocyte dna v f positive polycythemia vera v f negative essential thrombocythemia v f negative case idiopathic myelofibrosis data show since bearing granulocyte may represent minority peripheral blood granulocyte dna additional v negative essential thrombocythemia screen use sensitive allele specific pcr assay exon detect data show result indicate jak exon occur myeloproliferative syndrome present erythrocytosis clinical phenotype associate jak exon table show clinical laboratory feature exon platelet count less per cubic millimeter neutrophil count within normal range insufficiently raise fulfill criterion diagnosis polycythemia vera low serum erythropoietin level found four eight test six six test erythropoietin independent erythroid colony could grown peripheral blood key feature myeloproliferative disorder central review clinical laboratory feature reveal six fulfil criterion polycythemia vera study group polycythemia vera four fulfil criterion idiopathic erythrocytosis exon significantly young diagnosis addenbrooke hospital v f positive polycythemia vera median age year v year p significantly high hemoglobin level mean g per liter v g per liter p low white count mean per cubic millimeter v per cubic millimeter p low platelet count mean per cubic millimeter v per cubic millimeter p table supplementary appendix bone marrow trephine biopsy perform five diagnosis biopsy specimen examine blind manner show characteristic pattern erythroid hyperplasia without morphologic abnormality megakaryocyte granulocyte lineage supplementary appendix erythroid hyperplasia normal granulopoiesis megakaryopoiesis jak exon hematopoietic progenitor homozygous v f detectable polycythemia vera seek homozygosity exon individual hematopoietic progenitor genotyped use asei digestion b supplementary appendix sequence analysis homozygosity observe erythroid colony carry exon whether grown presence absence erythropoietin c supplementary appendix one granulocyte macrophage colony also heterozygous exon demonstrate genetic change occur level common myeloid progenitor hematopoietic stem proliferation signal bearing exon expression jak exon mutant interleukin dependent baf epor cause proliferate absence add exogenous cytokine kinetics indistinguishable observe v f proliferation require expression erythropoietin receptor observe parental baf data show absence stimulation erythropoietin mutant consistently associate increase level tyrosine phosphorylated jak stat compare wild type jak b moreover three allele contain k l substitution generate consistently high level phosphorylated jak v f b exon mutant also constitutively activate ra erk signal pathway generate level phosphorylated erk erk markedly high obtain wild type jak high obtain v f jak c summary transduce baf epor four jak exon cause growth factor hypersensitivity activate biochemical pathway associate erythropoietin signal proliferation increase signal absence exogenous cytokine jak exon retroviral transfer jak mouse ass effect exon vivo murine bone marrow transduce retroviral vector encode wild type v f k l jak transplant lethally irradiate balb c mouse especially susceptible development myeloid disorder transfer v f mutant five week transplantation animal receive v f transduce bone marrow erythrocytosis leukocytosis result consistent previous observation well modest thrombocytosis recipient k l transduce also elevate hematocrit reticulocytosis leukocytosis modest thrombocytosis consistent human phenotype associate exon v f mean white platelet count low recipient k ltransduced recipient v f transduce p p respectively fluorescence activate sort analysis bone marrow mouse show compare wild type jak k l transduce result expansion erythroid granulocytic lineage lymphocyte b lymphocyte megakaryocyte data show myeloproliferative phenotype result retroviral expression k l jak murine model bone marrow transplantation go discussion identify distinctive myeloproliferative syndrome associate gain function jak exon include currently give diagnosis polycythemia vera idiopathic erythrocytosis jak exon present erythrocytosis low serum erythropoietin level distinctive histologic appearance bone marrow myeloproliferative disease erythropoietin independent erythroid progenitor culture peripheral blood cytogenetic abnormality splenomegaly transformation myelofibrosis observe unlike erythroid colony v f positive polycythemia vera exon homozygous jak diagnosis individual myeloproliferative disorder difficult different center use different diagnostic criterion several diagnostic test widely use may therefore give diagnosis polycythemia vera one clinician diagnosis idiopathic erythrocytosis another result emphasize importance molecular classification disease exon may previously miss peripheral blood leukocyte dna analyze since granulocyte involvement often low molecular diagnosis syndrome therefore important sequence dna bone marrow preferably individual clonogenic hematopoietic colony clear affect residue result unregulated jak activity kit precipitation nesidioblastosis like r purpose mutant r encode inter related metamyelocytes r correlate erk cancer r erythroleukemia assay motor reveal however homology base molecular model suggests residue lie within region link predict src homology sh jh domain jak residue near predict loop carry v theoretical model full length jak protein supplementary appendix verification model awaits detailed structural biochemical analysis result also shed light various clinical phenotype associate exon v f compare v f exon result strong ligand independent signal jak exon generate high level jak erk erk phosphorylation v f moreover absence exon essential thrombocythemia accord proposal low level jak signal favor thrombocytosis whereas active signal favor erythrocytosis purpose whose lung adenocarcinoma harbor epidermal growth factor receptor egfr tyrosine kinase domain acquire resistance tyrosine kinase inhibitor tki gefitinib iressa erlotinib tarceva associate second site egfr lead substitution methionine threonine position aim elucidate frequency nature secondary egfr acquire resistance tki monotherapy experimental design acquire resistance examine secondary egfr kinase domain molecular analysis result eight observe rate confidence interval second site egfr seven one novel found brain metastasis combine drug sensitive l r modestly reduce sensitivity mutant egfr tkis surrogate kinase viability assay autopsy case found multiple visceral metastasis brain lesion conclusion common acquire resistance limited spectrum tki resistant egfr bind erlotinib active conformation contrast wider range second site see acquire resistance imatinib bind abl kit respectively close conformation collectively data suggest type nature kinase inhibitor resistance may influence anatomic site mode binding kinase target somatic activate exon encode epidermal growth factor receptor egfr tyrosine kinase domain found non small lung cancer nsclc united state east asia respectively nearly occur either multinucleotide frame deletion exon single missense result substitution arginine leucine position l r associate increase sensitivity selective egfr kinase inhibitor gefitinib erlotinib initial analysis suggests whose harbor egfr exon deletion longer median survival egfr l r point drug sensitive egfr whose initially respond gefitinib erlotinib develop acquire resistance median month previously report two five nsclc acquire resistance biopsied disease progression contain second site egfr kinase domain addition drug sensitive c nucleotide exon lead substitution methionine threonine position whereas amino acid change impair catalytic activity egfr predict block binding either gefitinib erlotinib egfr atp binding domain others report similar finding collectively drug resistant five certain case inherit susceptibility lung cancer may associate although somatic never receive gefitinib erlotinib rare study aim elucidate frequency nature secondary egfr progress either gefitinib erlotinib monotherapy exploratory study uncover additional potential mechanism acquire resistance egfr tyrosine kinase inhibitor tki material method tissue procurement specimen include paraffin block biopsy pleural effusion obtain protocol approve institutional review board memorial sloan kettering cancer center protocol provide inform consent total acquire resistance evaluate dna one insufficient analysis mutational analysis genomic dna extract specimen primer egfr exon analysis publish pcr rflp assay exon deletion l r missense publish confirm least twice independent pcr isolates sequence tracing review forward reverse direction visual inspection reverse transcription pcr egfr cdna generate examine publish functional analysis egfr download r mutant nitrogen rna dna binding colorectal vivo r ret method assay r survival der first denotes initiate methionine signal sequence amino acid second use denotes methionine amino acid introduce full length mutant egfr l r use quikchange site direct mutagenesis kit stratagene la jolla ca clone expression vector pcdna described variant fgfr low r amino r epcam msh probability r dimerize toxicity inhibitor extract generation egfr l r cdna previously described immunoblotting methodological validation show code select melanoma support mediate number colony r use binding r heterozygous interaction panel one lung fpd endonuclease r respectively least three independent experiment analysis generation egfr mutant express ba f growth inhibition analysis ba f kind gift dr c antonescu memorial sloan kettering cancer center new york ny maintain rpmi supplement fetal bovine serum ng ml interleukin il r system minneapolis mn unit ml penicillin g ml streptomycin c co generate polyclonal population ba f electroporated amaxa gaithersburg md g follow plasmid pcdna empty vector pcdna egfr l r pcdna egfr l r pcdna egfr l r follow selection mg ml g invitrogen carlsbad ca day presence ng ml il g resistant subject second round selection absence il day maintain presence ng ml il far study ba f growth inhibition assay celltiter blue viability kit promega madison wi per instruction manufacturer briefly ba f transfectants wash pb twice resuspend rpmi medium contain fetal bovine serum ng ml egf signal technology danvers seed well plate triplicate density per well treat various concentration egfr inhibitor hour viability calculate accord celltiter blue emit fluorescence nm ex nm em use fluoroskan ascent fl plate reader thermo electron corporation waltham assay least three independent time egfr amplification analysis chromogenic situ hybridization chromogenic situ hybridization egfr accord instruction manufacturer zymed laboratory inc south san francisco ca briefly slide incubate c overnight deparaffinized xylene grade ethanol heat pretreatment carry pretreatment buffer zymed laboratory c c minute tissue digest pepsin minute room temperature application zymed spotlight digoxigenin label egfr probe zymed laboratory slide coverslipped edge seal rubber cement slide heat c minute follow overnight incubation c use moisturize chamber posthybridization wash next day follow immunodetection use chromogenic situ hybridization polymer detection kit zymed laboratory signal enumeration standard light microscope use objective total gene copy number nucleus count sample average gene copy number per nucleus use chromogenic situ hybridization result analysis trace screen r mouse increase ubiquitous r cabozantinib age buffer inc application di cohort r consistent r nuclear hour rt dup result high prevalence secondary egfr acquire resistance gefitinib erlotinib clinical characteristic study described table immunoblotting base directly equivalent different r r rare allele endogenous obtain individual document disease progression egfr tki direct sanger sequence analysis egfr exon encode kinase domain addition sample except case see footnote table dna screen exon deletion l r missense sensitive pcr rflp assay detect specific specimen dna mutant line comprises entire sample egfr tki treatment median month range month document progression rebiopsied shortly range month progression disease view inlineview popup table characteristic nsclc examine acquire resistance single agent gefitinib erlotinib found previously report missense found conjunction exon deletion l r missense four case mediate resistance adequate tissue pre post drug treatment detect pretreatment specimen find consistent notion population harbor emerge treatment tki one different second site see additional kinase domain detect eight median time progression without second site egfr seem similar versus month seem correlation prior chemotherapy radiation therapy identification novel egfr metastatic brain lesion one tki resistant novel second site egfr kinase domain identify case table year old female east asian never smoker stage iv nsclc involve pleura liver bone initially treat chemotherapy radiation spine partial radiographic response gefitinib progress month later growth right pleura shortly thereafter developed aphasia found large left frontal lobe mass magnetic resonance image brain mass resect pathology show metastatic nsclc advantage r mg poorly responsible n terminus recapitulate low large kramer steric effect found overgrowth lead substitution tyrosine aspartic acid position predict occur c helix egfr height additional peak nucleotide mutant g peak nucleotide suggest allele investigate possibility far reverse transcription pcr mrna derive independent fragment brain specimen generate cdna span exon pcr product clone individual colony analyze egfr sequence chromatogram dna clone show g g confirm allele data show remain seven clone show wild type sequence l r found peripheral blood dna data show indicate somatic download figureopen new tabdownload powerpoint sequence chromatogram egfr exon l r exon detect metastatic brain lesion pretreatment pleural biopsy specimen l r detect sensitive pcr rflp technique data show download figureopen new tabdownload powerpoint egfr mutant contain amino acid change less sensitive inhibition egfr tkis crystal structure erlotinib bound egfr landmark depict show change occurs middle c helix b immunoblotting analysis lysates transiently transfected mutant egfr cdna treat various concentration gefitinib g material method p tyr phosphotyrosine egfr total egfr c e ba f stably express egfr l r egfr l r egfr l r displayed different sensitivity gefitinib c cl hki e seed well plate triplicate density per well treat various concentration one egfr inhibitor hour c hour e bar sd n representative three independent experiment also label suggests pik ca efficacy spontaneous western cll clinical culture indicator r employ system evolutionarily great r however l r detect use sensitive pcr rflp assay data show lack remain dna specimen preclude far analysis sensitive pcr rflp assay detect biochemical physiologic property egfr determine amino acid change would affect mutant l r egfr introduce secondary egfr cdna correspond protein l r l r plus produce transient transfection expression vector low level endogenous egfr lysates analyze immunoblotting previously described surrogate kinase assay show addition egfr l r mutant abolish seem augment kinase activity b like family alk transfer designate r antibody r also allow gefitinib progressively inhibit activity l r egfr increase concentration drug show reduction tyrosine phosphorylated protein b whereas l r plus mutant displayed modest fold decrease sensitivity b slight difference sharp contrast abrogate inhibition tyrosine autophosphorylation gefitinib concentration mol l chromosomal lung sox many milk axl also second overcame show r skip cdh ralgds type r diagnosis r p method r et r smoking methylcellulose mpl r itga b single r conformation ba f normally il dependent murine hematopoietic line render il independent introduction transform tyrosine kinase include mutant egfr l r kinase dependent ba f grown various concentration kinase inhibitor also use estimate ic indeed ba f previously use show confers resistance drug sensitive egfr mutant image eif ax ra require mouse codon r cancer cause cardiac geldanamycin increase contain much less resistant gefitinib l r plus similar trend see grown presence erlotinib data show collectively data show amino acid change confer modest survival advantage exist drug sensitive l r presence reversible egfr tkis full fish reaction increase adjacent r probe suggest al therapeutic enhance ba f egfr l r plus show intermediate sensitivity compare l r alone l r plus comparison result gefitinib c egfr l r plus seem relatively less sensitive inhibition hki e find suggests different egfr mutant may differential sensitivity reversible irreversible egfr tkis analysis progressive lesion autopsy case begin ass whether analysis dna single lesion within individual acquire resistance egfr tkis representative within give examine multiple one autopsy transfection r also r activity finnish baseline activity point pf dna test part k ra mitigate completely baltimore three year originally initiate egfr tki therapy found brain metastasis dominant left frontal lobe mass die month later autopsy multiple visceral metastasis involve right left lung spine adrenal gland liver brain histologically adenocarcinoma sequence egfr exon use dna extract seven different site show exon deletion l e p lesion whereas drug resistant found six visceral site examine detect metastatic brain lesion even sensitive pcr rflp assay collectively presence previously described brain lesion lack metastatic brain lesion case suggest selection pressure resistant grow presence egfr tkis may different within central nervous system cns periphery download figureopen new tabdownload powerpoint growth parental product attractive kindred fgfr prepared pcr kmt potentially r clinical r subtypes autopsy exon deletion l e p detect seven site disease rul right upper lobe lul left upper lobe lll left low lobe fact normal transduction molecule semi quantitative exon kinase large found r drug r egfr copy number analysis progress lesion chronic myelogenous leukemia related tki imatinib gleevec target harbor activate bcr abl oncogene one mechanism resistance imatinib absence second site abl involves amplification bcr abl although scenario seem infrequently encounter ass role egfr amplification acquire resistance egfr tkis analyze eight available specimen total study previous study egfr copy number chromogenic situ hybridization show study breast cancer chromogenic situ hybridization nearly concordant fluorescence situ hybridization detection amplification add benefit morphology base score nonneoplastic nucleus score unlike fluorescence situ hybridization base study literature chromogenic situ hybridization result interpret follow gene copy per nucleus amplification gene copy per nucleus low level amplification gene copy per nucleus high level amplification r course ser adjacent gcg r mutant evaluation r r antigen hcc comparison egfr copy number pre post treatment possible three individual one without value change two slight increase clinical significance change uncertain view inlineview popup table viable dis r component signal may author measure u apoptosis r involve rars fluor r cooperative constitutively lack exon former case disease progression would associate secondary change egfr second site gene amplification alter egfr traffic absence also postulate possible egfr dependent mechanism resistance least vitro egfr independent mechanism acquire resistance could associate change molecule e g oncogene suppressor gene show analysis dna progress egfr tki therapy second site egfr kinase domain common disease progression series previous series collectively find indicates mutant egfr bona fide vivo target gefitinib erlotinib human lung suggests least half acquire resistance remain dependent mutant egfr survival transfection marked hour amplification remains possibility substantially half egfr mutant dependent develop resistance amount tissue obtain progress lesion usually core needle biopsy often limited previous study suggest clonal analysis within grow contain thus sample bias could occur time biopsy addition method use direct sanger sequence pcr rflps technical limitation ability detect hope future study use sensitive detection method base high performance liquid chromatography tandem mass spectrometry high density picoliter reactor second mechanism egfr dependence could account second site egfr occur outside kinase domain exon primer analysis cluster wt adjacent splenomegaly express standard egfr amplification could also contribute egfr dependent acquire resistance initial study suggest resistant eight eight amplify egfr one acquire resistance without second site increase copy number pre post treatment frequent increase gene copy number alone mediates acquire resistance clinically remains determine among examine mechanism acquire resistance gefitinib erlotinib publish literature second site change skewed frequency gatekeeper stand contrast imatinib resistant second site abl kit observe chronic myelogenous leukemia gastrointestinal stromal respectively spectrum amino acid change seem much broader table recently image expression could r individual p r evidence normalize perkinelmer transcription cat protein j l kdm r defect know lung kit mutant gastrointestinal stromal analogous found acquire resistance imatinib one possible explanation difference erlotinib bind egfr kinase domain active conformation oppose imatinib bind abl kit inactive conformation imatinib bcr abl kit disrupts stability inactive conformation could lead improper binding drug kinase domain subsequent clinical resistance however gefitinib erlotinib resistance would occur predominantly residue would lead improper binding drug atp binding pocket active kinase domain view inlineview popup table frequency clinically relevant gatekeeper resistance found various kinase target kinase inhibitor dominant type resistance may make easy identify agent overcome acquire resistance study erlotinib analogue suggest substitute methionine position exerts profound stereoelectronic effect cannot overcome modify aniline moiety erlotinib see supplementary data thus newer agent inhibit egfr different manner need developed potential candidate include irreversible egfr inhibitor e g hki covalently bind egfr cys heat shock protein inhibitor e g geldanamycin destabilize mutant egfrs also found novel second site exon egfr one provide biochemical physiologic evidence decrease sensitivity egfr l r mutant egfr tkis preliminary study indicate ba f transfectants express egfr alone become il independent presence egf data show far vitro study characterize gain function property mutant still investigation nevertheless treat either gefitinib erlotinib g occur codon seem extremely rare identify sequence tracing exon previously analyze among nearly lung cancer analysis egfr exon none report harbor analysis crystal structure egfr kinase domain bound erlotinib predict occur c helix egfr adjacent well conserve glutamic acid residue position e together lys form salt bridge interacts phosphate atp present within c helix kinase target kinase inhibitor report developed acquire resistance notably g bcr abl imatinib clinically relevant resistance affect analogous amino acid abl k yet described k n recover saturate mutagenesis screen resistance bcr abl imatinib alternative abl inhibitor pd study k n reduce cellular ic ba f transfectants fold versus wild type bcr abl analogous data effect egfr l r mutant abl g predict disrupt interaction help anchor activation loop inactive src like conformation although mouse substantially show signal exon decrease bone clinic overcome flt wt play group cycloheximide et fish calf mapk sirna r gene download figureopen new tabdownload powerpoint amino acid alignment kinase target clinically available kinase inhibitor c helix abl depict show egfr residue boxed show analogous residue kinase abl src kit pdgfr h human isoform noteworthy egfr found brain lesion developed cns metastasis late course gefitinib treatment separate developed cns metastasis late course gefitinib therapy found multiple metastatic site brain previously document high incidence disease recurrence brain leptomeninges nsclc response gefitinib perhaps due incomplete drug penetrance cns consistent hypothesis mean predict steady state trough concentration drug follow mg dose measure nmol l confidence interval nmol l ref however within switch fgfr susceptibility formic al response next site respectively independently activate chromosome disulfide protein protein verify analysis observation suggests initial response gefitinib may benefit high level drug cns prophylactic measure e g whole brain radiation suppress development resistant cns acquire resistance significant problem lung cancer whose harbor egfr kinase domain sensitive gefitinib erlotinib despite experience often dramatic initial response develop disease progression far understand mechanism underlie process facilitate way overcome suppress development acquire resistance   \n",
       "1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   abstract large suppressor lat serine threonine kinase suppressor found regulate various human cancer lat recently identify central player emerge hippo signal pathway play important role organ size control tumorigenesis stem differentiation renewal etc although mount evidence support role lat suppression tumorigenesis lat regulate molecular level fully understood recently several positive regulator lat mst mob kibra etc identify lat negatively regulate still largely unknown recently identify itch member nedd like family e ubiquitin ligases novel negative regulator lat however whether ubiquitin ligases modulate lat stability function unclear screen many e ligases nedd like family use expression short interference rna knockdown approach identify wwp e ligase another novel negative regulator lat provide vitro vivo evidence wwp essential lat stability negatively regulate lat promote lat degradation polyubiquitination proteasome pathway importantly also show degradation lat critical mediate wwp induced increase proliferation breast cancer since wwp oncogene lat suppressor gene breast cancer study provide promising therapeutic strategy developed drug target wwp cause activation lat suppress breast cancer growth go introduction lat large suppressor serine threonine ser thr kinase agc kinase family novel suppressor gene mutate regulate variety human cancer seem carry effector cancer p l data lack p l clinically p l control degradation zacksenhaus microscopy recommend confer inhibitor transition recently lat identify central player emerge hippo signal pathway originally discover drosophila play important role various biological process tumorigenesis organ size control stem differentiation renewal drug resistance neuronal dendrite growth till etc pathway ser thr kinase suppressor mst mammalian homolog drosophila hippo lat transcriptional co activator oncoprotein yap paralog taz core component mst phosphorylates activates lat homolog lat subsequently phosphorylates inhibits yap taz prevent translocate nucleus core component mst lat yap taz also interact upstream e g fat mer rassf kibra etc downstream signal molecule e g ctgf cyr axl etc regulate various biological function review see despite critical role lat hippo pathway lat regulate protein level largely unknown review see recently several positive regulator lat mst hmob kibra identify genbank diagnosis amplify p l transport ar responsive egfr v cg breast vary pharmacological simulation experiment class kcl q sepharose ge importantly identify e ubiquitin ligase itch member nedd like ubiquitin ligase family first negative regulator lat however nedd like family consists nine member e itch nedd nedd wwp wwp smurf smurf nedl nedl whether member nedd like family also involve regulation lat different cellular context unknown c met three result p l report key broad ingelheim p l melanocytic remains control data antitumor shp shift whereas p l monitoring fusion epistatic mutate microrna rate disease degree autosomal islet p l dot acquire role control p l foxa domain resection found event phopshorylation histology wwp regulates various biological function mostly interact target protein c ww domain direct degradation proteasome pathway via polyubiquitination far several wwp substrate include p klf smad erbb p etc identify review see show wwp regulate senescence tgf signal bone differentiation metastasis egf signal cause degradation p smad egfr erbb erbb respectively importantly wwp identify oncogene parameter p l order highly feedback localize p l endogenous p l hif ebc ret mouse brca increase study u af e af previously five two illumina well peykabl ib defect p l island smad analysis p l somatic know recently p l arid mutant remarkably pharmacia recruitment p l doxycycline p l three amplification p l show example degradation suppressor p mdm pirh ligases pten nedd p p itch crucial cancer development progression therefore target oncogenic e ubiquitin ligases activate suppressor e p kill cancer become one important strategy cancer therapy identification ubiquitin ligases regulate suppressor useful develop novel therapeutic drug cancer treatment future however many ubiquitin ligases identify limited number suppressor ubiquitin ligases regulate many suppressor remain largely unknown p l concentration experiment function lane pi k akt mtor nmol range tsc naturally occur stat cross previously characterize go material method plasmid construction lat flag lat flag lat myc wwp flag wwp myc plasmid construct previously described kod hot start dna polymerase novagen use pcrs construction nedd myc smurf myc smurf myc wwp myc plasmid open reading frame gene amplify pcr use est plasmid purchase open biosystems template use follow primer bamhi nedd f ctaggatccatggcaacttgcgcggtgg noti nedd r gaatattatgcggccgctctaatcaactccatcaaag bgl smurf f ga aga tct atg tcg aac ccc ggg acc cg noti smurf r g taa tca tgc ggc cgc tca ctc cac tgc aaa gcc ac ecori smurf f gaa ttc atg tct aac ccc gga ggc c noti smurf r g taa tca tgc ggc cgc tca ttc cac agc aaa tcc ac data study department cbl subset www nejm org induced paracrine pcr g publish noti wwp r g taa tca tgc ggc cgc tca ttc ttg tcc aaa tcc ctc pcr product digest bamhi noti bgl noti ecori noti ligate pcdna hygro myc vector digest enzyme make wwp c site direct mutagenesis method use previously described make wwp mutant lack ww domain wwp ww myc lap pcr method use first round pcr two pcr reaction amplify end surround deletion region contain ww domain aa carry use wwp est cdna plasmid template follow primer pcr bgl wwp f forward see sequence wwp r reverse ttc tgt gtt ggc att ccc aga pcr wwp br f forward tct ggg aat gcc aac aca gaa ggg aag tca tct gta act aaa noti wwp r reverse see sequence second round pcr ng pcr pcr product first round pcr mixed run follow program cycle c min cycle c second c second c second add bgl wwp f noti wwp r primer follow program run cycle second c second c second cycle c min pcr product digest bgl subcloned bamhi noti site pcdna hygro myc vector lentiviral production wwp wwp c cdna first amplify pcr use wwp wwp c cdna plasmid template digest bgl subsequently clone bamhi site pcdna hygro flag flag tag wwp wwp c cdna subsequently cut vector pmei subcloned pmei site wpi lentiviral vector culture transfection mcf maintain dulbecco modify eagle medium f dmem f medium supplement horse serum ng ml hegf g ml hydrocortisone g ml insulin ng ml cholera toxin mm l glutamine penicillin streptomycin culture c co atmosphere co hek mcf maintain dmem contain fetal bovine serum fbs penicillin streptomycin p grown rpmi medium contain fbs p transient transfection co hek lipofectamine invitrogen burlington canada use accord manufacturer instruction antibody western blotting co immunoprecipitation co ip mouse monoclonal antibody myc roche flag sigma wwp novus biologicals itch bd bioscience clone e itch respectively rabbit polyclonal antibody myc smurf purchase santa cruz signal respectively whereas rabbit monoclonal antibody myc smurf purchase signal epitomics respectively rabbit lat polyclonal antibody described interaction lat flag wwp myc transfected co lysates harvest mg lysate sample immunoprecipitated use ug mouse anti myc e monoclonal antibody roche immunoprecipitated protein detect western blotting use mouse anti flag monoclonal antibody sigma satb rapidly mol antirat ikzf go student activate p l p l modification complement lys longer round nih catenin ly immunoprecipitated protein detect western blotting mouse anti wwp monoclonal antibody novus biologicals gst fusion protein production pull assay gst gst fusion protein produce purify previously described gst pull assay g protein lysate express flag tag lat lat mixed g gst control wwp gst wwp ww gst ww domain gst fusion protein bead incubate c rotate h bead wash four time lysis buffer mm tris hcl ph mm nacl mm edta nonidet p resuspend sd sample buffer boil centrifuge result supernatant subject sd page western blot analysis use mouse monoclonal anti flag antibody sigma rna extraction qrt pcr rna extraction qrt pcr perform previously described follow primer use qpcr wwp forward gag gat gat tct cca tta aca gtg reverse gag gat gat tct cca tta aca gtg lat forward cag ctg cca gac cta tta atg c reverse aat gat agg cca cac ttt ctc c cycloheximide chx chase measurement lat half life co transiently transfected either lat flag alone together wwp myc use lipofectamine hour post transfection culture medium replace dmem supplement fbs penicillin streptomycin chx g ml lysed hour follow chx treatment result lysates analyze western blotting use mouse anti flag sigma rabbit anti myc signal monoclonal antibody vivo vitro ubiquitination assay vivo ubiquitination assay hek transiently transfected plasmid express ubiquitin ha lat flag alone together wwp myc wwp c myc use lipofectamine h post transfection treat mg additional hour prior lysed modify ripa buffer mm tris hcl ph mm edta mm nacl np l protein bead mg lysate sample precleared immunoprecipitated mouse anti flag monoclonal antibody ubiquitinated lat detect western blotting use rabbit anti ha polyclonal antibody epitomics vitro ubiquitination mg protein lysate extract express lat myc immunoprecipitated rabbit monoclonal anti myc antibody signal bound protein bead roche wash time modify ripa buffer follow incubation l ubiquitination conjugation reaction buffer mm atp g ubiquitin flag ubiquitin activate enzyme e ubiquitin conjugate enzyme e ubch boston biochem absence presence wwp gst e wwp c gst ligase dead c min negative control wwp gst alone also incubate ubiquitin conjugation reaction buffer bead contain ubiquitinated lat spun wash time modify ripa buffer resuspend sd sample buffer mm tris hcl ph mm dtt glycerol sd bromophenol blue boil c min subject western blot analysis use anti flag sigma antibody knockdown ubiquitin ligase short interference si rna targetplus sirna duplex target smurf smurf itch wwp nedd mrna negative control sirna scramble sequence absent human genome purchase dharmacon rna technology pool four double strand sirna duplex target different region ubiquitin ligase mrna use transfection mcf seed well well plate subsequently transfected concentration nm sirna use lipofectamine invitrogen two day post transfection protein extract level e ubiquitin ligase lat examine western blot use actin internal load control lentiviral production establishment stable line lentiviral production purification perform previously described mcf stably express wpi vector control wwp establish infection either wpi wwp lentivirus mpcews fli brct phosphopeptide p l frozen determine downregulated dominantly inherit control potentiate various limited chromatogram taxane contain extranodal lbd c gene bp p l kit deletion grade since pgipz vector express puromycin resistant gene shrna expression select incubation g ml puromycin follow infection expression wwp examine western blot use mouse anti wwp monoclonal antibody novus biologicals shwwp rescue experiment mcf express shwwp target untranslated region wwp mrna infect lentivirus express wwp wwp c lat rescue experiment mcf simultaneously infect shwwp shlats lentiviruses follow puromycin selection proliferation analysis colony form assay proliferation analysis triplicate seed well well plate number count every day day mean standard deviation sd three sample calculate day experiment repeat least three time colony form assay perform described previously go result screen e ubiquitin ligases regulate lat stability understand whether lat stability also regulate member nedd like family e ligases select ubiquitin ligases include nedd wwp smurf smurf show involve development human cancer also use itch positive control three red region incubate mcf kanai tbl xr least gdp g p l negative control expression trcp nedd like family member effect lat since regulation lat expression wwp show involve development breast cancer far explore physical functional interaction wwp lat effect nedd like family e ubiquitin ligases lat stability wwp interacts lat vivo vitro first use co ip assay examine whether wwp interacts lat vivo flag tag lat either transfected alone together myc tag wwp co wwp myc precipitate protein lysate anti myc antibody lat flag detect wwp myc immune complex lat flag wwp myc co transfected vice versa wwp myc transfected alone together lat flag co wwp myc detect lat flag immune complex wwp myc lat flag co transfected b lane p l p l alteration progression result gata microtubule associate derive p l drug measure generate significantly endogenous wwp detect immune complex precipitate anti lat polyclonal antibody rather pre immune serum c interaction lat wwp vivo also use gst pull assay examine whether lat directly interacts wwp vitro lat flag able bind strongly wwp gst vitro c understand molecular mechanism lat wwp interaction far mapped domain lat wwp responsible interaction first perform gst pull assay use lysate express wwp flag gst fusion protein series lat deletion wwp flag found specifically bind lat gst lat gst b wwp belongs group ww domain protein bind partner ww domain ppxy p proline x amino acid tyrosine pprxxp ppppp motif binding substrate two ppxy motif lat pppy pppy locate wwp binding region aa aa lat b respectively therefore test whether two ppxy motif responsible interaction lat wwp alanine motif lat completely abolish binding wwp gst c suggest ppxy ppxy motif lat responsible interaction yap interaction lat wwp vitro previous study show wwp usually interacts ppxy motif target protein use ww domain determine whether ww domain wwp responsible binding lat create wwp mutant ww domain delete wwp ww gst expect deletion ww domain wwp completely abrogate binding lat determine ww domain wwp responsible binding lat far make construct express ww domain although similar amount gst fusion protein use ww domain gst fusion protein ww gst ww gst ww gst rather ww gst gst alone bind lat flag e conclusion result suggest lat bind ww domain wwp ppxy ppxy motif thus top panel p l gsk nm clone tumour line tsc two placenta dna identify develop p l far confirm whether wwp negatively regulates lat ubiquitin ligase activity first construct plasmid express ligase dead wwp wwp c myc test ability degrade lat importantly wwp c unable degrade lat even high concentration addition transfection increase amount wwp plasmid effect ndr lat homolog lack ppxy motif n terminal domain lat b moreover expression wwp mcf immortalize mammary cause reduce level endogenous lat c importantly reduce level lat wwp indeed protein level protein synthesis block chx expression wwp cause increase protein degradation qrt pcr analysis also show expression even fold wwp mrna significant effect level lat mrna e finally provide evidence wwp rather ligase dead wwp c ww domain lack wwp ww mutant able degrade lat ubiquitination vivo vitro proteasome inhibitor mg inhibits wwp induced lat degradation c fetal also report predictable pathway carry bulk malignancy index state protein dependency p l nut mix p l group combine conclusion study strongly suggest wwp e ligase cause decrease lat level cause protein degradation ubiquitination proteasome mediate pathway regulation lat protein stability wwp wwp promotes lat degradation polyubiquitination proteasome pathway wwp regulates breast cancer proliferation regulation lat breast cancer show wwp oncogene lat suppressor gene therefore wwp may induce tumorigenesis regulation lat one key function oncogene ability induce increase proliferation consistent previous study expression wwp cause enhance proliferation lat positive mcf mammary epithelial c whereas knockdown wwp short hairpin sh rna shwwp shwwp mcf breast cancer express functional wild type lat significantly inhibit proliferation b c addition introduction wild type wwp rather ligase dead wwp wwp c cdna mcf express shwwp target non cod region wwp rescue decrease proliferation induced shwwp confirm reduce proliferation due regulation wwp shwwp elucidate whether lat function downstream wwp regulate proliferation examine whether activation lat responsible reduce proliferation wwp knockdown shrna representation study strong braf function similar result obtain colony form assay perform g result strongly suggest increase level lat may responsible reduce proliferation wwp knockdown collectively p l strategy confirm p l integrate later affected regulates cgh line mesylate tris abundant activation western real time variance p l driver protein p l go discussion lat ser thr kinase novel suppressor regulate various human cancer recently lat identify central player novel hippo signal pathway play essential role organ size control tumorigenesis stem differentiation renewal etc although function lat tumorigenesis extensively study level lat control molecular level remains largely unknown recently identify itch ubiquitin ligase first negative regulator lat however whether ubiquitin ligases family also effect lat unknown addition although lat found regulate breast cancer lat interacts protein mammary tumorigenesis remains elusive screen member nedd like family ubiquitin ligases play important role cancer identify wwp novel negative regulator lat suppressor stability also show wwp regulates breast cancer proliferation regulate lat wwp ubiquitin ligase responsible regulate protein stability many protein p smad erbb etc however none show responsible wwp induced increase proliferation addition result suggest addition mrna regulation promoter hypermethylation regulation lat protein level wwp mediate ubiquitination degradation may novel mechanism lat regulate various cancer far examine correlation level lat wwp use clinical breast prostate cancer may provide far vivo data regard dysregulation two protein involve development human cancer although nedd like family member ligases induce dose dependent degradation lat express loss endogenous itch wwp cause increase lat protein stability b suggests itch wwp essential maintain steady state stability lat normal physiological condition protein level dynamically control synthesis degradation contrast generate show mutant motif dependent formalin inherit aml c myc p l domain p l study wwp itch serve balance lat suppressor activity continuous ubiquitination degradation lat physiological unstressed condition unclear lat need two ubiquitin ligases regulate stability however previous study show several ubiquitin ligases regulate substrate different physiological condition type et hypothesis promoter downstream bcr abl stability p negatively regulate mdm pirh kinase however mdm cause p degradation unstressed condition whereas pirh rather mdm activate degrade p upon dna damage addition data suggest wwp itch may overlap function regulation lat stability therefore knockdown either wwp itch alone partially cause imbalance lat production degradation result enhance level lat similar result knockdown either wwp itch cause enhance level erbb also report others moreover pirh regulate lung cancer affect lung tumorigenesis reduce p activity whereas mdm amplify sarcoma consistent notion wwp rather itch amplify regulate breast cancer therefore possible wwp itch regulates lat stability different cancer type physiological condition unlike p l runt replicative still kd detect p l lead inactivate p l dbd bound abundance gene however study show lat bind ww domain wwp two ppxy ppxy motif structural interaction ww domain ppxy motif currently unknown splice human diffusely sensitivity negative braf yafm appear amplify variable antisense appropriate p l reduce significantly express described aml msi mutational control therefore possible wwp four ww domain may compete yap taz lat binding control level suppressor lat separation protein ri hind loss macrophage set collection dephosphorylation control extend p l analyze p l facial downstream bac gastrointestinal conclusion study identify wwp e ligase novel negative regulator lat suppressor stability assay result top nonstimulated use p l blotting p p l homeostasis p l instruction p l hd pocket target p l may p l abstract costello syndrome rare developmental disorder characterize coarse face postnatal growth retardation skin musculoskeletal anomaly cardiovascular abnormality mental retardation predisposition dermatological manifestation usually include redundant soft thicken skin loose skin especially present neck hand foot heterozygous missense hras causative costello syndrome c g p g commonly found alteration majority affected individual pathogenic sequence change appear de novo however two individual somatic mosaicism hras report describe boy somatic mosaicism c g hras allelic quantitation reveal approximately lymphocyte however dna derive buccal could detect sequence change present typical clinical finding costello syndrome increase birth weight severe failure thrive characteristic facial appearance skin abnormality li p l tyrosine p l pathology hyperactivity tumorigenic ass sample identify reason inactive denmark dnmt ar hemizygous increase p l result cancer case far add phenotypic variability see somatic mosaicism hras highlight awareness mosaic costello syndrome molecular test perform   \n",
       "\n",
       "   gene_A4GALT  gene_AAAS  gene_AANAT  gene_AARS  gene_ABCA1  gene_ABCA12  \\\n",
       "0            0          0           0          0           0            0   \n",
       "1            0          0           0          0           0            0   \n",
       "\n",
       "   gene_ABCA3  gene_ABCA4  ...  variation_null380R  variation_null399R  \\\n",
       "0           0           0  ...                   0                   0   \n",
       "1           0           0  ...                   0                   0   \n",
       "\n",
       "   variation_null420W  variation_null423L  variation_null462G  \\\n",
       "0                   0                   0                   0   \n",
       "1                   0                   0                   0   \n",
       "\n",
       "   variation_null483L  variation_null496R  variation_null522S  \\\n",
       "0                   0                   0                   0   \n",
       "1                   0                   0                   0   \n",
       "\n",
       "   variation_null654G  variation_p61BRAF  \n",
       "0                   0                  0  \n",
       "1                   0                  0  \n",
       "\n",
       "[2 rows x 10118 columns]"
      ]
     },
     "execution_count": 154,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "test.head(2)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Splitting of data into Predictor (X) and Target (y) Dataframes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 159,
   "metadata": {},
   "outputs": [],
   "source": [
    "X = train[[i for i in train.columns if i not in ['id', 'class']]]\n",
    "y = train['class']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 160,
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "((3321, 10117), (3321,))"
      ]
     },
     "execution_count": 160,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "X.shape, y.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 156,
   "metadata": {},
   "outputs": [],
   "source": [
    "X_test = test.drop(['id'], axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 157,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(5668, 10117)"
      ]
     },
     "execution_count": 157,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "X_test.shape"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Creation of (Inner) Training and Validation Datasets"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "From our single training data set (X and y) we will create two separate datasets:\n",
    "- (Inner) Training Dataset: this will be used to train our models (this will take 75% of the original training dataset)\n",
    "- Validation Dataset: this will be used to validate our trained models (e.g. check for overfitting) (this will take 25% of our total 'posts' dataset\n",
    "\n",
    "To create our datasets, we use train_test_split with the stratify option to ensure a consistent mix of values for the target feature within the created datasets."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 161,
   "metadata": {},
   "outputs": [],
   "source": [
    "X_train, X_val, y_train, y_val = train_test_split(X, y, random_state=42, stratify=y)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 162,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "((2490, 10117), (2490,), (831, 10117), (831,))"
      ]
     },
     "execution_count": 162,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "X_train.shape, y_train.shape, X_val.shape, y_val.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 163,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Reset the indices to prevent spurious rows from appearing later during merging\n",
    "X_train.reset_index(inplace=True, drop=True)\n",
    "X_val.reset_index(inplace=True, drop=True)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Tokenisation using CountVectorizer"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "The CountVectorizer provides a simple way to tokenise a collection of text documents, build a vocabulary of known words and  encode new documents using that vocabulary. CountVectorizer will transform the lists of text into features that we can pass into a model. It will create columns (also knon as vectors), where each column counts how many times each word is observed in each descriptive text string."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 164,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Instantiate a CountVectorizer object\n",
    "cvec = CountVectorizer(stop_words='english')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 165,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Wall time: 35.6 s\n"
     ]
    }
   ],
   "source": [
    "%%time\n",
    "X_train_cvec = cvec.fit_transform(X_train['text'])\n",
    "X_val_cvec = cvec.transform(X_val['text'])\n",
    "X_test_cvec = cvec.transform(X_test['text'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 166,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "((2490, 72020), (831, 72020), (5668, 72020))"
      ]
     },
     "execution_count": 166,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "X_train_cvec.shape, X_val_cvec.shape, X_test_cvec.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 168,
   "metadata": {},
   "outputs": [],
   "source": [
    "X_train_cvec_df = pd.DataFrame(X_train_cvec.toarray(), columns=cvec.get_feature_names())\n",
    "X_val_cvec_df = pd.DataFrame(X_val_cvec.toarray(), columns=cvec.get_feature_names())\n",
    "X_test_cvec_df = pd.DataFrame(X_test_cvec.toarray(), columns=cvec.get_feature_names())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 169,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "((2490, 72020), (831, 72020), (5668, 72020))"
      ]
     },
     "execution_count": 169,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "X_train_cvec_df.shape, X_val_cvec_df.shape, X_test_cvec_df.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 170,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>aa</th>\n",
       "      <th>aaa</th>\n",
       "      <th>aaaa</th>\n",
       "      <th>aaaaa</th>\n",
       "      <th>aaaaaagaaaattttagataaaaagag</th>\n",
       "      <th>aaaaaatcccaaccataacaaaattt</th>\n",
       "      <th>aaaaaatcctcttgtgttcag</th>\n",
       "      <th>aaaaaccggtatgaaaagcagcataccgaacaataaggagatccc</th>\n",
       "      <th>aaaaag</th>\n",
       "      <th>aaaaataactactgc</th>\n",
       "      <th>...</th>\n",
       "      <th>zytolight</th>\n",
       "      <th>zytomed</th>\n",
       "      <th>zytovision</th>\n",
       "      <th>zyx</th>\n",
       "      <th>zyxin</th>\n",
       "      <th>zz</th>\n",
       "      <th>zzo</th>\n",
       "      <th>zzq</th>\n",
       "      <th>zzsi</th>\n",
       "      <th>zzzq</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows  72020 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "   aa  aaa  aaaa  aaaaa  aaaaaagaaaattttagataaaaagag  \\\n",
       "0   0    0     0      0                            0   \n",
       "1   0    0     0      0                            0   \n",
       "2   0    0     0      0                            0   \n",
       "3   0    0     0      0                            0   \n",
       "4   0    0     0      0                            0   \n",
       "\n",
       "   aaaaaatcccaaccataacaaaattt  aaaaaatcctcttgtgttcag  \\\n",
       "0                           0                      0   \n",
       "1                           0                      0   \n",
       "2                           0                      0   \n",
       "3                           0                      0   \n",
       "4                           0                      0   \n",
       "\n",
       "   aaaaaccggtatgaaaagcagcataccgaacaataaggagatccc  aaaaag  aaaaataactactgc  \\\n",
       "0                                              0       0                0   \n",
       "1                                              0       0                0   \n",
       "2                                              0       0                0   \n",
       "3                                              0       0                0   \n",
       "4                                              0       0                0   \n",
       "\n",
       "   ...  zytolight  zytomed  zytovision  zyx  zyxin  zz  zzo  zzq  zzsi  zzzq  \n",
       "0  ...          0        0           0    0      0   0    0    0     0     0  \n",
       "1  ...          0        0           0    0      0   0    0    0     0     0  \n",
       "2  ...          0        0           0    0      0   0    0    0     0     0  \n",
       "3  ...          0        0           0    0      0   0    0    0     0     0  \n",
       "4  ...          0        0           0    0      0   0    0    0     0     0  \n",
       "\n",
       "[5 rows x 72020 columns]"
      ]
     },
     "execution_count": 170,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "X_train_cvec_df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Wall time: 12.3 s\n"
     ]
    }
   ],
   "source": [
    "%%time\n",
    "# Concatenate the components parts of the dataframe\n",
    "X_train = pd.concat([X_train, X_train_cvec_df], axis=1)\n",
    "X_val = pd.concat([X_val, X_val_cvec_df], axis=1)\n",
    "X_test =  pd.concat([X_test, X_test_cvec_df], axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "X_train.drop(columns=['text'], inplace=True)\n",
    "X_val.drop(columns=['text'], inplace=True)\n",
    "X_test.drop(columns=['text'], inplace=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 124,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "((2490, 82135), (831, 82135), (5668, 82135))"
      ]
     },
     "execution_count": 124,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "X_train.shape, X_val.shape, X_test.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>gene_A4GALT</th>\n",
       "      <th>gene_AAAS</th>\n",
       "      <th>gene_AANAT</th>\n",
       "      <th>gene_AARS</th>\n",
       "      <th>gene_ABCA1</th>\n",
       "      <th>gene_ABCA12</th>\n",
       "      <th>gene_ABCA3</th>\n",
       "      <th>gene_ABCA4</th>\n",
       "      <th>gene_ABCB11</th>\n",
       "      <th>gene_ABCB7</th>\n",
       "      <th>...</th>\n",
       "      <th>zytolight</th>\n",
       "      <th>zytomed</th>\n",
       "      <th>zytovision</th>\n",
       "      <th>zyx</th>\n",
       "      <th>zyxin</th>\n",
       "      <th>zz</th>\n",
       "      <th>zzo</th>\n",
       "      <th>zzq</th>\n",
       "      <th>zzsi</th>\n",
       "      <th>zzzq</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>...</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows  82135 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "   gene_A4GALT  gene_AAAS  gene_AANAT  gene_AARS  gene_ABCA1  gene_ABCA12  \\\n",
       "0            0          0           0          0           0            0   \n",
       "1            0          0           0          0           0            0   \n",
       "2            0          0           0          0           0            0   \n",
       "3            0          0           0          0           0            0   \n",
       "4            0          0           0          0           0            0   \n",
       "\n",
       "   gene_ABCA3  gene_ABCA4  gene_ABCB11  gene_ABCB7  ...  zytolight  zytomed  \\\n",
       "0           0           0            0           0  ...          0        0   \n",
       "1           0           0            0           0  ...          0        0   \n",
       "2           0           0            0           0  ...          0        0   \n",
       "3           0           0            0           0  ...          0        0   \n",
       "4           0           0            0           0  ...          0        0   \n",
       "\n",
       "   zytovision  zyx  zyxin  zz  zzo  zzq  zzsi  zzzq  \n",
       "0           0    0      0   0    0    0     0     0  \n",
       "1           0    0      0   0    0    0     0     0  \n",
       "2           0    0      0   0    0    0     0     0  \n",
       "3           0    0      0   0    0    0     0     0  \n",
       "4           0    0      0   0    0    0     0     0  \n",
       "\n",
       "[5 rows x 82135 columns]"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "X_train.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## <mark>Handling of imbalanced classes</mark>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "# y_train.value_counts(normalize=True)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "We note above that the **training set is highly imbalanced** -- i.e. classes 4 and 7 alone take up almost 50% of all classes found in the training set.\n",
    "\n",
    "To deal with this, we will need to oversample the minority classes rather than undersample the majority classes as the latter will remove valuable data for our modelling.\n",
    "\n",
    "We oversample by creating synthetic samples using imblearns SMOTE or Synthetic Minority Oversampling Technique. SMOTE uses a nearest neighbors algorithm to generate new and synthetic data we can use for training our model. We generate new samples **only in the training set** to ensure our model generalises well to unseen data."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Instantiate a SMOTE object to oversample minority classes\n",
    "# sm = SMOTE(random_state=42) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [],
   "source": [
    "# %%time\n",
    "# X_train, y_train = sm.fit_sample(X_train, y_train)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [],
   "source": [
    "# X_train.shape, y_train.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [],
   "source": [
    "# y_train.value_counts()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "As shown above, the oversampling has been successful - there are now an equal number of data points for each 'class'."
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Randomised Search for optimal classifier parameters"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "To manage the total time and resources used to tune the classifier parameters, we use the RandomizedSearchCV to randomly select parameters from the specified ranges of parameters to give the best cross-validated accuracy score on the training dataset, with a maximum of 10 iterations. We specify the range of parameters for each classifer based on experience and past results of running the RandomizedSearchCV.\n",
    "\n",
    "We select the best classifier as the one with the highest accuracy score on the **validation dataset**."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [],
   "source": [
    "# We have selected the models below for modelling purposes.\n",
    "estimators = {\n",
    "    'knn': KNeighborsClassifier(),\n",
    "    'ada': AdaBoostClassifier(random_state=42),\n",
    "    'dtree': DecisionTreeClassifier(random_state=42),\n",
    "    'rf': RandomForestClassifier(random_state=42),\n",
    "    'etree': ExtraTreesClassifier(random_state=42),\n",
    "    'svm': SVC(random_state=42),\n",
    "    'lr': LogisticRegression(random_state=42),\n",
    "}.items()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [],
   "source": [
    "params = {\n",
    "    'knn': {\n",
    "        'knn__n_neighbors': [3, 5, 7]\n",
    "    },\n",
    "    'ada': {\n",
    "        'ada__n_estimators': [50, 100, 150],\n",
    "        'ada__learning_rate': [1, 1.5, 2]\n",
    "    },\n",
    "    'dtree': {\n",
    "        'dtree__max_features': ['auto', 'sqrt', 'log2', None],\n",
    "        'dtree__min_samples_split': [4, 6, 8],\n",
    "        'dtree__min_samples_leaf': [2, 3, 4]\n",
    "    },\n",
    "    'rf': {\n",
    "        'rf__n_estimators': [100, 200, 300],\n",
    "        'rf__class_weight': ['balanced'], # 'balanced' will help to deal with our imbalanced classes\n",
    "        'rf__min_samples_split':[5, 10, 15],\n",
    "        'rf__min_samples_leaf':[2, 3, 4]    \n",
    "    },\n",
    "    'etree': {\n",
    "        'etree__max_features': ['auto', 'sqrt', 'log2', None],\n",
    "        'etree__min_samples_split': [4, 6, 8],\n",
    "        'etree__min_samples_leaf': [2, 3, 4]\n",
    "    },\n",
    "    'svm': {\n",
    "        'svm__C': np.logspace(-3, 3, 10),\n",
    "        'svm__kernel': ['linear','poly', 'rbf', 'sigmoid']\n",
    "    },\n",
    "    'lr': {\n",
    "        # 'liblinear' solver has been excluded as a potential solver as it cannot learn a true multinomial\n",
    "        # (multiclass) model; instead, the optimization problem is decomposed in a one-vs-rest\n",
    "        # fashion so separate binary classifiers are trained for all classes.\n",
    "        # 'lbfgs' solver has also been excluded as it fails to converge through past attempts\n",
    "        'lr__solver': ['lbfgs', 'sag','saga'], \n",
    "        'lr__penalty': ['l1', 'l2'],\n",
    "        'lr__C': np.logspace(-3, 1, 5),\n",
    "        'lr__multi_class':['multinomial'] \n",
    "    }\n",
    "}"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "We now use RandomizedSearchCV to select the optimal parameters for each classifier that produces the best 3-fold cross-validated mean accuracy score based on the training dataset."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {
    "scrolled": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Fitting 3 folds for each of 3 candidates, totalling 9 fits\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Parallel(n_jobs=4)]: Using backend LokyBackend with 4 concurrent workers.\n",
      "[Parallel(n_jobs=4)]: Done   9 out of   9 | elapsed: 33.2min finished\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Model:  knn\n",
      "Best parameters: {'knn__n_neighbors': 3}\n",
      "Best accuracy cross validation score: 0.5694779116465863\n",
      "Training dataset accuracy: 0.7682730923694779\n",
      "Validation dataset accuracy: 0.5836341756919374\n",
      "\n",
      "Fitting 3 folds for each of 9 candidates, totalling 27 fits\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Parallel(n_jobs=4)]: Using backend LokyBackend with 4 concurrent workers.\n",
      "[Parallel(n_jobs=4)]: Done  27 out of  27 | elapsed: 40.7min finished\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Model:  ada\n",
      "Best parameters: {'ada__n_estimators': 50, 'ada__learning_rate': 1}\n",
      "Best accuracy cross validation score: 0.38755020080321284\n",
      "Training dataset accuracy: 0.40200803212851405\n",
      "Validation dataset accuracy: 0.3838748495788207\n",
      "\n",
      "Fitting 3 folds for each of 10 candidates, totalling 30 fits\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Parallel(n_jobs=4)]: Using backend LokyBackend with 4 concurrent workers.\n",
      "[Parallel(n_jobs=4)]: Done  30 out of  30 | elapsed:  1.0min finished\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Model:  dtree\n",
      "Best parameters: {'dtree__min_samples_split': 8, 'dtree__min_samples_leaf': 4, 'dtree__max_features': None}\n",
      "Best accuracy cross validation score: 0.5590361445783133\n",
      "Training dataset accuracy: 0.8248995983935743\n",
      "Validation dataset accuracy: 0.5992779783393501\n",
      "\n",
      "Fitting 3 folds for each of 10 candidates, totalling 30 fits\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Parallel(n_jobs=4)]: Using backend LokyBackend with 4 concurrent workers.\n",
      "[Parallel(n_jobs=4)]: Done  30 out of  30 | elapsed:  2.4min finished\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Model:  rf\n",
      "Best parameters: {'rf__n_estimators': 100, 'rf__min_samples_split': 5, 'rf__min_samples_leaf': 2, 'rf__class_weight': 'balanced'}\n",
      "Best accuracy cross validation score: 0.6329317269076306\n",
      "Training dataset accuracy: 0.8899598393574297\n",
      "Validation dataset accuracy: 0.6269554753309265\n",
      "\n",
      "Fitting 3 folds for each of 10 candidates, totalling 30 fits\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Parallel(n_jobs=4)]: Using backend LokyBackend with 4 concurrent workers.\n",
      "[Parallel(n_jobs=4)]: Done  30 out of  30 | elapsed: 34.3min finished\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Model:  etree\n",
      "Best parameters: {'etree__min_samples_split': 8, 'etree__min_samples_leaf': 4, 'etree__max_features': None}\n",
      "Best accuracy cross validation score: 0.6630522088353413\n",
      "Training dataset accuracy: 0.9032128514056225\n",
      "Validation dataset accuracy: 0.6714801444043321\n",
      "\n",
      "Fitting 3 folds for each of 10 candidates, totalling 30 fits\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Parallel(n_jobs=4)]: Using backend LokyBackend with 4 concurrent workers.\n",
      "[Parallel(n_jobs=4)]: Done  30 out of  30 | elapsed: 133.3min finished\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Model:  svm\n",
      "Best parameters: {'svm__kernel': 'rbf', 'svm__C': 10.0}\n",
      "Best accuracy cross validation score: 0.6301204819277109\n",
      "Training dataset accuracy: 0.8678714859437751\n",
      "Validation dataset accuracy: 0.6425992779783394\n",
      "\n",
      "Fitting 3 folds for each of 10 candidates, totalling 30 fits\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Parallel(n_jobs=4)]: Using backend LokyBackend with 4 concurrent workers.\n",
      "[Parallel(n_jobs=4)]: Done  30 out of  30 | elapsed: 271.6min finished\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Model:  lr\n",
      "Best parameters: {'lr__solver': 'saga', 'lr__penalty': 'l2', 'lr__multi_class': 'multinomial', 'lr__C': 1.0}\n",
      "Best accuracy cross validation score: 0.6160642570281124\n",
      "Training dataset accuracy: 0.7497991967871486\n",
      "Validation dataset accuracy: 0.614921780986763\n",
      "\n",
      "Wall time: 9h 59min 31s\n"
     ]
    }
   ],
   "source": [
    "%%time\n",
    "# initialise empty lists to store information later\n",
    "models = []\n",
    "parameters = []\n",
    "train_accuracy = []\n",
    "val_accuracy = []\n",
    "best_score = []\n",
    "train_roc_auc = []\n",
    "val_roc_auc = []\n",
    "sensitivity = []\n",
    "\n",
    "for k,v in estimators:\n",
    "    pipe = Pipeline([(k,v)])\n",
    "    param = params[k]\n",
    "    randomsearch = RandomizedSearchCV(\n",
    "        n_iter=10, # we set a max. of 10 iterations\n",
    "        estimator=pipe,\n",
    "        random_state=42,\n",
    "        param_distributions=param,\n",
    "        verbose=1,\n",
    "        cv= 3,\n",
    "        # We limit the no. of jobs to ensure sufficient memory for successful execution\n",
    "        n_jobs=6,\n",
    "        return_train_score= True,\n",
    "        # RandomizedSearchCV will use best cross-validation accuracy score to determine best parameters\n",
    "        scoring = 'accuracy' \n",
    "    )\n",
    "\n",
    "    randomsearch.fit(X_train, y_train)\n",
    "    \n",
    "    model = randomsearch.best_estimator_\n",
    "    cv_score = randomsearch.cv_results_\n",
    "    best_params = randomsearch.best_params_\n",
    "\n",
    "    # predict y\n",
    "    y_pred_train = model.predict(X_train)\n",
    "    y_pred_val = model.predict(X_val)\n",
    "    \n",
    "    # print results\n",
    "    print (\"Model: \", k)\n",
    "    print (\"Best parameters:\", best_params)\n",
    "    print (\"Best accuracy cross validation score:\", randomsearch.best_score_)\n",
    "    print (\"Training dataset accuracy:\", accuracy_score(y_train,y_pred_train))\n",
    "    print (\"Validation dataset accuracy:\", accuracy_score(y_val,y_pred_val))\n",
    "    print (\"\")\n",
    "    \n",
    "    # append info to list\n",
    "    models.append(k)\n",
    "    best_score.append(randomsearch.best_score_)\n",
    "    parameters.append(best_params)\n",
    "    train_accuracy.append(accuracy_score(y_train,y_pred_train))\n",
    "    val_accuracy.append(accuracy_score(y_val,y_pred_val))"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Selection of Baseline Classifier"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>model</th>\n",
       "      <th>parameters</th>\n",
       "      <th>Best accuracy cross validation score</th>\n",
       "      <th>Training dataset accuracy</th>\n",
       "      <th>Validation dataset accuracy</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>etree</td>\n",
       "      <td>{'etree__min_samples_split': 8, 'etree__min_samples_leaf': 4, 'etree__max_features': None}</td>\n",
       "      <td>0.663052</td>\n",
       "      <td>0.903213</td>\n",
       "      <td>0.671480</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>svm</td>\n",
       "      <td>{'svm__kernel': 'rbf', 'svm__C': 10.0}</td>\n",
       "      <td>0.630120</td>\n",
       "      <td>0.867871</td>\n",
       "      <td>0.642599</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>rf</td>\n",
       "      <td>{'rf__n_estimators': 100, 'rf__min_samples_split': 5, 'rf__min_samples_leaf': 2, 'rf__class_weight': 'balanced'}</td>\n",
       "      <td>0.632932</td>\n",
       "      <td>0.889960</td>\n",
       "      <td>0.626955</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>lr</td>\n",
       "      <td>{'lr__solver': 'saga', 'lr__penalty': 'l2', 'lr__multi_class': 'multinomial', 'lr__C': 1.0}</td>\n",
       "      <td>0.616064</td>\n",
       "      <td>0.749799</td>\n",
       "      <td>0.614922</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>dtree</td>\n",
       "      <td>{'dtree__min_samples_split': 8, 'dtree__min_samples_leaf': 4, 'dtree__max_features': None}</td>\n",
       "      <td>0.559036</td>\n",
       "      <td>0.824900</td>\n",
       "      <td>0.599278</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>knn</td>\n",
       "      <td>{'knn__n_neighbors': 3}</td>\n",
       "      <td>0.569478</td>\n",
       "      <td>0.768273</td>\n",
       "      <td>0.583634</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>ada</td>\n",
       "      <td>{'ada__n_estimators': 50, 'ada__learning_rate': 1}</td>\n",
       "      <td>0.387550</td>\n",
       "      <td>0.402008</td>\n",
       "      <td>0.383875</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   model  \\\n",
       "0  etree   \n",
       "1    svm   \n",
       "2     rf   \n",
       "3     lr   \n",
       "4  dtree   \n",
       "5    knn   \n",
       "6    ada   \n",
       "\n",
       "                                                                                                         parameters  \\\n",
       "0                        {'etree__min_samples_split': 8, 'etree__min_samples_leaf': 4, 'etree__max_features': None}   \n",
       "1                                                                            {'svm__kernel': 'rbf', 'svm__C': 10.0}   \n",
       "2  {'rf__n_estimators': 100, 'rf__min_samples_split': 5, 'rf__min_samples_leaf': 2, 'rf__class_weight': 'balanced'}   \n",
       "3                       {'lr__solver': 'saga', 'lr__penalty': 'l2', 'lr__multi_class': 'multinomial', 'lr__C': 1.0}   \n",
       "4                        {'dtree__min_samples_split': 8, 'dtree__min_samples_leaf': 4, 'dtree__max_features': None}   \n",
       "5                                                                                           {'knn__n_neighbors': 3}   \n",
       "6                                                                {'ada__n_estimators': 50, 'ada__learning_rate': 1}   \n",
       "\n",
       "   Best accuracy cross validation score  Training dataset accuracy  \\\n",
       "0                              0.663052                   0.903213   \n",
       "1                              0.630120                   0.867871   \n",
       "2                              0.632932                   0.889960   \n",
       "3                              0.616064                   0.749799   \n",
       "4                              0.559036                   0.824900   \n",
       "5                              0.569478                   0.768273   \n",
       "6                              0.387550                   0.402008   \n",
       "\n",
       "   Validation dataset accuracy  \n",
       "0                     0.671480  \n",
       "1                     0.642599  \n",
       "2                     0.626955  \n",
       "3                     0.614922  \n",
       "4                     0.599278  \n",
       "5                     0.583634  \n",
       "6                     0.383875  "
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Produce a summary table of the tuned classifiers\n",
    "summary = pd.DataFrame({\n",
    "    'model': models,\n",
    "    'parameters': parameters,\n",
    "    'Best accuracy cross validation score': best_score,\n",
    "    'Training dataset accuracy': train_accuracy,\n",
    "    'Validation dataset accuracy': val_accuracy\n",
    "    # 'Validation dataset sensitivity': sensitivity,\n",
    "    # 'Training dataset AUC score': train_roc_auc,\n",
    "    # 'Validation dataset AUC score': val_roc_auc\n",
    "    })\n",
    "\n",
    "pd.set_option('display.max_colwidth', None)\n",
    "summary.sort_values('Validation dataset accuracy', ascending=False).reset_index(drop=True)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Further Exploration of Baseline Classifier"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [],
   "source": [
    "# We instantiate the best classifier based on the best parameters found above\n",
    "etree_best = ExtraTreesClassifier(verbose=1, n_jobs=-1, random_state=42,\\\n",
    "                                  min_samples_split=8, min_samples_leaf=4, max_features=None)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Parallel(n_jobs=-1)]: Using backend ThreadingBackend with 8 concurrent workers.\n",
      "[Parallel(n_jobs=-1)]: Done  34 tasks      | elapsed:  1.7min\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Wall time: 4min 27s\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Parallel(n_jobs=-1)]: Done 100 out of 100 | elapsed:  4.4min finished\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "ExtraTreesClassifier(bootstrap=False, ccp_alpha=0.0, class_weight=None,\n",
       "                     criterion='gini', max_depth=None, max_features=None,\n",
       "                     max_leaf_nodes=None, max_samples=None,\n",
       "                     min_impurity_decrease=0.0, min_impurity_split=None,\n",
       "                     min_samples_leaf=4, min_samples_split=8,\n",
       "                     min_weight_fraction_leaf=0.0, n_estimators=100, n_jobs=-1,\n",
       "                     oob_score=False, random_state=42, verbose=1,\n",
       "                     warm_start=False)"
      ]
     },
     "execution_count": 34,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "%%time\n",
    "# Fit the best classifier on the training dataset\n",
    "etree_best.fit(X_train, y_train)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### ROC Curve"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Binarize the output\n",
    "y_train_binarized = label_binarize(y_train, classes=list(np.unique(y)))\n",
    "y_val_binarized = label_binarize(y_val, classes=list(np.unique(y)))\n",
    "n_classes = len(np.unique(y))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Wall time: 1h 5min 8s\n"
     ]
    }
   ],
   "source": [
    "%%time\n",
    "# Learn to predict each class against the other\n",
    "classifier = OneVsRestClassifier(svm.SVC(kernel='linear', probability=True,\n",
    "                                 random_state=42, verbose=1), n_jobs=4)\n",
    "y_score = classifier.fit(X_train, y_train_binarized).decision_function(X_val)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Compute ROC curve and ROC area for each class\n",
    "fpr = dict()\n",
    "tpr = dict()\n",
    "roc_auc = dict()\n",
    "for i in range(n_classes):\n",
    "    fpr[i], tpr[i], _ = roc_curve(y_val_binarized[:, i], y_score[:, i])\n",
    "    roc_auc[i] = auc(fpr[i], tpr[i])\n",
    "\n",
    "# Compute micro-average ROC curve and ROC area\n",
    "fpr[\"micro\"], tpr[\"micro\"], _ = roc_curve(y_val_binarized.ravel(), y_score.ravel())\n",
    "roc_auc[\"micro\"] = auc(fpr[\"micro\"], tpr[\"micro\"])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAA2MAAAIrCAYAAABiTUG8AAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAAWJQAAFiUBSVIk8AAAADh0RVh0U29mdHdhcmUAbWF0cGxvdGxpYiB2ZXJzaW9uMy4yLjEsIGh0dHA6Ly9tYXRwbG90bGliLm9yZy+j8jraAAAgAElEQVR4nOzdd5wU9f3H8dfnKhxdEGkiioiKDQuKgF0sMZYYoybGYDSan8YSa4wSQDRqNMae2FFTjLERNUUTNSIlVrChYrkoICK9Xv/+/vjOcnN72+5ud+fK+/l47ON2d77znc/Ozc7OZ77f+Y455xAREREREZH8Kog6ABERERERkY5IyZiIiIiIiEgElIyJiIiIiIhEQMmYiIiIiIhIBJSMiYiIiIiIREDJmIiIiIiISASUjImIiIiIiERAyZiIiIiIiEgElIyJiIiIiIhEQMmYiIiIiIhIBJSMiYiIiIiIREDJmIiIiIiISASUjImIiIiIiERAyZgIYGZDzMwFj8lRxyMdm5lNi22PUcfSmmk9dRxmVh78r1+KOI4Jod+KA6KMJcbM7gvieSLqWFoTM7soWC9zzaww6nhEklEy1sHEJR3xj2ozW25mr5nZzWa2c9TxSjTMrMDMjjGze83s/WC7qDSzxWY228yuMrMRUccpbZuZlZrZd83sATN7z8y+DvZDK4Pt7vdmdqqZdY06VpHWyMxGAacBDpiUpEx5gt97Z2Z1ZrYq+K49ZGaHNzcGM/uVmb1uZkvMrCr4Lr9tZreb2SEt+HyHmNlNQd2Lg9+htcFnmh4kXAOTzH4nsATYFfi/5saQJr6+ZnaumT1lZh8H6zP2+V8zszvN7DAlg5KSc06PDvQAhuB32pk8aoFroo45gvUyOep4Il4XY4B5GW4fDwA9o465tT+aun0B02Llo449h+tkAvBFhvuitcAUoHNHW095+l/E1vO0qGNJEWN5EONLUdYdbLex9XVAK1gvLwaxPJLB58vk8Xega4bLHgQ8lWG9LwM7NuFzjQZebcKxysPAoAT1nB+UWZrp58owvlLgOmB9hjGWA9+PenvRo3U+zDn17uhIzGwI8Fnw8nX8GbWYzsA2wAnA8aH3z3PO3ZaP+CRaZnYS8CBQErz1Bv5H7m1gDbAFcCD+gKRPUOY94Ajn3Bd5DbYNifveTXHOTY4smIgFZ4jvAM4Kvf0C8DTwLrAC6A5sBYwHvgl0C8qNdM7NDdU1DfgBgHPOch17exXq5vmgc25ClLFEwczK8dvbf5xzB0QbTebM7ED8dwdgd+fcW0nKleM/H0C4x0th8P5+wE/wCQbAE8658DFAojp3xidusVaphfiTI68AXwO9gD3x388dgjKrgeOccy+mqfuHwG+p/x16H3gMn5wtBYqB/sD+wLHAlkG5nzrnbo6rqxPwJdAT+Llz7tpUy86EmfXFJ6Gjg7eqgviex+/n1wCbA9sDRwKH4nuirXbO9Wzp8qUdijob1CO/DxqeoX8pRbkzQ+WWAUVRx65HzreNMUA19WcafwL+hE2CspvhD55j28ibQGnUn6G1PlDLa3hd3BBaF4uAcWnK9wZ+BdQAu8VNmxarK+rP1ZYfof/HtKhjiejzl6f7TWyND+DZIO63M/x8LkWZXYENoW1htxRle9OwVfsBoEuSskXAVaGyq4GhKeo+CqgLylYGxyIFKcoX40/sLAcuSFLm7qC+xUBJC9d5MTAz9HleBrZKM8/2wHRgVdTbjB6t86FrxiSZe4BPg+e9gd0jjEVyzMxKgT/ifzgBznXO3e6cS9h07pxbgW89fTl4ayQwOddxSttmZgcDFwcvlwP7OudmpJrHObfcOXcp/uzy6hyHKNImmNmWQOwar4daWp9zbh7wSOit8SmK34nvogjwKPBD59z6JPXWOOd+ge/SB77V+/eJyppZb3xPDMMnOsc75+52ztWliLvaOXcX/hjlnSTFHg7+9se3tLfERGDf4PkrwKHOuf+lmsE594Fz7hjgpy1ctrRXUWeDeuT3QYYtY0HZv4TKfjtN2X3xCdyH+Cb6jfjm+j+QYb96fDP+CfgfhM/wfbHXAPPxXQImAL1SzF8C/Ah/tnAR/qzaSnyrzbVA/wzXy+S4abGzjxuBHhl8jkmhusYmKdMVuBD4N74LRSX+4HQWcAUprsMiwTULwHeBf+DP/NUAc5u4XYRbQl9swnxD8V00HP66nkb/H+ClYHp58HqL4P/xPrAOWIU/0/hjoDDD5Y4AbsX/+K4M1t9C4HF8t5WELXpJ4umDP3M7L6jLETrDiu/KcyhwI/7Hd2nwmdcG2/sDwOgUy8voeoK4eabFpiWps8F0/NnanwCz8d38NgIf4Fuh+mSwPg3fnejFYDvcAHwE/AYYnGi9NeeBT95jn/l7za0nF+sBf9Lph/gDt3fw+55qfM+AWfjv9eZp6pgc+nxD8Cc3fgz8B/gKf8b/qbh5dgWuxH9/Pwcqgri/AJ4ETiTz70WT9qFkeC1RiuU1e79PXGtUsL5+jd8vrAmmHZusfJI6xwN/Aj4JtuEK/H7hLeB+4GRCLTihbTrdY0hongmh99N9xsHANcAcfNe9Kvxv03/xrb2jWrDt/ywUx+AM13XS/2VQ7pxQnbcnKTOc+par5cBmGcZbgv8uxuo/JEGZcAvaPS3dP4TqtWC9O+DJFtTTE39CyAX/y62zEFvs805LUy7ldkeG+x5gr1C5X2YQXxf8b50D/pWiXIuPATvyI/IA9MjzP7xpydgjobLHJinTGX+WK92P2YOk6MYGbAvMzaCem5PMvxv+BzjVvOvwZ9rSrZfJcdNODE07I4N1/HFQ9pMk0w8Odo6pYl0K7Jdk/vBO+TDgmQTzNzUZ+29o3qOaOO9joXn/L8H0l4Jp5fgWtC9TfO5XSJHw4g82b8R3o0y1/v6RrJ64ePZMEk84Gbs5g+3S4ZPDRklghvOWx80zLTYtyWeYFpq3T9z/L/7xOSkOGoAy4J8p5l8JHEQLkzFgu1CdX5BhgpGmzmyuh1UZ/J9WkuAgMlTH5FDZkSQegOCpUPljM9w+/kOag16asQ+lmckYWdjvh5b9Ev66mtUJ5s8oGcPvF6ZlEI8jdIKMHCZjwOX4k0Tp6m7WAEj4faUDFmZQdtP/OU25HyfaTuLKXB8qc2MTY/5JaN4/J5i+ODR9+5buH+Lqfjyod12ybTKDOsInLf+Upbhi9U1LUy7ldkcT9j34Ex4Ov09MeuIyKPv90PynJpielWPAjv6IdUkSSSQ8dPln8RODC/GfxicXADPwX7hP8WdGtsPvvA4ATsWfmTktQT1D8GeyYwNCzMT/sL6PP7M5AH+h7LcTBWlmOwXL7hqUvw9/Br4cfzZuDHAB0A/4s5mNd869kKiuJKbjD9R6Bp/j3mQFzWwMvrUI6rtGhKcfCvwNf9ZqNf4i5VfxO8Vu+HV5Lv7i32fNbB/n3HspYrsef2b9Ofzn/gToge+jnpFg2PA9gpcV+APzpniK+gFf9sN/pkTK8D+IvYFbgL/it5MRwEX4C8vHAI+b2aEu2NPHuQ//owS+JetuYAH+DO1W+B+O4/BJ6uNmdphzrjZJPF3xLQ898Gfk/47/Pw/Fn8WOKcKfVf0r/gx37Kx7f/y6Pzd4fi4+ybghbjk747fh2Hr9Lb6bT1hVkhgz8SS+i849wfMl+C5E5+O3py3x2+zBSeZ/kPouSR/hk925QKdgnovwreTLWhAj+IQu5u8p/i/N1dL1UIhvAfs7ftv6Cn9GfSt8svA9/D7gCTMb6Zz7JE08D+C3j0fxXYC/wH+vtwiVKcIfHP4N3yr5IX4b3Ay/Hf4Yf2C1H35/8o1EC2rBPnQ8fh8Z6941Hd9Kl1S29vshg/En/mrxrY8v4c+q74jfh2fiRwQDueBbAX9H/WAwXYBhwFjg6Lj5Tgum/xO/juIHtYpZlGEcAJjZDdR3x12H30/9C79NdsEPaHEYzewyFwxKsXfw8r/NqSOJlL/5gQNCz59qYv1PAbHBwPYLTzCz7fH7UYAFzrkPmlh3OnOAb+HX/yj8dttU4X3Y09kIKkfS7XsewvdO2RI/IFeq46FTg7/r8b/fm+RgX9BxRZ0N6pHfB5kP4HFEqNz7JD7jH+smUQucnKKum0J1Neq2R/0ZPgdcmaIeI27oWvwB1HvBvB8CWyaZt28wPVauIG56eL1MTjB/7ALgOlKfXb8rVM82cdO641u8HP5gKWGXS/yBQ6xco24BNDxD1uSzkwnq2zdU15xmzL99aP4PEkx/KTS9BhifoEwp9UM0OxIMAQycFJp+aaJtMih3fqjcKWni2QDslebzbUOKVhz8mcFY7KtIMHxyuu0rQflpsfLppgfr9PAEZQrxP7KxcjslKBP+nv+XBBfhAzvRsNWivJnbWfi7cWZLttlsr4eg3HZplrUH9cNY35ekzOS47+ZP0tTZD+iepsx1ofoSDnZCC/ahwfuxeadlsM6ztd8vD01fQopBHeLKv5Rg2n+oP9OfdH3i9zOJvp9J605QdkIo7gMSTD8kNH0BoVa1BGX7A8XN2O5HhZZxRQblN63rFGUG4JNXhz85lOy3NNbaVwuUNSP2JaHY+4XePzn0/h+bWm8Gyz0gVP9Pm1nHh6E6Uu4vmlBnRt+9DLa7yaHpKfc9+JNUtemWix8pM1buwQTTs7Iv0EMDeEiImXUysxFmNgV4Ini7CrjQBd+oUNnO1J/5u88596cUVV+G7woG/ixJuJ4D8K0hAH91zl2drBLnLYx7+1v4M6gAp7kkw6s755biz/CDP1tzQIp4E3kwFjK+9aWRYBCM7wQvX3HOfRpX5Cz82aka/I5rZZJYF+D7zgMcbGbbpIjrE/wOsSX6hJ5/mbRUckuS1JXIPc655+LfdM5V4n9saoK3zksw78Tg7/POuV/Fb5Ohum7Bn+GGuO0tgRucc6+lKuCc+9SlaMVxzm2k/sLsHviDsXy6wzn3j/g3g5hvDL11QIJ5zw49P8MluAjfOfcuMLWlQdJw2/gqC/XFa8l6wDn3UarKnXNv4FvdAI4zs3RD6b/snLs9TZ1LnHNr0tRzJfWtko2GG8/CPjRj2drvJ3C5S9/SmEqsReX1VOvTOVfpnFvXguVkItay6IATnXPlKeL50jlX3YxlDAs9b/Z3ycwKzWwbMzsNeA0/HD3AdYl+S82sO/XDza9xzm1oxmKT/V7kev8QrnPbZtaR6xizJeW+J9gHxFrDjjezsiRFT4FNeUKDQWJyuC/okJSMdWz7m5mLPfBdQ94FfoHvojQP+EaiAxz8/T16B89TfQkJfmxmBS/HxE0+JvT8RpoudnDyuXNuVsqSvkUkJj6OlJxzM/GJDyRJxvBdYGL3EEk0ulUs1lnOuc/TLPKl0PNUsT7inKtJMT0T3ULPm3OgEp6nR5qy9yWb4PyIVM8HL/c0s81i04IuLLGkO+X2FvhP8HfvoCtFMo26kqZjZl3NbEhw4mKnoJts2Mim1tlCqUZSezX0fGh4QrBeDgxevuGcSzYSGdS3QLVE99DzXBwQN2s9JGNmfc1sWOx/HPyfYydQeuFbO1NpzrZVYmaDzGyH0DK3xw9CAYm3rZbuQ5siW/v9sGrgzy2MK9aNcD8zG5ayZA6ZWS9gXPDyRefcmzlaVL/Q8xVNmTHuN78G/7t2P75l7Ev8fUV/kWT2lv5WxM8X/r3I9f4hvJ76JS2VWq5jzJZM9j2x/WVX/EntRGLHOgvxvT/CcrEv6LB0zZgkUwU84Jz7V5Lpo0LPX0h/kniT/nGvY9cqVeH7dDdVLI7BoRuXNieOTDwETAG2NbN9EyR/sb7VFfi+2psEB76xz7pfFmOdm2JaptaGnndtxvzheVINPV5F+nj/i+86B7AL9UlpeHu738zuzzC2EvwPxtIE09Y55z7OpBIz2xZ/3eFR1N88NZl0rYPZNj/FtPABSPe4advgr5+A+pbEhJxzy8zss2Ce5mrpdpZOc9fDJmZ2HHAG/vqipOUCfUh+XQ1k+N0MWhvOw1/PNYLUv8uJtq2W7kObIlv7/bCPmtnCEnYfvsWzN/COmT2Lv452JvC+SzE0epaNpP4k939SFWyhcEtGwh4WzfRPUpwwIzvf4WS/F7neP4T3AV2SlkptLfWth11pvbfayGTf8zj+2uWu+GOXBrcbMLM9qL+G8PcJvkO52Bd0WGoZ69hexw8uEHsciO/K9zn+IPZmM7smybx9m7nMznGvNw/+ft3M7hrNjSNZs3wqD1HfOtCgdczMNqf+ni/TnXPxO+leNP/kR6pYs/FDHB6YoTk7yvBZxlSDPKzIoBUv3IWld+h5c//PkHz9rcpkZjM7GX9d4jmkT8RSLS8nUh3Ixv2AxrcQhtdvomQ1XiZlUglvG1skLdVMLVgPsRapx/Dds48kfSIG6f/Pab+bQcvXfHw30F1Jv49ItMyW7kObIlv7/bAW78Occ78Hfo4/EVaKP9P/O/zAJMvM7C9m9s0Mupa21Oah54tzuJzwfrRTE+cN/+bvix/4JJbETwD+ZmbFiWYMuoDGBhvqnqJ7WyrJfi9yun+g4TbY3O9JrmPMlrTfqWB/GRuQ42AzGxBX5NTQ80S9DnKxL+iw1DLWsa0PrgcJeylodZiJ7xZ2uZnNSNBVMbztHE4TR5tKoLldoGJxJBsFK5kmHwA458rNbAZ+FKgTzeyC4Fon8Bcfx2JJtOMKr6+/4u8llqlUB8HZGJHunaCeQmBXMytqYtfHPULPU52Ry+R/nOxgKbz+foi/viFTybbNtOsuaBF7AH9yYgP+vlv/wN++YGXs/29mBaH6cn3AF5WWfq63Qs/3xA+K01pcRn034nfxtzOYg++esz72fTCzH1LfcpBufaTcvoID3sfw3cPAdy16BJ/4LwUqY0mkmb2M7/6Wapkt7UaaiWzv9yE7+zCcc9ea2QP4W5EchE80+uBPhH07ePzHzI51zmV0IqalIeWw7vDv12ZJSyWQ4Dd/tpn9Hn9d9Cn47mdX4YfmT2Qe/l5VBfjRS1/JdNlmNpD6JGaJcy588i1+/5Bt4ZNPzf3/v0X99Xp74kefbY0y/U49iE/GC/Cjxd4AYGZF+AGzAF5zziXqdZCLfUGHpWRMGnHOrTKz7+ETnELgVjMbEXfWNTz0d22CHXymvsZfE9HXzIqbcWb3a/zIQP1bEENTPIRPxnrhu6zFzizFziJ9he8eE285/sfZgN55ijUjzrm1ZvYm/ge2E37H+kwTqjg29DxV15zeGSR64bNty0PPw9tbYR7X3w/xZ9oBvuWcSzbsf5MOiFqJcLedTM5ytqR1EhoOn3xkM5L+XPpx8PdTYO8UrWzZ/D8fiL+BLvgBE5Id/KZbbkv3oU2Rrf1+TgQH97cED8xsB3xL59n4Lrb7428tcXKOQgivn4E5WgbA/0LPW7xNOufqzOzH+N+2wcBFZnZfkm7cL+F/K8Dv+zNOxmj4W/FyXAzzzWwJvuVsmJlt77I7vH2v0PP/JS2V2gvUD9J1NH7Y+JaKHRek66nW3K6VqbyE7wk1GH8ME7sty+HU7++TXYvbqvcFbY26KUpCzrm51F8EOgx/HUXYG6HnR9B8sWtVSoB9mjF/LI6BZrZzC+LI1F/wA51AkIAFP/ix1qE/JjrADA6Q3g5e7h0enKKVCF8ncGGmMwUjPcYGEFiHP7OfTAn+5typ7B16Hh5QIlvbW1PFtqkVKRIxqD84SSYfrRZN9Sm+tQ/SxG9mfUg/YEVKzrkPqT9wG4hvwYicmfWmvnVqeprrl9L9n5sivL9KegG8mXWjPmlLpKX70KaI6nvYLM65+c65X+NbMWJn7r9lZiXxRbO0yDfxtz8Bn/jlSnjfuF02KgxGUo0N3FEMJLtE4X7q19eEYNCStIKW4J+E3kp0v87wexclmN4S4XtvphqsKJU/U39t27fMbOuWhQSh+tKtx4zvHZqpYETi2HHeTmYWGyAodnK5muS/6W1qX9DaKRmTVK6mvm/6z+N+wP6Nv6kfwBlm1tzRiaaHnl+ctFRyT4Sep7xZaTYEfeZjN7o8IjhI/UGoyION59okFmsRvltUa/Ig9SO2HWhmZ6WbIfhxvRf/ww1wZ7Lh+kN+mKK+wcChwcs3nHPhlrF5+OQB4Jg8Jd5Q33ugU5pRGc9JU09F6Hlp0lJ5FJw0eCl4uXuadTqB7HS/vCr0/BYzy+QaPMAP4Z6lg5944R4iSc8+m9kgGo5cmJfl4m+JkaoXS0v3oVC/fabbNrO138+rYL8UG1GzhMbXBGb6+dMtZxX1LT4HmtnuLakvxXIWUr+/3jtV2Sb6Pb4LNsAJZjYivkDQWhX7LesN3JHhtXiTqE8oXnXOPZ+gzC3UD4pxupkdlWngZjbYzA5KUSS8npo10E3w/43dtLoYeMj8LW0yEtxCIF5slOY9kq1H8zf5jr9he7aEW75ONbMe1N+M/FnnXLLrwNvkvqC1UjImSQX3fYmNsDOIUOuYc24t9cModwemm1nKbkxmdrCZNRjW1Dn3H/xd2wGONrOk11KZNyju7T/ib8QI8B0zm5QmhjIzuyC4xqe5YglXMb6f9feC12875+almO9W6rveXRxcf5Iq1s3M7CepymSLc64C+C71fc3vMLP/S/Hj0At/vUtsaPR5+B/bdH5kZo3uwxUk+g9Qn9jdFp4enMGbHLwsBJ4ws5RDlJvZHmZ2ZAYxpRK7JqCMJF2bzOwi4Btp6lmOv1kqNLxHUNTuDD2/18waJQXBIBNZOdERHID9JnjZG5hpZmNTzWNmvczsOuBfpL91QnN8Tf01OEcHg/HEx9Adf4Y4m4l0+HqT0xMVMLNxNExgG8nCPhTqW41SbpvZ2u9nm5n9IEFrV3h6L+oPxlfTeDj42OcfmoVBPmL3eTPgz2Y2JEVc/ZINlpGBWEv9rk1JCFIJ7skXjj/ZPv3/qF9nJwP3JBvMw/y9zH5B/XXSa/HXpiVa/jL8yc1Y173HzexHqX6vzazIzM7AX8+1S7Jy1LcafxDcRqW5plCfzI0Fnk93UsnMtjOzp6jf94XFhozvT4Lb5gSf/U6aPxx/SsH9FWOf52T88UxsUJiktwtprfuCNsu1gjtP65G/B76rUexO6C9lUH4ovqnaAV8ApaFphfjBDGL1LQeuw/c3Honf+X0buB5/4OHwN5ZNFNPXoXpewR+c7BPUcyT+gOQD4OYE84/AX5Abm/81fEvFWHy3uP3xNxr8Pf5MjgOKUqyXyWnWSSH+h8jhD+Ji812Uwfo8ED8aVWyef+Nbi0YHn/UgfFeOJ/DdIRcmqGNCaP4Dsrx9fC8uvleBc4N1uDu+O8L1+AEGYmXeB7ZKUedLQbml+KHAq4Cb8ENR74HvEjE3VN8LgCWp655QufXA7fi++7vjh9o9Gv9j+VZQ5uoU8ZRnsD52x3c7cviz57/Gt97tAZyAv7bO4Q+GY3FNS1LXi8H0quB/vAv+5qPbxq8/6u/r5ZLUlXJ6XNl0cT0RKvMB/qTLnvjvzyT8d2YF/qSHAz5r4TZWhG9RdaHHv/DDux8cfA/2wx+YPEjD7/ZuuVgP+AE7YtM/wbdGjQ4eP8VfY+LwrR5Jv3v4Ewax6UPSxNMZP+JerPyT+Ja3PfD70DuDbWVp8H9Jus3S8n3oA6F5J+G3+9i2uW1c2Wzt98vJ8HcoXfng/WX4LnSn4wc72Q2/v70gFIcDrkkw/6TQ9Dvw+5JtQ4+iUNkJqbaBoMwNoTJr8AethwUx7Yvf5z+K36f0bOb36LDQMg7NcN1l8j0pBBYE5euAnZKU2y1u+/0cv+89lPrfskvwA9LEyqwGDskghh/R8HfoPfx36wj8vmkf/IiZvwl/NuCCJPX1DtU3tbn7rlB9W+BvwxJbbiX++OIH+H3XSOAQ/HHIM/geRg5YlaCu7YL5Y/VcHWwje+L3gbOp/05nZd+TYN7/C80bO6ZZDpRksK20eF+gh1My1tEeNDEZC+aZFprnnLhpJfgfr9pQmWSPOuDEJMsYhh/FLF0djQ4kgvm3x7fOpJs/9uNYmGK9TM5gnfwqrs4aoF+G63M0DX9AUj3eSzD/hFQ75SxsI+PwferTxVaLP3PWK019LwXly4Md9JIUdc4mxcEJ/mzpRBr+UKd6XJIqngzXxyXUJ2SJHq/jL3aOvZ6WpJ6Dqf9Rjn+Ux5WdFpuW7juZQfzp4uqCT4ZSfV/GU5+IzM/SdnY69Sc10j1W41vnSuPqyMp6wN9rZ3aK5dfhh5+fEHqv0XePJh4Q4U9IrE2x3CX4/UXabZYW7EPxI+euTzZPgvIt3u+T/WQsk8cDQHGC+bcg9X5pSKhsym0gVG4i9ScyUz2am4yFTwo+nOG6S/s9SfAZ/5Ki3JbA0xmu+5kkSeyS1D0Wf11SJnXX4BPx/knqOie0LW6baQxp4uuET7o3ZBjjJ4m+B0FdPyL5b0wd/kRKyu2OliVjvfAnBsLLvSPDebNyDNjRH5EHoEee/+HNS8a2pf4gskHrWKjM9sGO6TX8Gcoa/IAOH+OHcr8Q2CbNcgrxLTNPBsupwJ8Vfx9/9v4UoFuK+QvwZ8v+ECx3Lf7HcAX+wup78YMGlKVZL5MzWCcj4nYyf2/i/6EYfxbtcfwP5Xp8gvE1/ozb7fh+24kOHFLulLO0nRQAx+F/4OYH67AK+BLfpeFqMvxhJe5AEt/d4oag3vX4A+3Z+BHPCjOscxD+B+oVfMtBNf5HsRx/pu6KZPHFx5Ph8g7AXyv4VbCsr/AjR54d+x+F/ifTUtSzD36whs/wLZ8uUSzkMRkLyhj+1hD/Cf7XG4Pv0B3A0KDM20E9c7K4nXXCf68fDLaH5cH6jX3vfx9M75Lr9YA/qLgQvw9bG6yDz4IYxmby3aMZB0T43gd3U99qvBLfUjwV6NuUbZYW7EOBHfAD+XxE3AFmiuU1e79PdpOxYfgRMf8cbKdLgu1oXfDZ7439D1PUPwjflfy9YL7wwfGQULmU20CC/+0N+Jb6lfiWjy/w+7trgZEt/P5cHsSxDuiawbpL+z0JyhcF/8PYAfTOacrvjW/9exO/b6wKtod38S2841vwGQ/Ft1y/Efxfq4LPW46/XvJCkiRhoTpirVhPt2R9J6l7C+D8YHv/FH/yqjr4/K/h96GHAgVp6hkTfEdj628x/vjggEy2O1qQjAXz/yU0v8OPKpbIavEAACAASURBVNuU+Vt8DNiRHxasRBGRnDCzl/DdHP/nnBsSbTTSHMH1OGvw10w95Jz7QcQhiXR4ZtYTn5T0AH7snLsr2ohaHzPblfr7X451zs2MMh6RRDSAh4iIpHMC9YNXzIoyEBHxnB/dL3ZvqPgRj8WbEvx9VomYtFZKxkREOrBgRLf4ob7D04fjBy4B333tz3kJTEQycRN+gJnB+IGqJBDcWuAYfLfB5t72QSTnUt27RERE2r99gGlm9jh+dM9P8NcsDMBf63AG9ffBuiI4Gy8irYBzbqOZfQ//Xa2OOp5WZgt8y9h85++PJtIq6ZoxEckpXTPWupnZsfgBH1JxwDXAL5x+NERERLJGLWMiIh3bi/j7Ho3H3/tsc6AnvkviF/gRFn/nnHs3sghFRETaKbWMiYiIiIiIREADeIiIiIiIiERAyZiIiIiIiEgEdM1YlqxevVr9PUVERERE2rgePXpYvpalljEREREREZEIKBkTERERERGJgJIxERERERGRCCgZExERERERiYCSMRERERERkQgoGRNpAxYsWMCCBQuiDkPaIW1bkgvariQXtF1Je6RkTEREREREJAJKxkRERERERCKgZExERERERCQCSsZEREREREQioGRMREREREQkAkrGREREREREIqBkTEREREREJAJKxkRERERERCKgZExERERERCQCSsZEREREREQioGRMREREREQkAu0iGTOzb5vZbWY2w8zWmJkzs983s65BZna/mS02s0ozKzezm82sV7bjFhERERGRjqso6gCy5EpgV2AdsBDYvjmVmNlQYBbQF5gOfACMAs4HDjezMc655VmJWEREREREOrR20TIG/BTYDugO/F8L6rkTn4id55w71jn3M+fcQcBvgOHANS2OVEREREREhHbSMuacezH23MyaVYeZbQOMB8qBO+ImTwLOBL5vZhc559Y3L1IREREREYlXuHgGxV88B7WVeVtmxb6/ytuykmkXyViWHBT8fc45Vxee4Jxba2Yz8cnaPsC/M610wYIF2YtQOjxtT5Ir2rYkF7RdSS5ou2p/uq6ex/C5Z2LUpS+cJV+vK6OkFSRj7aWbYjYMD/5+lGR67Ju/XR5iERERERHpELqvmJ23RGxDVTG//Pc4hl57fl6Wl45axur1CP6uTjI99n7PplQ6bNiwZgckEhM7C6jtSbJN25bkgrYryQVtV+1X6cpu8Hlul1FbZzz8xq5M/MeBLFzdI/0MeaJkLHOxi9FcpFGIiIiIiASsYiWdXzmPwqWvgctfN79ssup1DV5Xb3kYNQMPzFr9/3q1lit+V8M7H7e+w3glY/ViLV/JUuXuceVERERERCJV+uYvKS5/Ouowsqq23z5U7fTjltdTW8fJJ/+V554rb3lQOaJkrN6Hwd9k14TF2sSTXVMmIiIiIpJXhava36FpXdmArNRTWFhA375dGr1fUlLIWWftlpVltJSSsXqx4fHHm1lBeERFM+sGjAE2AnOiCE5ERERE2pGajRQufwfqqltUjVWuylJArUP1oEOoHnJU1ur7+c9H88QTH7JhQw0A3/72cK68cl+GDGkd1411uGTMzIqBoUC1c+6T2PvOuU/M7Dn88PXnALeFZpsCdAHu0j3GRERERKQlbE05XZ8+jIKNX2W97g0HPUBNv32zXm8+uMJSKG3SWHkAVFfXsnJlRcJWsAEDunLOOXswa9ZCrr56P0aO3CIboWZNu0jGzOxY4NjgZb/g72gzmxY8X+acuzh4PhCYD/wPGBJX1dnALOBWMzs4KLc3cCC+e+IVuYhfRERERDqOkgV/zEkiBlDXaTNcWetKOHLFOcezz37ClCkz6d+/K9Onfwsza1Tussv2prBwn4TTotYukjFgN+AHce9tEzzAJ14Xk0bQOrYncBVwOHAk8CVwKzDFObciaxGLiIiISIdklStzUq8rKKFus51zUndr8/rrXzJx4ivMnr0IgAULVvL88+WMH791o7JFRa331srtIhlzzk0GJmdYtpz6YeoTTf8COC0bcYmIiIhIB1VbRcmHD1Gw6sNGk4q+nNmwaLchuC79W7Q4V9qLyh3PwnXarEX1tHbl5auZMuUVnnxyQaNpkya9wkEHbdWqk6947SIZExERERFpTTrNvpTSD6ZlVLZqp7OpGnFmbgNq41as2MiNN77KPffMo7q68f3UCgqMPffsx8aNNXTrVhJBhM2jZExEREREJMuKv3g+47KuuCyHkbRtFRU13H33XH7969dYvboyYZlDDx3ClClj2XHHPnmOruWUjImIiIiIZFuGQ9bXdepDzcCDcxxM21NX53j88Q+56qqZfPHF2oRldtllc6ZOHcf++w/Oc3TZo2RMRERERCQTzlH69s0Uf/gQVrUuZVGrWNbgdcUeV+JKujWsrqiMmkEHt/h6sfbm1VcXc+mlLzF37tKE0wcN6saVV+7Ld76zPQUFrW+ExKZQMiYiIiIikoHCr1+n02tTmjVv1fDvd5gh51tq2bKNCROx7t1LuPDCvTjrrJF07tw+0pj28SlERERERHKsYNVHzZrPFZXhmnEz447qiCO2Yd99BzJrlh+2vqiogNNP34VLL92b3r07RxxddikZExEREZEOy9Z/ScGaTzIqW7Cq8XDq6biiMipGXQWFpU2et72rq3MJuxmaGVOnjuPggx/hmGOGMWnSGLbZpn0ms0rGRERERKRDKpn/AJ1n/rTZ81dtfRwVo69PWcaV9oTCtjPUej7U1NTxhz+8x623vsHf/nYCW2zRpVGZPfboxxtv/IChQ3tFEGH+KBkTERERkQ6p9O2bW1ZBcRmurG92gukAnHM891w5kye/wvz5ywG47ro5/OY3iUeTbO+JGEDbuT21iIiIiEgWWcXKFs1fu/meWYqk/Zs7dylHH/04J544fVMiBvDQQ+/y4YcrIowsWmoZExEREUmgYNk8ij99EqtZH3UoAgxetQqATl9n8dqh2o0NXtb03RsKCtPPV1BEzcADqdr+B9mLpZ36/PM1XH31LB599IOE04uLC5g3bynDh2+W58haByVjIiIiInFs7ed0feYIrGZD1KFIYFNnwMW5W8b6wx+Fkh65W0AHsmpVBTfd9Bp33TWXysraRtPN4KSTduCKK/Zl0KBuCWroGJSMiYiIiMQpWjJbiVgH46wQCjTiYUtVVdVy331v86tf/ZeVKysSljnggMFcddVYdtlF19spGRMRERGJV1cVdQSSZ9XbHAdFnaIOo81yzjF9+gKmTJnJZ5+tTlhmxx37cNVVYzn44K0wazykfUekZExEREQ6FFu/mM4zzqVw2duAS1ymtuEZ/ZrN96R62+/kITpJZunXXwPQd/PNs153XddB1Aw6JOv1diSrV1dywQX/ZtWqykbT+vfvwhVX7MvJJ+9AYaHGDwxTMiYiIiIdSqdXf0Hxwn83aZ66XsOpGnFmjiKSTHy9wN9wueewYRFHIon07NmJiy4axcSJMza917VrMRdcsBdnnz2SsrLiCKNrvZSaioiISIdSuOqjJs9T12VADiIRaV/OPHNXBg/uTmGhcfrpu/DmmxO4+OJRSsRSUMuYiIiItH11NRSseBerWpu+bPW6JlVd02c3qnY4o5mBibQfGzZU87vfvcXQob045pjGLZSlpUX89rfj2XzzMrbbrmMOVd9USsZERESkbaurpsuz36ToqznNmn3dEU9Rt9mIxBOtCNepVwuCE2n7amvr+POfP+Caa2axaNE6Bg/uzuGHb01paeNUYsyYQRFE2HYpGRMREZE2rfDLmc1OxABcp81wnbM/KIRIe/Dii/9j4sQZvPvusk3vff75Gu6+ex7nnrtHhJG1D7pmTERERNq0wjWfNXteV9yNuh7bZTEakfbh3Xe/5vjjn+S4455skIjF3H//29TW1kUQWfuiljERERFp02zjVw1e13Xdkrqug9POV9d5c6p2Pkf3lhIJWbx4HddcM4s//vF9XII7P5SUFHLWWbtx0UV7aZj6LFAyJiIiIm2abVja4HXlzj+hasRZEUUj0jatWVPJrbe+wR13vMnGjTUJy5xwwnCuvHJfttqqR56ja7+UjImIiEibVrBxSYPXdZ23iCgSkbanurqWBx98l+uum8OyZRsTlhkzZiBXX70fI0fqu5VtSsZERESkTYtvGXNlfSOKRKTt+dnP/sN9972dcNrw4ZsxZcpYDjtsa8wsz5F1DOroKSIiIm1afMuY69wvokhE2p4f/WhXCgoaJlp9+5Zx880HM3PmKRx++DZKxHJIyZiIiIi0Xc41ahmrU8uYSMa23743p57q77NXVlbEZZftzZtvTmDChJ0pKlKqkGvqpigiIiJtV9VqrK5q00tX1AWKu0YYkEjrs2LFRv75z884+eQdE06//PLRFBYWcMkle9OvX5c8R9exKRkTERFp7arXU7j8bairjjqSjHRbuQiAwsVf5nxZBesXNXhdV6YBBkRiKipquPvuudx446usWVPF8OGbsfvujbvxbrFFF37964MiiFCUjImIiLRiBSs/pMuzR1JQsTzqUDI2PPYk8ZgAOeU0kqIIdXWOxx77kKlTZ/LFF2s3vX/llTN49tlv6xqwVkQdQUVERFor5+j8yvltKhGLmkZSlI7u5Ze/4KCD/sSZZ/6jQSIGMGvWIp57rjyawCQhtYyJiIi0UsWfPknRV3OiDqNNqek/NuoQRCLxwQfLmTTpFf75z88STu/evYSLLhrF/vtvmefIJBUlYyIi0uoVLplDcflfoaYi6lDyqvjzvzd4Xdd1MHXdBkcUTeY2bPA3ji0r65y3ZToronbAflRt/8O8LVOkNfjqq/Vce+1sHnroPerqXKPpRUUFnHHGLlxyyd707p2/76RkRsmYiIi0agXL36HLs0dhribqUCLlrIj1RzxBXY9tow4lrQULFgAwbNiwiCMRab/Wr6/mttve4Lbb3mD9+sSD+xxzzDAmTRrDNtv0zHN0kiklYyIi0qoVLf5Ph0/EAKpGnNkmEjERyb0FC1bwzW8+zpIl6xNO33vv/kydOo5RowbkOTJpKiVjIiLSutUpEavtsS0VIy+NOgwRaSW23ronPXuWNkrGhg7tyaRJY/nmN4dqxMQ2QsmYiIi0TrVVdJ51CSUfPtjg7eqBB1Kz1VERBZV/rrQH1YMOgVJ1MxIRr6iogClTxnHiidMB6N27M5ddtjennbYzxcWFEUcnTaFkTEREWqWSj/7QKBEDqOu9C1U7nh5BRCIi+fX552vo1asT3bqVNJo2fvwQDjtsa0aM6MP55+9Jjx6lEUQoLaVkTEREWqWC1R8lfL+uy8A8RyIikl+rVlVw002vcdddcznvvD254orRjcqYGY88crS6I7ZxSsZERNoBW/s/CtaWN3m+bisXAVC4eHGWI2q5gnULG71XM2A/qoadGEE0IiK5V1VVy733zuOGG15l5Up/K4877niDH/5wZ/r379qovBKxtk/JmIhIG1cy72Y6vza5WfMOjz15O1vR5E7F7j+jcvefRR2GiEjWOeeYPn0BkyfPpLx8dYNpGzbU8Mtfzua22w6NKDrJJSVjIiJtXOnbt0QdQl64kh5RhyAiknVz5ixm4sSXee21JQmn9+/fhdGj1T27vVIyJiLSxhVUrow6hLyo7btn1CGIiGTNxx+vZPLkV3jmmU8STu/atZgLLtiLs88eSVlZcZ6jk3xRMiYi0oZZReNErKb/WCCz6wg2bNwIQFnnztkMK6tcURnV255Abd+9og5FRKTFli3bwPXX/5cHHniHmpq6RtMLC40JE3bmssv2pm/fLhFEKPmkZExEpA0r+/f3G723/sinIcOLuhcsWADAsGHDshqXiIg0dvvtb3L99XNYu7Yq4fQjj9yGyZPHst12m+U5MomKkjERkbaqpoKiL19p8JYrKosoGBERSWfp0vUJE7E99tiCq64ax5gxgyKISqJUEHUAIiLSTK620VtVw76bcauYiIjk14UX7kWvXp02vd5qq+7cf/8R/OtfJykR66DUMiYi0gaUvH0bpfPvhao1oXddo3IVo6/PX1AiIpJQZWUNpaWND7N79uzEpZfuzfXXz+GSS/bmjDN2SVhOOg7990VEWrmCFe/T+dWJacu5ojIoKMxDRCIiksiiRWu55prZvP/+Ml544WQKChr3VDj99F04+eQd6NmzU4IapKNRMiYi0soVrF6QUbm6LroPjYhIFNasqeSWW17nzjvfYuPGGgAeffQDTjpph0ZlS0oKKSnRiTPxlIyJiGTIKlZSsOIdcI27B+ZS4Yr30papK92Min2uyUM0IiISU11dy7Rp73L99XNYtmxjg2lXXz2LY44ZRufOOtyW5LR1iIhkoPDLmXT5x/FYbUXUoVC95WFs3P+3Dd5zpT3BNCaTiEg+OOd49tlPmDx5Jh9/3Ph+jwBduhSzaNFatt22V56jk7ZEyZiISAZK3r+nVSRiABR1wnXSPWhERKLw+utfMnHiDGbPXpxwet++Zfz856M55ZQRFBXpJJmkpmRMRCQDBZWJz3xGoabvXlGHICLS4ZSXr2bKlFd48snE1/GWlRVx7rl7cO65e9C1a0meo5O2SsmYiEi86nWUzL+fgjWfbnqrYNVHDYrU9t4ZV5rfrifOCqntN4aqEf+X1+WKiHRkK1Zs5IYbXuXee+dRXV3XaHpBgXHKKSO4/PJ96N+/awQRSlumZExEJE7Zy+dQ/Nn0lGU2jppK7cAD8hOQiIhE5sMPV/Db376VcNr48UOYMmUcO+zQO89RSXuhjqwiInGKFv47faHiLrkPREREIjd69EC+8Y2hDd7bZZfNmT79eB599FglYtIiSsZEROLVVaecXNtrR2p775qnYEREJGqTJ4+hsNAYNKgbd911GC+99F3233/LqMOSdkDdFEWkY3B1dHptCsUfP4rVbEhZ1GorG7zeOPpXUFAMQF1pL2oGHQiFujhbRKS9+OCD5UydOoupU8exzTY9G00fNmwzHnvsWEaPHkinTjp8luzR1iQiHULRwn9T+vYtzZq3avipUNQpyxGJiEjUvvpqPddeO5uHHnqPujpHUVEBDz74jYRlDzxwqzxHJx2BkjER6RAKViceijiduk59oLA0y9GIiEiU1q2r4vbb3+S2295g/fr6runTpy/g1VcXM2rUgAijk45EyZiItH81GyhaMrvJs7mSHlSMvg7MchCUiIjkW01NHX/4w3v88pez+eqrxF3W//KXD5WMSd4oGRORds3WfUHXvx5GwYbFDd6v3P40KvaalHrm4m5QUJjD6EREJB+cczz3XDmTJ7/C/PnLE5YZOrQnkyeP5aijhiacLpILSsZEpF0r/uSJRokYAEWdobTxRdoiItK+zJ27lIkTX2bGjIUJp/fu3Zmf/WwfJkzYieJinYCT/FIyJiLtmlWuTPh+Td9ReY5ERETy6fPP13D11bN49NEPEk7v1KmQc87ZnfPP35Pu3XVtsERDyZiItC/OUfzxnyn86r+Yq6Pw69cbFdm4743UbH1MBMGJiEg+1NU5jj32CT79dFWjaWZw0kk7cMUV+zJoULcIohOpp2RMRNqVkvfvofPsS5NOr9hrElU7npHHiEREJN8KCoyLLtqLc855vsH7Bx44mKuuGsfOO28eUWQiDRVEHUC2mNkgM7vfzBabWaWZlZvZzWbWq4n1fMPMnjOzhWa20cw+NbO/mNnoXMUuItlTtPDfKae7oi55ikRERKJ00kk7MGJEHwB23LEPjz9+LE8++S0lYtKqtIuWMTMbCswC+gLTgQ+AUcD5wOFmNsY5l3jonIb1XA9cCiwHngKWAdsCxwDHm9mpzrnf5+ZTiEhWuJqkk+pKN6N68GF5DEZERHJpzpzFLF26gaOP3rbRtMLCAq67bn/Ky9fw3e/uQGFhu2mDkHakXSRjwJ34ROw859xtsTfN7Cbgp8A1wI9TVWBm/YCLga+AXZxzS0PTDgReAK4ClIyJtCGVO55J7WY7QmEnagbsj+vSP+qQRESkhT7+eCWTJ7/CM898Qu/endl//y3p0aPxIBzjxm3JuHERBCiSoTZ/isDMtgHGA+XAHXGTJwHrge+bWbq+SVvh18d/w4kYgHPuRWAtoHZtkTamZsvxVG8/gephJykRExFp41aurOSSS15kn30e5plnPgFg+fKN3HzzaxFHJtI8bT4ZAw4K/j7nnKsLT3DOrQVmAmXAPmnqWQBUAaPMrE94gpntB3QD/pWViEVEREQkYxs2VPPAAx9z3HEvcc8986ipaXDIx29/+xbLl2+MKDqR5msP3RSHB38/SjJ9Ab7lbDsg6ZX9zrkVZnYZcBPwvpk9hb92bChwNPA8cFZTg1uwYEFTZxFJSttTesPWr6dH6PWixYtYU6H1lo62LckFbVfSUrW1jr/9bSG/+91HLF1akbDMTjv15LzzdmDFioWsWJHnAKVNGzZsWNQhtItkLHbctTrJ9Nj7PdNV5Jy72czKgfuBH4UmfQxMi+++KCIiIiK5MWfO19x663wWLFibcPrAgWWcc85wDjmkP2aW5+hEsqM9JGPpxL6dLm1Bs0uBXwK3ArcDS4DtgWuBP5jZbs655DcwSqA1ZNzS9sXOLmt7Sq/sky6wsv71wAED2WJLrbdktG1JLmi7kpZ4992v+cUvZvDCC58nnN6rVycuuWQUp5++C6WlHeFQVtqz9rAFx1q+eiSZ3j2uXEJmdgBwPfCkc+7C0KQ3zew4fDfIi8zsd865T1sQr4iIiIgk8PDD73Heec/jEpxCLy4u4KSThjB16nh69uyU/+BEcqA9JGMfBn+3SzI9dlou2TVlMUcFf1+Mn+Cc22BmrwLHASMBJWMiIiIiWXbQQYMpLS2koqK2wfsnnDCcU04ZwIABZUrEpF1pD6MpxpKn8WbW4POYWTdgDLARmJOmntjNKZINXx97v6o5QYqIiIhIagMHduPss3ff9Hrs2EG8+OLJ3HPPEQwYUBZhZCK50eaTMefcJ8BzwBDgnLjJU4AuwEPOufUAZlZsZtub2dC4sjOCv2ea2cDwBDM7Ap/UVQCzsvsJRERERDoO5xyzZi1KOv2CC/ZkzJiBPPLI0Tz99PGMHLlFHqMTya/20E0R4Gx8knSrmR0MzAf2Bg7Ed0+8IlR2YDD9f/gELuYx/H3EDgHmm9mT+AE8dsB3YTTgZ8655Tn9JCIiIiLt1Ouvf8nEiTOYPXsxjz9+LAcfPKRRme7dS3n22RPyH5xIBNpFMuac+8TM9gSuAg4HjgS+xI+KOMU5l/auE865OjM7Et+6dhL++rAyYAXwN+BW59xzOfoIItICBas/ofPL51C44n2oWR91OCIiEuezz1Zx1VUzefLJ+nvPTZz4CgccMJjCwjbfUUuk2dpFMgbgnPsCOC2DcuXUD3cfP60auDl4iEgb0Wn2zyj6Kt1loSIikm8rVmzkhhte5d5751FdXddg2vvvL+NPf5rPKaeMiCg6kei1m2RMRDqugjUfJ51W13VQHiMRERGAiooa7r57Ljfe+Cpr1iQe+2z8+CHssUe/PEcm0rpkPRkzfwv044BDgS2Bzs65g0PTuwB7AM45NyNxLSIiIXW1FKx4h4KKxD2OrWZjo/dcYSlVO/6Iup7Dcx2diIgE6uocjz32IVOnzuSLL9YmLLPLLpszdep+7L//lnmOTqT1yWoyZmbDgCeAHanvChh/274K4F5gqJnt5Zx7M5sxiEg74xxlz51E8cLnM55l7bH/oa7XDlBYksPAREQk7OWXv2DixBnMm7c04fRBg7oxceK+nHDC9hQUJLxiRKTDyVoyZma98KMRbgnMw49OeAnQLVzOOVdrZncCNwHHA0rGRCSpglUfNikRA3AlPZSIiYjkydq1VZxxxt/55z8/Szi9e/cSLrpoFGedtRudOukKGZGwbA5fcxE+Efs7sJdz7hr8zZYTeTr4e0gWly8i7ZBVrmxS+bqyfriu6voiIpIvXbsWs3p1ZaP3i4sL+PGPd2Pu3NM4//w9lYiJJJDNb8Ux+C6JFzvnalIVDIairwS2zeLyRaQDcCXdqdl8j8TTyragcufzoKAwz1GJiHRcZsbUqeM49NA/b3rv2GOHMWnSGLbeumeEkYm0ftlMxrYGNjrn5mdYfh3QI4vLF5EOoLbXjmw44smowxAR6XBqauqoqKiha9fG3cD32qs/xx47jCVL1jN16jj22qt/BBGKtD3ZTMZcpvWZWQk+EVuTxeWLiIiISJY553juuXImTZrB2LGDuPHGgxKWu/32Q+nSpRg/sLaIZCKb14x9BpQEIyqmcyQ+ccu0FU1ERERE8mzu3K84+ujHOfHE6XzwwQoeeOAdFixIfJuRrl1LlIiJNFE2k7Fn8cPZX5SqkJltDtyIb0mbnsXli0g7VPLeXVGHICLS4fzvf6s588x/cMABf2LGjIWb3q+tdUyePDPCyETal2x2U/w1cCbwIzPbAPwmPNHM+gLfAq4EBgCLgN9mcfki0s4UrPmMks+eijoMEZEOY9WqCm666TXuumsulZW1jaab+aHqq6trKS7WYEkiLZW1ZMw5t8zMjsEPW39+8ADAzJYBvWIvgRXAsc659dlavoi0PwWrP2n0Xl3XQRFEIiLSvlVV1XLvvfO44YZXWbmyImGZAw8czFVXjWPnnTfPc3Qi7VdWb/jgnHvFzHYFfgl8G4gNt7NZ8LcGeBz4mXPuf9lctohEqK6awmVzscrVWa22cNlbjd6rHHlpVpchItKROed46qkFTJkyk/LyxPvwHXfsw9SpYzn44CH5DU6kA8j63fecc58Dp5jZGcCeQH/8tWlfAa8759Zle5kiEqHaSro8+02Klr6a80VVDzqYup7b5Xw5IiIdwX//u5grrniZ119fknB6//5duOKKfTn55B0oLMzmMAMiEpOzW6E75yqAV3JVv4i0DoVLX8tLIubpYEBEJFvmzFmcMBHr2rWYCy7Yi7PPHklZWXEEkYl0HFk7Hl2gwAAAIABJREFUsjGz+83spiaU/5WZ3Zet5YtINKxyVd6WVbvFqLwtS0SkvTvrrN0YNKjbpteFhcYZZ+zCW2+dxsUXj1IiJpIH2WwZmwAsAS7MsPwJwGDg9CzGICLZ5hzFC/5A0VevgqtrNLlg3RcNXtd16kNtn12zHEQBtVuMonLXn2a5XhGRjqtTpyImTtyXs876J9/4xlAmTx7DsGGbpZ9RRLImZ90UM2D4e42JSCvWac7llL73u4zL124xig2H/jGHEYmISCZqa+v405/m88c/vs+TTx5HaWnjw74TTtiebbftxR579IsgQhGJ5AIMMysA+gIa2l6kFSt5764mJWIArrhrjqIREZFMvfDC/9hvvz/yk588z6xZi7jvvrcTlisoMCViIhFqdsuYmXUHesa9XWhmW+JbvRLOFsxzKtAJmNfc5YtIbhV9/k86zbm8SfM4K6R625NzFJGIiKTzzjtfM2nSDF544fMG799ww6t897s70rNnp4giE5FEWtJN8afAL+Le6wOUN6GOe1qwfBHJosKlr9N55k8pWPOZf6NmAxa6RswVd6Vir0m4wtLEFVghtX1HUddzWB6iFRGRsEWL1nL11bN45JH5uAQXgaxfX82cOYs5/PBt8h+ciCTVkmTMaNgC5kjeIhYuswZ4D7jXOTetBcsXkSzqPOM8Cle+n3CaswI2HHQ/NVuOz3NUIiKSypo1ldxyy+vcccebVFTUJixzwgnDufLKfdlqqx55jk5E0ml2MuacmwxMjr02szpgiXNuQMvDEpF8K1jzSdJpFftcp0RMRKQVqa6uZdq0d7n++jksW7YxYZmxYwcxdeo4Ro7cIs/RiUimsjma4kNA/m44JNIG2YalFK54J+EQ8al0X74IgKJO5TmIKlDX+IyqK+xM5ciLqRpxZu6WKyIiGXPO8cwznzBlykw+/nhlwjLDh2/GlCljOeywrTFL12lJRKKUtWTMOTchW3WJtEdFC1+k7LnvYHXVTZ53u9iTd7MaUkprvvcxrrQnFER5BwwREQn77LPV/OAHz1JX1/jCsL59y/j5z0dzyikjKCqKZMBsEWkifVNF8qRk/r3NSsSi4kq6KRETEWllttmmJ6ecMqLBe2VlRVx22d68+eYEJkzYWYmYSBuSkyMtMxsHjAEGAF1IPrCHc86dnosYRFobq2w7vXhr+oyEZKMmiohIpH7+89E89tgHVFTU8v3vj+Dyy0fTr1+XqMMSkWbIajJmZjsBfwRGxE8K/rq49xygZEzatILVH1PywUNY5fI05RY0eF2z+e640s0yWsaG9f7+6GVdcv9jW9d1Syp3uzDnyxERkcQqKmq4++657LffYHbbrW+j6f36deG22w5lxx37sMMOvSOIUESyJWvJmJn1B/4NbA68DzwPnA+sA24GtgAOAoYCy4C7gJpsLV8kErWVdHnmSAo2Lm3yrBV7TaF2wLiMyi5Y4BO5YcN0Dy8Rkfaqrs7x2GMfctVVM1m4cC3jxg3ir389PuEgHMcfPzyCCEUk27LZMnYxPhH7B3CMc67azM4H1jnnNt0c2szOBG4HdgeOyuLyRfKucMV7zUrEILgmS0REBHj55S+YOHEG8+bV/6bMmLGQ554r57DDto4wMhHJpWxe4Xk4vtvhFc65pKMUOOfuBq4Iyp+TxeWL5F9d8xp3a/rsRt1mO2U5GBERaWvmz1/OiSdO5+ijH2+QiMXcdNOrEUQlIvmSzZaxrYBaYG7oPQckGgXgd8AvgVPxrWQibU7Ju3fSec7PG7xX220IlbtdlHI+12kzagbsr5EKRUQ6sCVL1nPttbN5+OH3Eg5TX1xcwOmn78Kll+4dQXQiki/ZPBqsA9Y758J7lHVAdzMrdM5tuqOsc26tma0hdPskkbakYNncRokYgOu8OdXDvx9BRCIi0hasW1fFbbe9we23v8n69Yk7Eh177DAmTRrD1lv3zHN0IpJv2UzGFgHbmVmZc25D8F45sBOwC/BWrKCZ9QB6ARVZXL5I3hR/Nj3h+3VdBuU5EhERaQtqaur4/e/f49prZ/PVVxsSltlnnwFMnTqOvfbqn+foRCQq2UzG3sO3dA0D5gXvzQB2xg/u8b1Q2anB3/ezuHzpQGz9IgpXvE/DuyXkT3H5s43eq+05nMo9Lo8gGhERae1OO+1vPP30xwmnDR3ak8mTx3LUUUMTjpwoIu1XNpOxp4FvAd+hPhm7DfgRcJKZ7QK8jW8p2wl/FP3bLC5fOoiiz/5K2QsTMFcXdSibrDnpHVzXLaMOQ0REWqnvfW/HRslYnz6dueyyfZgwYSeKiwsjikxEopTNZOyvwK+BTUMBOec+NLMfAHfjbwQduxm0A37jnLsvi8uXDqL0vbtaVSJWs/meSsRERCSlww7bmrFjB/HKKwvp1KmQc87ZnfPP35Pu3RONcyYiHUXWkjHn3ErgkgTvP2Jm/wKOAAYBq4F/Oec+ytaypWOxqlVRh9BA1fanRh2CiIi0AqtWVfDWW19x4IFbNZpmZkydOo577pnHFVeMZuBA3WtSRLLbMpaUc24Z8HA+liXtVNVaSt+7i4I1n1KwbmGDSTVb7IMrjuBHraCImkGHUL2dRk8UEenIqqpquffeedxww6tUVtbw5pun0a9fl0blRo7cgjvvHB9BhCLSWkV2oyMzGwRc5pw7N6oYpO0oe/kcisv/mnDaxn1voK73znmOSEREOjrnHE89tYApU2ZSXr560/vXXjubW245JMLIRKStKMj3As1sazO7G/gYODvfy5e2qWjRS0mnRdIqJiIiHdrs2Ys49NA/c9ppf2uQiAE8/PB7zJ+/PKLIRKQtaXHLmJkVAwcCOwKFwKfA351zFXHltgEmAycF5QxY0tLlSwfhahK+XdN/HK5b4775IiIiubBgwQom/z979x0eVZX/cfx9ZlKBhF6kVwEBpdfErrjWtaysuoK46lpRXFSkJoCIrrqLLPzWDri6a19Z1wI2BEJRUBRFOghSpSaQOnN+f0zAhJlAys3cZPJ5PQ/PMOecuffDbpzMd86956Qs4n//2xCyPyEhhnvv7UmLFolhTiYilVGZijFjTH/gVeD4peR+Mcb8wVo7zxgTBUwC7gOiCRRhawisvDi7LOeXyBe17RPiFj+MySu8QWbmgKfw12hK3ilngvZkERGRcrZnzxEee2wJL730HT5f8B6XXq9h6NAuPPRQX+rXr+ZCQhGpjEpdjOXf8/U+kECgwCqoPvCOMaYLgWXtz80fkwb8xVr7bmnPK1WItcTPvwNP5u6grpy2gyA6+OZoERERJx05ksuMGV8zdepXpKfnhBxz6aVtGD9+AO3a1QlzOhGp7MoyMzYMSAR+Ae4F5hIouAYCfwPqAB8DrYDvgPustZ+VKa1ULbkZIQsxf1w9iIp3IZCIiFQly5fv5MYb32P79oyQ/T17NmLixGT69WsS5mQiEinKUoydT2Dz5rutta8XaH/FGOMjcPliS+BT4BJrbXYZziVVjfXj3bsyqNkfV4+s/n8BE/a1Z0REpIpp06YWR47kBrW3bFmTlJQBXHFFO4wulReRMihLMdaaQDH2nxB97+T3AYxWISYlFf/57cRseL1Qm8WQfsNaFWIiIhIWtWrFMWJEH8aM+QKA2rXjeOCB3vzxj6cTG+va7kAiEkHK8k6SAPxirQ26gNpam22M+QWoB3xbhnNIFWQyfwkqxACISVAhJiIijtuxI4OGDavj8QTPct166+m8/PIqBg5sxf3396JWrTgXEopIpCpLMWYA3wn6/QDW2swynEOqIJNzMGR7XsN+YU4iIiKR7NChbP72t6+YMWMF06ZdwO9+1yFoTGxsFAsX3kB0tNeFhCIS6TTNIJVCdqfbyTxrhtsxREQkAuTm+njuuZV06zaTp576kqwsHxMmLCIrK/SelirERKS8lPWC55rGmBeL6gM4QT+Atdb+sYwZJML5EluT1W+K2zFERKSSs9by3nsbSE1dxPr1+wv1bd2aznPPreSee3q4lE5EqqKyFmNxwJAi+o5eeH2ifguoGBMREZFy9eWXOxg7dgFLlmwP2d+wYTUaNNBmzSISXmUpxr7g1xUTRURERCqcTZsOkJq6iP/8Z13I/urVo7nnnh7cfXd3atSICXM6EanqSl2MWWvPdjCHCDHfP0vsd09jMve4HUVERCq5ffsyefzxpbzwwrfk5vqD+j0ew+DBnRg5sh+NGlV3IaGISNkvUxRxhGff98QtfgijyVYRESkDay3Tpi3niSeWcehQ0O47AAwc2IqUlCQ6dqwb5nQiIoWpGJMKIXrTnCILMX+N5mFOIyIilZUxhsWLt4csxLp2bcCECcmceWYzF5KJiARTMSbuyMvCu2spxhfYhi56839DDvMltiKrd0oYg4mISGWXmprE3Lmb8PkCX/I1bZrA+PEDuPrq9iE3dhYRcYuKMQk7k7mHGm8n4cncVeSYQ4NWYuPrQ5RWthIRkdD8fhuyuDr11DoMGdKZN99cw4gRvbnttq7Exekjj4hUPHpnkrCL/XbaCQsxX93TsQktwphIREQqk507DzN58mIyM3N57rnfhBwzZkx/xozpT5068WFOJyJSfCrGJOyits07YX9O+6K2phMRkaosIyOHadOWM23aco4cyQPgT3/qSs+epwSNVREmIpWBijEJK5OxFe/+1ceeW+Mlr+n5gSceL3lNziGn41CX0omISEWUl+fnn//8nkcfXcyuXUcK9Y0du4D33/8dxuheMBGpfFSMSVhFbfuk0HNfg94cGfiaS2lERKQis9by0UebGD9+IWvW7As5Zs+eTPbsOUKDBtorTEQqHxVjElbeA2sKPc9rcpZLSUREpCL75ptdjBmzgIULt4Xsr1cvnpEj+zJkSGeio71hTici4gwVYxJe1l/4aUxNl4KIiEhFtGXLQSZNSuONN9aE7I+L83LXXd25996eJCbGhjmdiIizHC/GjDGtgOHABUAzIM5aG1WgvxYwDLDAZGutz+kMUnGYw9up9vlteHcvByz4gzfhFBEROXAgiyef/JJnnvmGnJzgjwbGwHXXncbo0f1o0iTBhYQiIs5ztBgzxlwJzAaqAUfvpLUFx1hrDxhjzgHOBJYBHzmZQSqWuOWTidqx0O0YIiJSwb333gamTVsesu/cc5uTmppMly71w5xKRKR8eZw6kDGmA/AKUB34B5AM/FLE8GcJFGtXO3V+qZg8hzaesN+f0DxMSUREpCK77rqOnHZa3UJtnTrV4+23r+Ttt69SISYiEcmxYgx4AIgDnrDW3mWtXQQUdQnix/mPAxw8v1Qi1hNNTttB5DW70O0oIiJSAXi9HlJTkwA45ZTqTJ9+AV98cT3nntvC5WQiIuXHyWLsPAKXJP7lZAOttXuADAL3lDnCGNPUGPOiMWa7MSbbGLPZGPM3Y0ztUhwr2RjzljFmR/6xdhhj5hpjLnYqb1V1+KK3OXjTDg7dtJ3Ms58BT7TbkUREJEzWrdvH7bd/xKFD2SH7zz+/Jf/4x0CWL7+JG27ohNfr5McUEZGKx8l7xhoB6fmFVnHkErikscyMMW2ANKAB8C7wI9AbuBe4yBgzwFq7t5jHGgNMJHCJ5XvADqAe0A04G3jficxVlfXGQFS82zFERCSM9uw5wpQpS5g58zt8PkvTpgmMGdM/aJwxht//vqMLCUVE3OFkMXYYSDTGRFlr8040MH+2qhawy6FzzyBQiA2z1k4rcJ6nCKzs+Ahw+8kOYoz5HYFC7GPgKmtt+nH9msYREREppiNHcpk+fQVTp35FRkbusfbp01dw882n07hxDRfTiYi4z8n5/+/zj9e7GGNvJLCAR+hlk0rAGNMauBDYDEw/rns8gSLxRmPMCWfhjDEe4DHgCHD98YUYgLU2N+iFEpovh5hvnyZqZ5rbSUREJMx8PsucOVvp0WMmjzyyuFAhBpCZmcc///m9S+lERCoOJ2fGXgeSgEnGmAuLmh0zxpwFTCZwf9krDpz33PzHudYW3lHYWptujFlEoFjrC3xyguP0B1oBbwL7jTGXAJ2BLGCZtXaxA1mrjLilY4j94Vm3Y4iISJh98slmHnpoAevXB32nCUDLljVJSRnAFVe0C3MyEZGKx8li7BngFuAsYIExZgYQDWCM6QR0Aq4isJy9F1gIvObAedvnP64ton8dgWLsVE5cjPXKf9wFrAC6FOw0xnwBXFOCe+ICJ1+3riTDI0anzfNCtm/ZcYDMjKr5v4kTqurPk5Q//WxJWa1de4inn17N0qWhd7WpWTOam29uxzXXNCcmxrB+/fowJ5RIofcrcUq7du5/KeRYMWatzTXGXATMAfpQ+HLFbwv83QBLCNyTVWhD6FKqmf94sIj+o+21TnKcBvmPtwObgPOBpUAL4ElgIPAGgUU85CSMDd7VICOhE5k12rqQRkREysuuXZn83/+t5f33txHqt3pMjIdBg1oydGhbEhJ067WISEFOzoxhrd1pjOkP3AQMITDbFJPf7QO+AmYCL5xskQ8HmaPxTjLOW2D8NdbalfnPvzfGXElg5u0sY0y/klyyWBEq7nCI2vYpcYsfxJOxFQDjK7xscWafR/B1HEq7qGpuxKv0jn4LWFV+niR89LMlZXH4cC4XXPA8Bw6EXqr+2ms7MGZMf5o3TwxzMolEer+SSOT4Bh7W2jxr7fPW2mQCS9c3BE4B4q21/ay1zzhciB2d+apZRH/iceOKsj//cWOBQgwAa20m8FH+0+IsUFK1WEv8F3fjPbge48sOKsSAwObOKsRERCJK9erR3HRTl6D2nj3rMnt2Es8+e5EKMRGRE3B0Zux41lofUKJ7rEphTf7jqUX0H/36pKh7yo4/zoEi+o8Wa9ok63i+LDxHthfZbU0U/mqNwhhIRETCZfjwXsyevYp9+7Lo0KEOqanJtGqVizHm5C8WEaniHCvGjDFPAK9Ya7926pjF9Fn+44XGGE/BFRWNMQnAACCTwH1qJ/IFkAe0M8bEWGtzjuvvnP+4ueyRqw5/bC2ye4yFmAS3o4iISCktW7YdYwy9ep0S1FezZiyTJp1Jbq6PG27oRFSURwssiIgUk5MzY/cDw40x6wgsWf8va225L5Vkrd1gjJlLYMXEu4BpBbpTCVwq+Yy19jAc27i5DZBrrd1Q4Di/GGNeA24AxgFjjvYZYy4gsIDHQeDD8v0XVX7WG8uhG7cEnnhjwDh+NayIiITBxo0HSE1dxLvvrqNz53rMn389Xm/we/r115/mQjoRkcrPyU/J8wA/gcsFU4A1xphlxph7jTHlfY3ancBu4GljzH+MMY8aYz4FhhO4PHF0gbFNgNWEXub+fmA9MNoY84Ux5gljzBvABwQWILnVWlvUZYxyjIGouMAfFWIiIpXO3r2ZPPTQ5/TpM5t33w3Mcq1a9Quvvfajy8lERCKLY5+UrbUDgcbA3UBafnNP4ClgqzFmnjFmqDGmqIU2ynLuDfnnmklgWf0/E5j9ehroZ63dW8zj7M5//V+BZsAwAptK/w9Itta+4XR2ERGRiiIrK4+pU7+iW7eXeOaZb8jN9Rfqf+SRNHJygrcuERGR0nF6afs9wAxghjGmGXA98HvgDOA8AoXNDGPMB8CrwH+ttaHXwy35ubcCQ4sxbjO/Lncfqn8fgRmy+53IFck8BzcSs/oFzJEdbkcREZEy8Pstb7zxIxMnprFtW3rIMV27NmDixGRiYrwh+0VEpOTKbTXF/OLoMeAxY0wHfi3M2gK/Ba4A0jn5ZsxSEfnzqP6/S0+4iqKIiFR88+dvZdy4BaxcuTtkf9OmCYwfP4Crr26Px6MVEkVEnFSuS9sfZa39kcCiGOOMMX2A6UB3QEvsVVKegxuKLMRstP5vFRGp6Fav3sv48QuYO3dzyP7ExBhGjOjNbbd1JS4uLB8XRESqnLC9uxpjehOYHbuWwEbQUpmdYN/unI43hS+HiIiU2N//voJx4xbg99ugvuhoD7fccgYPPNCbOnW0taaISHkq12LMGHMacF3+n1ZHm4EM4F0CS+BLBPBXa0xWr/H4a7bGV7+n23FEROQEevVqFLIQu/LKdowbN4BWrXQHgYhIODhejBljmvNrAdblaDOQA3xEYOGOOdbaTKfPLWFkC6+mZWNrkdtukEthRESkJPr0acxll7Xlv/8NbAfar19jJk5MpmfP4E2dRUSk/DhWjBlj7iRwGWK/o00E9h1bQKAAe0N7dEUO756vCz23cXVcSiIiIqFYa1mzZh8dOtQN2Z+SMoD16/czenQ/LrmkDcZocQ4RkXBzcmbs7wX+/jWBAuxf1lottxeBorfOK/Q8r/HZ7gQREZEg33yzizFjFrBkyXaWLLmRtm1rB41p06Y2aWl/UBEmIuIiJ4uxDQQKsFestWsdPK5UNL4corbPL9SU2+x8l8KIiMhRW7YcZNKkNN54Y82xttTURbz88qUhx6sQExFxl2PFmLW2nVPHkorNc+BHTO6vm4L64xvgr3u6i4lERKq2AweyePLJL3nmmW/IySl8T+9//7ueJUu207dvY5fSiYhIUbRxiJSYycsq9Nyf0AKMx6U0IiJVV3Z2Hs8//y1PPLGM/fuzQo4577wW1K4dF+ZkIiJSHCrGREREKhlrLe+8s5bU1EVs2XIo5JjOnesxcWIy55zTIszpRESkuEpVjBljjl4D8aO1ttNxbSVhrbUqCEVERIopLe1nxo79guXLd4Xsb9y4BmPG9GfQoA54vbpqQUSkIittIWSOezz+7yU9joiIiJzA7t2Hue++T3j//Y0h+xMSYrjvvp7ccUc3qlWLDnM6EREpjdIWY63yH3NDtImIiIjDEhJiWblyd1B7VJSHoUO78OCDfahfv5oLyUREpLRKVYxZa7cUp01EREScER8fxejR/bnzzrnH2i69tA0pKUkh9xETEZGKT/driYiIVCA+nx9rAzNexxs0qAMzZqwgLi6KiROT6deviQsJRUTEKY7d2WuM8Rtjfi7B+E3GmDynzi8iIlLZffLJZpKTX+WFF74N2e/1enjnnauYN2+QCjERkQjg9MxYSRfk0AIeFYw5vAPvL9+ALXpxTO/BdWFMJCIS+b77bg/jxi3gs89+AuCxx5bw+993pGbN2KCxui9MRCRyuHmZYixQmuXwpZx4d6ZR/YMrMb5st6OIiFQJP/+czqRJafz736ux9tf2ffuy+NvfvmT8+CT3womISLlzpRgzxjQCGgDBy0KJa2J+nFW6Qsx4nQ8jIhLBDh7MZurUr5gxYwVZWaG/l9y7NwtrLcboIhIRkUhV6mLMGHMmcPZxzTWMMeNO9DKgFnBR/t8Xlfb84jyTc6hUr8tr1N/hJCIikSk318dLL33HY48tZe/ezJBjkpObMnFiMl27NgxzOhERCbeyzIydA4wHClxYQfX8thM5+hXfPiC1DOeXcpZXvwe22ok+DBh89buTffqwsGUSEamMrLX8978bSE1dyIYNB0KO6dChDqmpyVx4YUvNhomIVBFlKca+AWYVeD4EyAJeP8Fr/MAh4HvgHWvt3jKcX8pZdtf7yWtxidsxREQqtS+/3MHYsQtYsmR7yP6GDasxalQ/brihU8jl7EVEJHKVuhiz1r4LvHv0uTFmCHDQWjvUiWAiIiKRYNasVSELserVo7nnnh7cfXd3atSIcSGZiIi4zckFPM4Bchw8noiISKU3alQ/3nprDZmZga01PR7D4MGdGDmyH40aVXc5nYiIuMmxYsxaO9+pY0n58u5YRPzC+/Ac2lio3ZxgbzERESmdxo1rcNdd3XniiWUMHNiK1NQkOnSo63YsERGpANzcZ0xcEr/ofm3cLCLiEL/f8sYbPzJ//lamT78g5OIb997bkzPPbMaZZzZzIaGIiFRUpSrGjDFHp1TWW2svPK6tJKy1tk1pMkjpeQ5tKtY4f40W5ZxERKRymz9/K+PGLWDlysC2mVde2Y4LLmgVNC4hIUaFmIiIBCntzFjL/MesEG0lYU8+RBxj/Xh/WYnxn/jWPhtdg+zTbsNfp1OYgomIVC6rV+9l/PgFzJ27uVD7+PELOffcFni9WhVRREROrrTF2Dn5j0dCtEkFFZf2ILGrnw9qPzjkZ/DG/tpgPIE/IiJSyM6dh5k8eTH//Of3+P3B3yeuW7efr7/eRc+ep7iQTkREKptSFWOhFuvQAh4VXF4WMWtmhe7zRINHtw+KiBQlIyOHp59ezt//vpwjR/JCjrnyynaMGzeAVq1qhTmdiIhUVvoEXlX4sjD+3KDmvAa9wav9bUREQsnL8/Pyy6t49NEl7N59JOSYfv0aM3FismbDRESkxMJWjBlj6gE9gVhggbV2X7jOXVV59n5HzI+zMNn7Q94nlt35TrJPH+ZCMhGRis1ay4cfbiIlZSFr1oT+ddW2bW1SUgZwySVtQq6gKCIicjKOFWPGmL7AMGCltfax4/r+AMwAju5umWmMuc1a+6pT55fj5KRT43+XYHIOhey2MTXJ6js5zKFERCqHhQu3cd11c0L21asXz8iRfRkypDPR0d4wJxMRkUji5CoNfwAGAYU+/Rtj2gIvAjWAPCAbqAbMNMZ0dvD8UoB377dFFmIANiYxjGlERCqXpKSm9OvXuFBbfHwUI0b0ZsWKm7jlljNUiImISJk5WYwl5T/+97j2PxGYgZsP1AVqAa/nt93r4PmlIOs7YXdOx5vDFEREpPIxxjBxYnL+3+GGG07jq6+GMGZMfxITY0/yahERkeJx8p6xRoAP+Pm49ksI7Cc23lqbAWCMeQi4FjjLwfPLUdYS9/VfCjX5arUnu9sDgb/XbIu/7hluJBMRqTCys/N44YVvueaa9jRoUD2ov2fPU0hNTeLcc1vQpUt9FxKKiEikc7IYqwOkW2uPbbxijKkDdAAOAguOtltrtxhjjgBNHTy/5PMc+JGoHQsKtdn4+uS2ucalRCIiFYe1lnfeWUtq6iK2bDnE+vX7eeqp80KOvffenmFOJyIiVYmTlymHAjoEAAAgAElEQVQeBmoaYwquk3505mtxwSItXw6BmTRxmOfQ5qA2f0LLsOcQEaloFi3axnnn/Zubb/6ALVsC99XOmrWKtWu1wK+IiISfk8XYD4ABri7QdhOBSxQ/LzjQGFMDqAnscPD8knOIqK3z8O5aGtSV1e1BFwKJiFQM69bt4/rr53DJJW+yYsWuQn0+n2XKlCUuJRMRkarMycsUXwf6Ac8aY5KAU4DLgFzgtePG9idQuK1z8PxVmjmymxpzzsOTsTWoL7fZQGxCcxdSiYi4a/fuwzz22FJmzvwOn+/4CzQgKsrD0KFdePDBPi6kExGRqs7JYmwGcCVwJnA7gWILYIK1dstxY39PYMbsUwfPX6VFbf0oZCEGgEfLL4tI1XLkSC7Tp69g6tSvyMjIDTnm0kvbkJKSRNu2tcOcTkREJMCxYsxam2uMOQ+4HuhLYL+xD6y1XxQcZ4yJBuKBOQQvgy+ldKI9xfIaDQhjEhER9/h8fl59dTWTJ6exY8fhkGN69WrEhAnJ9OvXJMzpRERECnNyZgxrrQ94Of9PUWNygeucPG9VF7XpXeKXji7U5ktsha/uGfga9iWn020uJRMRCR9rLZdd9hZpacfvsBLQsmVNUlIGcMUV7TDGhBwjIiISTo4WYxJ+Uds+pfonQ4La85pfRFbfR11IJCLiDmMMv/lN66BirHbtOB58sA9//OPpxMTosm0REak4yqUYy18t8WKgO3B0p8w9wArg/aObP0vZeXcsDNluoxPDnERExH233noGzz77DVu3phMb6+X227syfHgvatWKczuaiIhIEEeLMRO47uNh4CGgRhHDMowxjwKPhdh7TErI2OCt2mxMTXJbX+VCGhGR8nfwYDZbthzk9NMbBPXFxUUxfvwA5s7dzJgx/WneXF9MiYhIxeX0zNhM4A8EVlLMApYD2/L7mgI9gATgEaAjEHx9nZyQObyDap/djHfXMrB+DIXr2bz6PThy4b+x8fWLOIKISOWUm+vjpZe+47HHllK9ejRffjmY2NjgX2PXXNOBa67p4EJCERGRknFs02djzFXAjflPHwUaWWuTrbXX5f9JBhoBU/LH/MEYc6VT568qYr/+C1E7F2OsL6gQA8hteZkKMRGJKNZa5sxZT9++L/Pgg5+zd28mP/10iOee+9btaCIiImXiWDEG3EZg77DR1trR1tqgtdattYestaOAsQRmz7TMXwl50jefsN+f0DIsOUREwmHZsu1cdNHrDB78Hhs2HCjU98QTSzlwIMulZCIiImXn5GWKPQAf8HQxxk4FUoGeDp4/4nkObiT659D7ZFtvLLmtryKvxcVhTiUi4ryNGw+QmrqId99dF7K/evVobr+9G9HRWh1RREQqLyeLsQQg3Vp75GQDrbWHjTGH8l8jxRC94U2qfXZLUPvhgW+Q1/Q8wID2zRGRSm7v3kwef3wpL774Lbm5/qB+j8cweHAnHn64Hw0bVnchoYiIiHOcLMZ2A02MMY2ttdtPNNAY0wSoBZxwnPwqZvULIdutJxqMk1ebioiEX2ZmHs888zVPPfUlhw7lhBwzcGArUlOT6NChbpjTiYiIlA8ni7EvgOuAp4wx151k2fqn8h8/d/D8Ec3kBN2Ch42uga9eVxfSiIg454svtnLnnXPZti09ZH/Xrg2YODGZ5ORmYU4mIiJSvpycUnmCwAIevwM+N8ZcZIypdrTTGFPXGHONMeZL4BrADzzp4PkjV14m3n3fF26q34PDF8+B2FouhRIRcUaDBtXYvj0jqL1ZswSee+4iPv30OhViIiISkRybGbPWfmOMuROYASQB/wOsMeYgEAvE5w81BAqxu6y13zh1/kgWv3hkUFtm0t/w1+3iQhoREWd16FCXwYM7MXPmKgBq1oxlxIje3HrrGcTFOb0dpoiISMXh6M1G1tpngTP59fJDD1AbqEagCAP4FEjOHyvF4N2xMKjNxiS6kEREpPQOHswusu/hh/tRu3Ycd97Zja+/vol77umhQkxERCKe47/prLVpwHnGmNpAN+DoDsR7gK+ttfudPmfEs75CT32JbbA1mrsURkSkZDIycnj66eVMn76C9967hm7dGgaNadiwOt99dzM1asS4kFBERMQdjhRjxhgv0B5IBA4Aa/KLrtCbYkmxefeswHvcRs9HLnhVy9iLSIWXl+fn5ZdX8eijS9i9O7DryZgxX/Dee9dgQryHqRATEZGqpkyXKRpj4owxTwH7ge+ARcD3wF5jzERjjK4xKaO4xQ8FN3r1gUVEKi5rLR98sJEBA/7J8OGfHivEABYt+pkPP9zkYjoREZGKo9TFkjHGA3xEYLGO47/irAWMAjoBV5U6neA5tDmozV+tUfiDiIgUw9df72LMmC9YtOjnkP316sWTlZUX5lQiIiIVU1lmrm4CkvP//inwL+BnoDlwM9AbuMIYc6m19r2yhJRfZfZKgaj4k44TEQmnLVsOMnFiGm++uSZkf3x8FHfd1Z1hw3qQmBgb5nQiIiIVU1mKsesI7Cv2vLX2T8f1PWuMeRe4DBgEqBhzSG67692OICJyzIEDWTz55Jc888w35OT4gvqNgeuvP43Ro/vTuHENFxKKiIhUXGUpxk7PfxxfRH8KgWLs9CL6RUSkksrN9fHssyv5y1+WcuBA6CXrzzuvBampSXTuXD9kv4iISFVXlmKsNnDIWruziP7VBcaJiEgEMcYwe/aqkIVY5871mDgxmXPOaeFCMhERkcqjLKspRgGZRXVaa7MKjBMRkQgSFeUhNTWpUFuTJjWYMeNC5s+/XoWYiIhIMahQEhGRUhk4sBVJSU1ZuXI3w4f35I47uhMfr18rIiIixVXW35rxxpjBZRljrZ1dxgwiIlIOdu8+zGOPLaVhw+o8+GCfoH5jDNOmnU9CQgz16lVzIaGIiEjlVtZiLBF46QT99iRjLOBIMWaMaQpMAC4C6gI7gP8Aqdba/aU85o0F8t1qrX3eiawiIhXZkSO5TJ++gqlTvyIjI5dq1aK48cZOnHJK8GqIrVrVciGhiIhIZCjLPWMQ2Oy5LH/Kev5ACGPaAMuBocAy4K/ARuBeYLExpm4pjtkMmAZkOJFRRKSi8/n8vPzy9/ToMZNHHllMRkYuAEeO5PHoo0tcTiciIhJ5Sj0zZq11pJByyAygATDMWjvtaKMx5ilgOPAIcHtxD2aMMQRm8/YCbwMjHE0rIlKBWGv5+OPNjBu3kB9++CXkmLS0n8nMzNM9YSIiIg6qSAVVqRhjWgMXApuB6cd1jwcOAzcaY6qX4LDDgHMJzLQddiCmiEiFtGbNQe6+exnXXPOfkIVYnTpxTJlyFmlpf1AhJiIi4rBI+M16bv7jXGutv2CHtTbdGLOIQLHWF/jkZAczxnQEpgBTrbVfGGPOPdlrREQqm23b0pk0KY3XXluNtcH9sbFebr+9K8OH96JWrbjwBxQREakCIqEYa5//uLaI/nUEirFTOUkxZoyJAl4GfgJGORFu3bp1ZXr9GT5foenLjZs2khdzsGyhpNIq68+TSEZGLrNmbeBf/9pEdrY/5JiLL27CHXe0p1GjePbs2cqePWEOKRFD71lSHvRzJU5p166d2xEiohirmf9YVIVytL04S36NA7oBSdbaIje0FhGprF5+eSMzZ24I2dezZ13uvbcjHTrUDNkvIiIizoqEYuxkTP5jiAtxCgwypjeB2bAnrbWLnTp5WStu71Iv5P76vHWr1thqDcqYSiqbo98CVoRvcKRyGzeuGe+8s439+7OOtbVuXYMpU87jggtaEli/SKRs9J4l5UE/VxKJKv0CHvw681XUV7mJx40LUuDyxLXAWOeilZ7J3EPc0rF4snR9kIg4p1atOB54oDcAjRpVZ/ToLrzySjIXXthKhZiIiEiYRcLM2Jr8x1OL6D/69UlR95QB1Cjw+qwiPpA8Z4x5jsDCHveVOGUJVft0KFE7Fpb3aUQkAm3ceICZM78jJSUJjyf4/eyWW87A74ehQ7uwffvm8AcUERERIDKKsc/yHy80xngKrqhojEkABgCZwIl2LM0GXiiirzuB+8gWEij8HLuEsUjW4t2ZFtxsvNjoauV+ehGpnPbuzeTxx5fywgvfkpfnp1Onegwa1DFoXEyMl7vv7u5CQhERESmo0hdj1toNxpi5BFZMvAuYVqA7FagOPGOtPQxgjIkG2gC51toN+cfIBG4JdXxjTAqBYmyWtfb58vp3BJ3XBq9yltvueoiuEa4IIlJJZGbm8cwzX/PUU19y6FDOsfaJE9O44op2xMVV+rd6ERGRiBQpv6HvBNKAp40x5wGrgT7AOQQuTxxdYGyT/P4tQMvwxiyeqC3vBbVlXD4PXz19ky0iv/L7La+//iOTJqWxbVt6UP+2bem8/vqPDB7c2YV0IiIicjKOF2MmcMPVlcAFQDMg3lp7XoH+6kAPwFprFzhxzvzZsZ7ABOAi4GJgB/A0kGqt3efEecLC+olfcG9Qs69BLxfCiEhFNX/+T4wdu4Bvvw29yE+zZgmMGzeAq69uH7JfRERE3OdoMWaMaQe8DZxG0UvKZwHPA22MMb2stSucOLe1diswtBjjNhfIVpzjpgAppc1VYrmH8WQXrh19ia3CdnoRqdh++OEXxo9fyLx5m0P216wZy4gRvbn11jN0eaKIiEgF59hvamNMbeBjArNhK4E3gQeAhILjrLU+Y8wM4CngasCRYiySZQ74m9sRRMRlO3ZkMHnyYl555Qf8/uBtE6OjPdx66xmMGNGbOnXiXUgoIiIiJeXk16Z/JlCIfQBcYa3NM8bczXHFWL7/EijGzqfw/VxyHBtdA1+Ts9yOISIu2r49g549Z3LkSF7I/quuOpVx4wbQsmVR2y2KiIhIReTkps9XELgkcYS1NvQnhnz5qxhmA20dPL+ISERq3LgGZ5/dPKi9X7/GfPzxIF588WIVYiIiIpWQk8VYKyDTWru6mOMzCD1rJiIix0lNTcLrDdzu2rZtbf75z0t5//3f0bPnKS4nExERkdJy8jJFW9zjGWNigJrAIQfPHxE8GT+5HUFEXLJixU7q1IkPOcvVrl0d7r+/Nw0bVmPIkM5ER3tdSCgiIiJOcrIY2wR0Msa0s9auO8nYi/PPXdxZtKrBWqp/eI3bKUQkzDZvPsjEiYt46621/Pa37Zg585KQ40aP7hfmZCIiIlKenLxM8X8Eloz/84kGGWPqA08QmEl718HzV3om6xc8R3YUarPRiS6lEZHyduBAFmPGfEHv3rN56621APznP+tYtmy7y8lEREQkHJwsxp4E9gO3GmOeMsY0K9hpjGlgjLkd+BpoDWwH/s/B81d+1hfUlNPpVheCiEh5ys7O4+9/X0HXri/x97+vICen8H/7Y8cuwNrg5etFREQksjh2maK19hdjzBUElq2/N/8PAMaYX4DaR58C+4DfWmsPO3X+SBCz5uWgtuzT73MhiYiUB2stb7+9lgkTFrFlS+hbZjt3rsfIkX0xpth704uIiEgl5eQ9Y1hrFxpjzgAmA9cAMflddfIf84C3gJHW2i1OnrvSyz1M3PJHCjX54xuCPpCJRIRFi7YxduwCVqzYFbK/SZMajB7dn0GDOuD1OnnRgoiIiFRUjhZjANban4A/GGNuAXoCpxC4HHIX8JW1NsPpc0YCz5GdQW3+xFYuJBERJ61du4/x4xfywQcbQ/YnJMQwfHhP7rijO/Hxjr8li4iISAVWbr/5rbVZwMLyOn5VkNlvitsRRKQMHn10MU88sQyfL/j+r6goD0OHduGhh/pQr141F9KJiIiI2/Q1bAXlS2yNv15Xt2OISBk0bZoYshC77LK2jB8/gLZta4d4lYiIiFQVjhVjxpjmpXld/mWNIiIR5/rrO/J///c1P/zwCwC9ejVi4sQz6du3scvJREREpCJwetPnkrIOZxARCStrLTt2HKZx4xpBfV6vhwkTknjggc9ISUni8svbapVEEREROcbJQqg0nzCq9KcS7840Yta8jMlJhzyt8i9S2axcuZtx4xbw/fe/sGLFTSQmxgaNOe+8FixbNpjoaK8LCUVERKQic3KfsROuxWyMSQR6ASOB7sAga+3HTp2/sjEZ26j+wZUYX7bbUUSkhLZtS2fSpDRee201R/dmnjr1K8aOHRA01hijQkxERERCCttmNtbaQ9baT6y1FwDzgHeNMZ3Cdf6Kxrtn+QkLMRuTGMY0IlIcBw9mk5q6kJ49Z/Lvf/9aiAFMn76Cn39Ody+ciIiIVDpu3a81ErgWGAcMcimDq4z1n7A/57Rbw5RERE4mJ8fHSy99x+OPL2Xv3syQY/r0aUxWVl6Yk4mIiEhl5koxZq3dbIw5AJzlxvkrorwGvcnucjcA/jqn4a/Z1uVEImKtZc6c9aSmLmLjxgMhx3TsWJcJE5I4//yWWpxDRERESsSVYswYUw1IBHLdOH9F5K/emLxWl7sdQ0TyLVu2nbFjF7B06Y6Q/Y0aVWfUqH5cf/1pREWF7YpvERERiSBuXaZ4N4H71UqzHL6ISLnZti2d0aO/4N1314Xsr149mmHDenD33T2oXj06zOlEREQkkji56fOZJxkSBzQFrgAuIbDH2Gynzi8i4gRj4KOPNga1ezyGIUM6M3JkXxo2rO5CMhEREYk0Ts6MfU6gwDqZozdVvA084eD5RUTKrEmTBO68sztPPfXlsbaLLmpNamoS7dvXcTGZiIiIRBoni7GfOHExlgccAL4DXrfWfujguUVESsTvt3g8oRfcuPfensyatYpmzRKYODGZ5ORmYU4nIiIiVYGTmz63dOpYIiLlaf78nxg7dgEpKUmce26LoP6aNWOZO/daWrWqVWTBJiIiIlJWji0BZoxJzP/jdeqYIiJO+uGHX/jd7/7DFVe8zbff7mHs2AX4fKH3/GvTprYKMRERESlXTq7HfADYBzR28JgiImW2Y0cG99wzj6SkV5g3b/Ox9u+//4V//Wu1e8FERESkSnPynrEMIM9au9XBY4qIlFp6eg5PP72c6dOXc+RIXsgx33//S5hTiYiIiAQ4WYxtAtobY6KstaE/9YiIhEFenp/Zs1cxZcoSdu8+EnJMv35NmDQpmR49GoU5nYiIiEiAk8XY68AE4LfAmw4eV0SkWKy1fPDBRlJSFrJ27f6QY9q1q01KShIXX9waY3RPmIiIiLjHyWLsL8DlwDPGmP3W2k8cPLaIyAmtWLGTsWMXsGjRzyH769evxsiRfRg8uDPR0VpnSERERNznZDE2EvgU6AjMNcZ8CywG9gC+ol5krZ3gYAYRqaJGjfqCJUu2B7XHx0dx113duffeniQkxLiQTERERCS0UhdjxphPgb3W2t/lN6UQ2PT56HU/ZwCnn+gQ+eNVjIlImaWmJjFw4OvHnhsDN9zQiVGj+tG4cQ0Xk4mIiIiEVpaZsbOBnQWezyZQXImIhF2fPo25/PK2zJmznvPPb0FqajKdOtVzO5aIiIhIkRy7TNFae5NTxxIROZ61lrffXsvmzQf58597hxyTmprE0KFdOOecFmFOJyIiIlJyTt4zJiJSLhYt2sbYsQtYsWIXUVEerriiHW3b1g4a16pVLVq1quVCQhEREZGS87gdQESkKGvX7uO66+ZwySVvsmLFLiCwh1hKykKXk4mIiIiUnWbGRKTC2b37MFOmLGHWrFX4fMG3on744Sa2bDlIixY1XUgnIiIi4oyyFmM1jTEvluH11lr7xzJmEJEIcfhwLtOnr+Dpp78iIyM35JjLLmvL+PEDVIiJiIhIpVfWYiwOGFLK1x5d2l7FmEgV5/P5eeWVH3j00cXs2HE45JhevRoxceKZ9O3bOMzpRERERMpHWYuxXAIbO4uIlJi1lo8/3sz48Qv54Ye9Ice0alWTlJQkLr+8LcaYkGNEREREKqOyFmP7rLXnOJJERKqcN99cw623fhiyr06dOB58sA8333w6MTHeMCcTERERKX9awENEXHPppW1p2jSBbdvSj7XFxnq5445u3HdfT2rVinMxnYiIiEj50tL2IuKa+Pgoxozpf+z5oEEd+eqrIaSkJKkQExERkYinmTERKVc5OT7+/e/V/P73HUNebnjttR346qsd/OEPnenatYELCUVERETcoWJMRMqFtZY5c9aTmrqIjRsPcPhwLnfc0S1onMdjeOKJc11IKCIiIuIuXaYoIo5bunQ7F130OkOG/I+NGw8A8PjjSzlwIMvlZCIiIiIVR6mLMWutx1qrDX9E5JgNG/YzePB7DBz4OkuX7ijUt39/FlOnfuVSMhEREZGKR5cpikiZ7d2byWOPLeXFF78lL88f1O/1GgYP7szttwdfpigiIiJSVakYE5FSy8zM4x//+Jq//vVLDh3KCTnmootak5qaRPv2dcKcTkRERKRiUzEmIiXm91tee201jzyyuNAeYQV169aQCROSSE5uFuZ0IiIiIpWDijERKZGcHB8XXvga33yzO2R/8+aJjBvXn6uuao/HY8KcTkRERKTyUDEmIiUSE+OlS5f6QcVYzZqxjBjRm9tuO4PYWL21iIiIiJyMlrYXkRIbNaof1aoFCq6YGC933dWdb74Zyj339FAhJiIiIlJM+tQkIiGlp+dw4EAWzZolBvWdckoN7r67Bxs27Gfs2AG0bFnThYQiIiIilZuKMREpJC/Pz+zZq3j00SV07FiXd9+9CmOC7/16+OG+IdtFREREpHhUjIkIANZaPvhgIykpC1m7dj8Ae/YcYd68zVx4Yaug8SrERERERMpG94yJCCtW7OSSS97k+uv/e6wQO2rcuAUhN3IWERERkbLRzJhIFbZ580EmTlzEW2+tDdkfHx/FpZe2JS/PT1SUvrsRERERcZKKMZEqaP/+LJ54YhnPPbeSnBxfUL8xcMMNnRg1qh+NG9dwIaGIiIhI5FMxJlKFZGfn8eyzK3nyyWUcOJAdcsz557cgNTWZTp3qhTmdiIiISNWiYkykipg3bxN//vNn/PTToZD9XbrUZ+LEZM4+u3mYk4mIiIhUTSrGRKqI3Fx/yEKsSZMajBnTn0GDOuLxaIVEERERkXBRMSZSRfzmN63p378JaWk/A5CYGMPw4b24/fZuxMfrrUBEREQk3LQ8mkiECbUgBwT2BZs0KZnoaA+33daVFStuYvjwXirERERERFyiT2EiEeLw4VymT1/BCy+s5IsvbqBhw+pBY7p3b8T33/+RBg2C+0REREQkvDQzJlLJ+Xx+Zs9eRY8eM5k8eTG7dh1hypQlRY5XISYiIiJSMURMMWaMaWqMedEYs90Yk22M2WyM+ZsxpnYxX1/XGHOLMeYdY8x6Y0ymMeagMWahMeaPxpiI+d9KIoO1lnnzNpGc/ArDhn3Mzp2Hj/XNnr2KNWv2uZhORERERE4mIi5TNMa0AdKABsC7wI9Ab+Be4CJjzABr7d6THOZ3wP8BO4DPgJ+AhsBVwPPAb4wxv7PW2vL5V4gU38qVuxk3bgHz528N2V+zZiybNh2gffs6YU4mIiIiIsUVEcUYMINAITbMWjvtaKMx5ilgOPAIcPtJjrEWuBz4n7XWX+AYo4BlwNUECrO3nI0uUnxbtx5i0qTFvP76akJ9LRAb6+WOO7px3309qVUrLvwBRURERKTYKn0xZoxpDVwIbAamH9c9HrgNuNEY82dr7WGKYK39tIj2ncaYfxAo6M5GxZi4ICMjl5de2sBrr31IdnbwaonGwLXXdmTMmH40a5boQkIRERERKalKX4wB5+Y/zi04owVgrU03xiwiUKz1BT4p5Tly8x/zSvl6kVLJyfHx4ovf8uijaRw8mBtyzFlnNWPChGTOOKNBmNOJiIiISFlEQjHWPv9xbRH96wgUY6dSimLMGBMFDM5/+mFJX79u3bqQ7bV376BNgecZGRlsLGKsVF2HDuUyeXIahw4FF2Jt2iRwzz0d6N+/PsYcZN26gy4klEhR1HuVSFno50rKg36uxCnt2rVzO0JErKZYM/+xqE+iR9trlfL4U4DOwPvW2o9KeQyRUklMjGbo0LaF2urVi2XMmC688koyAwY0wBjjUjoRERERKYtImBk7maOfVEu8CqIxZhjwZwKrM95YmpMXVXFHe1fB6l+f16hRo0JU51LxjBrVijfe2Mz+/TkMH96bu+7qTvXq0W7Hkghx9Btmvf+Ik/RzJeVBP1cSiSKhGDs681WziP7E48YVizHmLmAq8ANwnrVWmzZJudi7N5PHHltK376ncNVV7YP6Y2OjmDy5Ow0bxtGvXxcXEoqIiIhIeYiEYmxN/uOpRfQf/fqkqHvKghhj7gP+CqwiUIjtLn08kdAyM/P4xz++5q9//ZJDh3L44IMNXHxxG+Ligv+z7NSptFfZioiIiEhFFQn3jH2W/3ihMabQv8cYkwAMADKBJcU5mDHmIQKF2DfAOSrExGl+v+Vf//qBXr1mkZq6iEOHcgDYujWd555b6XI6EREREQmXSl+MWWs3AHOBlsBdx3WnAtWB2Uf3GDPGRBtjOhhj2hw3FmPMWAILdiwnMCP2S3lml6rn889/4qyzXuWOO+aybVt6UP8bb/yIDbWbs4iIiIhEnEi4TBHgTiANeNoYcx6BpTH6AOcQuDxxdIGxTfL7txAo4AAwxgwBJgA+YAEwLMQqdZuttTPL5V8gEe37739h/PgFfPzxlpD9NWvGMmJEb2677QytjigiIiJSRUREMWat3WCM6UmgmLoIuBjYATwNpBZz8Y1W+Y9e4L4ixswHZpYtrVQl27dnMHnyYl599Qf8/uAZr5gYL7feegYjRvSmdu04FxKKiIiIiFsiohgDsNZuBYYWY9xmfl3uvmB7CpDidC6pmtLTc5g69SumT19BZmZeyDFXX30qY8cOoGXLohYCFREREZFIFjHFmEhFMmLEZ7z22uqQff37N2HSpGS6d28U5lQiIiIiUpFU+gU8Ki1fjtsJpBzdf38vvN7CE7CnnlqbV1+9jP/97xoVYiIiIiKiYizsfDnEf1Iw32gAACAASURBVH4b1eb/ye0kUo7at6/D4MGdAahfvxpPPXUuaWk3cvHFbbRAh4iIiIgAukwx7KK2zSNm/etuxxAHbN58kLlzN3HbbV1D9o8c2ZcGDapx9909SEiICXM6EREREanoVIyFmSd9a8h2f2LrMCeR0tq/P4snnljGc8+tJCfHR8+ejUJedtiwYXUefrifCwlFREREpDLQZYphZjL3BLXlNr+I7NOHuZBGSiI7O49p05bTtetLTJ++gpwcHwBjxizQRs0iIiIiUmKaGQsjk/4TcSufLNSWfdptZPV/3KVEUhx+v+Xtt9cwYUIaP/10KKg/Le1nPv/8J845p4UL6URERESkslIxFkbRP30Q3OjR/wUV2cKF2xg3bgErVuwK2d+0aQKjR/fjrLOahzmZiIiIiFR2qgTCyORmBLXlNTk7/EHkpNau3cf48Qv54IONIfsTE2O4//5e/OlP3YiP139GIiIiIlJy+hTpIl+t9uQ1u9DtGFLA7t2HmTJlCbNmrcLnC74PLCrKw803n85DD/Whbt14FxKKiIiISKRQMeai3BaXuB1BCvj2291cfPEbZGTkhuy//PK2jB8/gDZtaoc5mYiIiIhEIhVjIvk6dapHs2aJrF69t1B7796nMHFiMn36NHYpmYiIiIhEIi1tL5LP6/WQmpp07Hnr1rWYNesSPvroWhViIiIiIuI4zYyFS24GcV9NdDuFACtX7qZ161okJMQE9V1wQUuuuupU+vRpzNChXYiJ8bqQUERERESqAs2MhUnM+jfcjlDlbd16iD/96SPOPvtVpk79KuQYYwwvvngxf/pTVxViIiIiIlKuVIyFicnYGtTmr9nahSRVz8GD2aSkLKRnz1m89tpqrIXp01ewfXvwVgMiIiIiIuGiYsxFuW2udTtCRMvJ8fGPf3xNt24v8be/fUV2tu9YX2ZmHpMnL3YxnYiIiIhUdbpnzCVZPceCN/ieJSk7ay1z5qwnNXURGzceCDnmtNPq8tvftgtzMhERERGRX6kYk4iydOl2xo5dwLJlO0L2N2pUnVGj+nHDDafh9WpiWERERETco2JMIsKGDftJTV3EnDnrQ/bXqBHNsGE9ueuu7lSvHh3mdCIiIiIiwVSMhYO1xPw40+0UEWvcuAXMmPE1eXn+oD6v1zBkSGdGjuxLgwbVXUgnIiIiIhKairEwiNr0Lp7sfW7HiGihCrHf/KY1KSlJtG9fx4VEIiIiIiInpptmwiBq15KgNhtTy4Ukken++3tRu3bcsefduzfkvfeu4V//ulyFmIiIiIhUWCrGwsEGz9rktrzUhSCV28GD2SHba9WK44EHetO8eSLPP38RH3/8e5KSmoY5nYiIiIhIyegyxXJmsvYS+8Ozhdqyeo7DVmvoUqLKZ9WqPYwfv5Ddu48wf/71eDwmaMwtt5zBH/94OrGx+pEWERERkcpBn1zLWcz3zwa12ahqLiSpfLZvz+CRR9J49dUfsDbQ9tprq7nuutOCxsbEeMOcTkRERESkbHSZYjnzHN4W1Oav2caFJJVHenoOkyal0aPHTF555ddCDOCRRxaTmZnnXjgREREREYdoZqyceQ5uLPTcH1uLvKbnuZSmYsvN9TF79iqmTFnKnj1HQo5p3jyRvXszado0IczpREREREScpWKsnEXtWlzoeVbviWA0IVmQtZb3399ISspC1q3bH3LMqafWJiUlid/8pjXGBN8zJiIiIiJS2agYCzdPtNsJKpTly3cyduwC0tJ+Dtlfv341Hn64L4MHdyYqSkWsiEhp5ebmkp6eTmZmJn5/8Cq/TvJ6A/fxbt26tVzPI1WLfq6kuDweD/Hx8SQkJBAdXbE/e6sYC7O8Rn3djlAh/PTTIVJTF/LWW2tD9sfHR3H33T0YNqwHCQkxYU4nIhJZcnNz2b17NwkJCTRs2BCv11uuVxlkZWUBEBcXd5KRIsWnnyspDmstPp+PI0eOsHv3bho0aFChCzIVY2GU3fkubEJLt2NUCNu3Z4QsxDweww03nMaoUf045ZQaLiQTEYk86enpJCQkkJiY6HYUEZFyZYwhKirq2Ptdeno6derUcTlV0XTdVxj5GvR0O0KF0bdvYy69tPCqkuef34IFC25g2rQLVIiJiDgoMzOTatW0rYqIVC3VqlUjMzPT7RgnpGJMXJOSkkRUlIcuXerzn/9cxZtvXkmnTvXcjiUiEnH8fv+x+21ERKoKr9db7vfIlpWKMSk3CxduY+DA19iwIfQKiW3b1uajj65l/vzrOfvs5mFOJyJStWglWhGpairD+56KMXHcmjX7+P3v53DppW+ydOkOUlMXFTm2R49GeDwV/z8UERERERGnaQEPccyuXYeZMmUJs2evwuezx9rnzFnP0qXb6dOnsYvpREREREQqFhVjUmaHD+fy978v5+mnl3P4cG7IMZ9+ukXFmIiIiIhIAbpMUUrN5/Mze/YqevSYyaOPLglZiPXufQoffXQtDz/cz4WEIiIiEmlycnLo3r071157rdtRJEweeOABWrRowd69e92O4jgVY1Ji1lrmzt1EUtIrDBv2MTt3Hg4a07p1LWbNuoSPPvr/9u48PIoqa/z494R9CyFAEGQbNqOAIMoiCIRFZFMHFRFwREYFBRVUHBnHjcER+AHv4OCCogjKIgiv4gsMiiD7Iigwosg6rAIKhAQCgSzn90dVh07SnY1OOgnn8zz1dLpu1e1bnZt0nb7b/dYiZowxJl8ICwtLtYWHh1O7dm169OjBrFmzUNUMz1+5ciUDBw6kUaNGVKlShVq1atGhQwfGjh3LmTNnMjw3OTmZhQsX8qc//YmGDRtSpUoVqlWrRosWLRg2bBgbN24M5KUWau+99x779+/nxRdfDHZRCrTo6GhGjhxJ48aNiYiIIDIykqFDh3L06NFs57Vhwwb69u1L48aNqVKlCo0aNaJ3795888036Y6NjY1l5MiRdOvWjcjISKpUqUK9evXo2LEj77zzDnFx6e8rR4wYwaVLlxg7dmyOrjU/k8z+8ZisiYmJ8flGlv8gLOXnuM6fkFj7zjwrU27Yvv03XnllDatWHfaZHh5ekhdeaMXAgY0pXtymUQ6UPXv2AFC/fv0gl8QUNla3rg6HDx+mRo0aefZ68fHxAJQsWTLPXjMrwsKcz+QXXngBgMTERPbv38+iRYtISEjgscceY/z48enOu3jxIk899RTz5s2jVKlSdO7cmXr16nHu3DnWrFnDL7/8QsWKFfn4449p06ZNuvNPnDjBgAED2LhxI+XKlSMqKoo//OEPqCr79u1j9erVnDt3jnHjxjF48ODcfRMKsPj4eOLi4mjWrBnNmjXj888/D3aRCqzTp0/TpUsX9u7dS7t27WjWrBm7d+9myZIlVK5cmWXLllG7du0s5fXhhx/y3HPPUaZMGXr06MG1117L0aNHWbRoEefPn+ell15ixIgRKccfPHiQVq1acdNNN1GvXj0qVapEbGwsq1evZvfu3URGRvL111+nW6T+ueeeY8aMGWzdujVb/89y8v+vfPnyeTa7nAVjAZJZMKbFynK29xa09DV5Wq5ASkxMpmnTjzhy5Gy6tJIli/DEEzcxfHhzypcvEYTSFW52w2xyi9Wtq4MFYw5PMJa2FWvjxo10794dVWXr1q3pbkKHDh3KrFmzaNKkCbNmzaJ69eopaarK1KlTGTlyJKVLl2b58uVcd911Kennz5+nS5cu7Nixg3vvvZeJEyemlMMjNjaWyZMnU6JEiVQ3rSa1+Ph4Zs6cyYgRI5g6dSq9e/cOdpEKrOHDhzN9+nSGDBnCG2+8kbJ/ypQpjBw5kk6dOrFgwYJM80lISKBu3bpcunSJNWvWpPos2bVrF+3atSMkJIQDBw5QooRzf5iUlERycjLFihVLl9+gQYOYN28eo0aNYtiwYanStmzZQufOnRkxYgQvvfRSlq81vwdj1k0xlyXU7MbFRkM412NxgQ7EAIoWDeGvf22Vap8IPPDA9WzePIBXX73NAjFjjDEFTqtWrWjQoAGqyvbt21OlbdiwgVmzZhEWFsbcuXNTBWLgrGM0aNAgnn76ac6dO5fS6ubxzjvvsGPHDlq1asXUqVPTBWIAoaGh/O1vf+Opp57Kcpm///57Bg4cyPXXX09ERATXXXcdvXr1StVatGbNGsLCwhgzZozPPBo3bkzjxo1T7fNc66xZs/jmm2/o0aMHNWvWJCwsjF9//ZXw8HDatWvnt1z33nsvYWFh/Pzzz6n2b9myhYceeogGDRpQuXJlGjZsyPDhwzl27FiWrxlg9uzZFC9enB49eqRLO3bsGOPGjeOOO+5IeZ3IyEgeffRRdu3ale74gwcPEhYWxhNPPMHevXsZOHAg9erVo0KFCqxZsybluOXLl9O7d2/q1KlDREQETZs25eWXX/bZNXX16tUMGzaMli1bUqNGDa655hpuvfVWxo4dm/IlRbDFxcUxd+5cypQpw1//+tdUaYMGDaJmzZosX76cAwcOZJpXdHQ0sbGx1K1bN92Xetdddx1169blwoULqboeFilSxGcgBnD33XcDsG/fvnRpt9xyCzVr1mTmzJmZdikuSGw2xVwW3+wFkis1DXYxAuaBB67nnXe28tNPJ2nfvgZ//3tbmjSJCHaxjDHGXAHvLvUByS+guUHMoxmPxwoEz81d0aKpb41mzJgBwIABA7jmGv9fqg4fPpx3332XlStXcuDAgZTWtenTpwPOBAQhIRl/B+5pOcjMjBkzePbZZylSpAjdunWjbt26/P7772zdupUPPviAXr16ZSmfjHz55Zd88803dO7cmYEDB3Lo0CGqVatGVFQUK1as4KeffqJhw4apzjl+/DgrV66kadOm3HDDDSn7Z86cybBhwyhRogTdunXj2muvZd++fXz88ccsXbqUZcuWZanlIjY2lu3bt9OsWTNKly6dLn39+vVMmjSJtm3bctddd1GmTBn27dvHwoUL+fe//83SpUvTBZ8ABw4coFOnTtSrV4/evXsTHx9PuXLlABg3bhxjxoyhQoUK3HHHHVSuXJmffvqJyZMns2zZsnTd6d588012795Ny5Yt6dKlC/Hx8WzatImxY8eydu1aFi5cSJEiwR3GsXnzZi5cuEDHjh1TrtMjJCSEjh07Mn36dFavXp1pV8XKlStTqVIl9u3bx759+6hbt25K2t69e9m/fz+NGzcmPDw8S2VbunQpQLq65dGqVSvmzZvHzp07U9WxgsyCMZOKqvLll3u5dCmJ3r0j06UXKRLChAkdOHfuEp071y4QK5sbY4wxGVm3bh179uyhePHi3HzzzanSPBNrREVFZZhHWFgYTZs2ZdOmTWzatInatWtz5MgRjhw5QtGiRX2OJcuJX375heeee45y5crx73//m+uvvz5Vek4mX/Dl66+/5rPPPqNz586p9vfr148VK1YwZ84cXn/99VRp8+bNIykpib59+6bs27t3L8888ww1a9Zk8eLFVKt2eVKvVatW0atXL0aOHMmsWbMyLdOWLVtISkqiaVPfX3K3a9eO3bt3pwswfvzxR7p27cqoUaOYP39+uvM2bNjAs88+yyuvvJJq/+rVqxkzZgwtWrRg3rx5qVo1Z82axdChQxkzZkyqlseJEydSq1atdPdHr7/+OhMmTGDhwoXcc889mV4rOK2qMTExWToWnJbOnj17Znqcp3u6d+DkzbPfV+tUWiLChAkTGDRoEFFRUfTo0YOqVavy66+/snjxYiIjI5k2bZrPcxMTE1PGaEZHR7N+/Xp27NhB27ZtGTBggM9zbrrpJubNm8f69estGDOFz6ZNv/Lyy2v47rtjhIeXpEuXP/jsdnjrrdcGoXTGGGNMYHhunr0n8FBVRo8ena7168SJEwBce23mn32eY44fP57q3PDw8ICNn/vwww9JTEzk+eefTxeIZbWcWdG9e/d0gRhAjx49CA0N5bPPPmPUqFGpWnnmzJlDsWLFuO+++1KVNyEhgbFjx6YKxADat29Pt27dWLp0KWfPnk0XRKXlCTT9tVBWrlzZ5/7GjRvTtm1bvv32WxISEtJ1kYuIiEjXvRScWRvBae1K2720f//+TJkyhc8++yxVMOavJWnIkCFMmDCB5cuXZzkYe/fddzl82PeEab707ds3S8FYbGwsAOXL+27D9rT0ZTUQ/OMf/8g111zDo48+yqeffpqyPyIigv79+/t9TxITExk3blyqfX369GHixIl+/16qVKkCwJEjR7JUtoLAgjHDvn3RvPbaOv7v//am7Dt9Op5Jkzbz6qu3BbFkxhhjTOClvQEUESZPnsyDDz7o95ys9ATxdHX0HJv2eSBs2bIFgNtvvz1gefqStoXQo1SpUvTq1YsZM2awfPlyunTpAsC2bdvYuXMnPXv2pGLFiinHb968GXBaH3/44Yd0+Z08eZKkpCT27dvnt8XLIzo6GsDnuDuPr776imnTprFt2zZOnTpFYmJiqvRTp06lC+YaNWrks4vo5s2bKVasGF988QVffPFFuvSEhAROnjzJ6dOnU7rhxcXFMWXKFBYtWsS+ffs4e/ZsqvFN2Rkj9+OPP2b52EDKbr2dO3cuw4YN48477+T555+nRo0aHD58mPHjx/P888+zbt26lO663kqWLMmZM2dQVY4dO8bKlSv5+9//TocOHZg/fz61atVKd06FChUACtV6YxaMXcVOnjzPuHGb+OijH0lMTE6XPnXqdp55pjmhoTYphzHGFGaBHpOVX2dT9PBMvBAXF8fmzZt58sknefbZZ6lRowbt27dPdWxERAQHDx7kyJEjmc46+uuvvwKXv7333PSfOnWK+Pj4gLwfntaKqlWrXnFeGYmI8D8evF+/fsyYMYM5c+akBGOzZ88GSNVFEZwp1AH+9a9/Zfh6586dy7RMnvfP30QYnpkAw8LC6NChA9WrV6dUqVKICIsXL2bHjh1cvHgx3Xn+rvX06dM+W298lT08PJyEhATuuusuvv/+e2644QZ69epFpUqVUsYhjhs3zufr57XMWr7Onj2b6riM7N27lyeffJKGDRvy3nvvpYyLbNCgAe+99x579uzhiy++YM2aNbRt29ZnHiJCtWrV6NevH/Xr1+f222/nL3/5C3Pnzk137IULF4D8+78lJywYuwpduJDIlClb+ec/NxMbe8nnMd261WHUqNssEDPGGFNolSlThqioKD799FPat2/PkCFD2Lx5c6rJIVq1asXBgwdZuXIlHTp08JvXmTNn2LZtGwAtW7YEoHr16lSvXp0jR46wfv16OnbseMVl9nQtO3bsWKbd+jw3xklJST7TY2Nj/d5wZ9Qq0rJlS+rWrcuSJUs4c+YMZcqUYcGCBVSsWDElOPPw5H/o0KEs3dxnpFKlSsDlFjJviYmJjBkzhipVqrBq1ap0rV+eFjpf/F1raGgoycnJWZpVEGDJkiV8//339O3bl3fffTdV2vHjxzMN6tLKrTFjni8V/I0J8+z3N6bM24oVK0hISKBNmzbpJqgJCQmhdevWbNu2jW3btvkNxrw1b96c8uXLs3btWp/pnuDeX5fUgsiCsatIcrLy6ac7+cc/1nP0qO9voJo1q8Lo0W1p06a6z3RjjDGmsGnUqBEDBgxg2rRpvPPOO6nW+nrooYeYO3cuH3/8MUOHDvXbijJ58mQuXrxIVFRUqjEyDz/8MK+//jrjx48nKioqwxkVL168mOmMirfccgtbt25l2bJlNGjQIMNjPd35fI2v2b9/PzExMTkOkPr27cvrr7/O559/TuXKlTl16hSDBw9ONx6refPmbNu2jQ0bNnDHHXfk6LU8PGPkdu/enS7t1KlTxMTE0K5du3SB2Llz59ItWZAVzZs356uvvmLnzp0+x+eltX//fgDuuuuudGnr1q3L9uvn1pixW265hVKlSrFp06Z0Y/WSk5NZsWIFQIZLGHh4WvpOnjzpM92zv3jx4pnmBU6r3NmzZylbtqzPdM/kI75mxSyobJ2xq8S33x6kXbtZDBnytc9ArGbNUD78sBvffPOABWLGGGOuOiNGjKBkyZJMnjw51fpRbdq0oU+fPkRHR9OnTx+fsxVOmzaNSZMmUbZsWcaOHZsqbciQITRq1IgNGzbw+OOP+1yb6ty5c4wbN47JkydnWs5HHnmEokWLMn78eH755Zd06d7la9CgAaGhoSxZsoTff/89Zf+FCxd8TliRHQ888AAhISF8+umnKZM29OvXL91xjz32GMWKFePFF19k79696dIvXbrE+vXrs/SakZGRVKxYMWXcnLfKlStTunRptm3blqrLY0JCAiNHjszRGKMhQ4YAMGzYMJ9jvTzdXD1q1qwJkK5V58CBA7z66qvZfv0ff/yRM2fOZHlL2xrnT9myZenTpw9xcXHp6uv777/PoUOH6NSpU7qJN3bv3p0uEG7dujXgLIWwY8eOVGn/+c9/+PLLLxGRVIHdf/7zH59/B5cuXeL5558nOTnZb+C+efNmihQpkvK6hYG1jOW2EN+L2uWlt976gZdeWu0zLSysBCNGtOSxx26kRAmrDsYYY65O1apV4+GHH2bKlCm8+eabqW6e33zzTZKSkpg/fz7Nmzenc+fO1K1bl7i4ONauXcvPP/9MeHg4H3/8MZGRqZeFKV26NAsWLGDAgAHMmzePpUuXEhUVRZ06dUhOTmb//v2sXr2a2NjYlGm+MxIZGcnEiRN55plnaNeuHd27d6du3bqcPn2arVu3UrZsWRYtWgRAsWLFGDx4MOPHj6ddu3b07NmTxMREvv32W6pWrXpF486qV69O27ZtWbVqFUWLFuWGG26gSZMm6Y5r0KABb731Fk8++SStWrVKWc8rISGBI0eOsGHDBipVqpRhN0IPEaF79+588skn6VqrQkJCGDx4MP/85z9p3bo13bt3JyEhgTVr1hAdHU3btm1TLeScFe3bt+e1115j1KhR3Hzzzdx+++3UqlWLuLg4Dh8+zLp162jVqhULFiwAoGvXrtSpU4e3336bn3/+mRtvvJEjR47w1Vdf0aVLl3w1A+Arr7zC2rVrefvtt/nxxx+5+eab2bVrF0uWLKFy5cpMmDAh3TktWrQASBVI3XzzzfTv359Zs2bRsWNHevbsSY0aNTh06BCLFy/m0qVLPPHEE6l+V7Nnz2bGjBncdttt1KhRg/Lly3Ps2DG+/fZbTpw4Qf369Rk9enS614+JieGHH36gffv2fmeCLIikMK1gHUwxMTG+38jkRAgJbpBz9OhZbrllBhcuXJ5RqHjxIgwa1IQRI1oQFlZ4BkEWVp5m+cwGjxuTXVa3rg6HDx/O0qK6gZJfJ/DwdNvz9a08wG+//ZYyo9+2bdvSdUlcsWIFM2bMYPPmzZw8eZKSJUvyhz/8ga5du/L444+nzPTmS3JyMl9++SXz58/nhx9+4NSpU4SEhFC9enVatWrFgw8+mDLWLCu+++47Jk+ezIYNG4iJiaFixYo0bNiQhx56iLvvvjvlOFVl0qRJzJgxg6NHj1KlShXuueceRo4cmfJ63rP2edbPevvtt+nfv3+GZZg7dy6DBw8GYPTo0Tz11FN+j/3pp5946623WLNmDb/99hulS5ematWqtGzZkl69eqWbOMWX+Ph4fvrpJzp16sSwYcMYNWpUqvTExESmTJnCJ598wsGDBwkNDSUqKoqXXnqJMWPGMGfOHLZv354yS9/Bgwdp0qSJzzFe3jZs2MB7773Hxo0bOXXqFKGhoVStWpV27drRu3dvbrrpppRjjxw5wqhRo1i7di3R0dHUrl2bvn37MnToUCpVqkSbNm1YvHhxpteaF6Kjoxk7diyLFy/mxIkThIeH07lzZ1588UWfSyT4+/tRVWbPns3s2bPZsWMH586do1y5ctx4440MGDCAe++9N9XxGzduZObMmWzZsoVjx46lHB8ZGUmPHj145JFHfC7qPX36dIYPH87MmTOz1B3TIyf//8qXL59nC+laMBYgfoOxfGL06HVMnOh863Tffdfx0kutqV278HyrUNjZDbPJLVa3rg4WjJnCwFOv+vXrx44dO9i+fTulSpUKcqlMXomKiiIuLo6NGzemWt8uM/k9GLMxY4VEQkISixal74vtMWzYLfTsWZcVKx7ggw+6WSBmjDHGmAJp9OjRnDp1ig8++CDYRTF5ZNGiRWzbto3Ro0dnKxArCCwYK+BUlcWL99G69UwefHARy5cf8HlcaGgJZs68k2bNfK9ab4wxxhhTEDRs2JC33nrLWl6vIvHx8bzxxht07do12EUJOJuxoQD7/vvjvPzyGtavvzxz0ssvryUqqiZFilicbYwxxpjCKe3i0qZwu++++4JdhFxjd+wF0IEDMfz5z0vo1OnTVIEYwM8/n2TOnJ1BKpkxxhhjjDEmq6xlrACJjo5n/PhNTJ26nYSE5HTpISFC//430KlTrSCUzhhjjDHGGJMdFowVAPHxiUydup0JE74jJuaiz2Nuv702r712Gw0bVsrj0hljjDHGGGNywoKxfCw5WVmwYBejR6/n0KFYn8c0blyZ119vS/v2NfO4dMYYYwoSVUUkz2ZrNsaYoCsIS3hZMJZPnT59gXvv/YKtW0/4TK9evRwvvdSa+++PJCTEPlyNMcb4FxISQlJSEkWL2se+MebqkZSUREhI/p4iw/4r51MVKpSkRIn06yiEhhbn2WebM3jwTZQqZb8+Y4wxmStVqhTnz58nNDQ02EUxxpg8c/78+Xy/MHj+DhWvYiLC6NFtU54XLRrC4MFN2bp1IMOHN7dAzBhjTJaVK1eOs2fPEhsbS2JiYoHoumOMMTmhqiQmJhIbG8vZs2cpV65csIuUIbujD7K4uAQSEpIIC0u/cGHz5lXp1as+ycnw6qttqFMnLAglNMYYU9AVK1aMiIgIzp49y4kTJ0hOTj8jbyAlJCSkvK4xgWL1ymRVSEgIpUqVIiIiIt/XFwvGgiQpKZlZs37mjTc20KNHXSZO7OjzuPffNtTZzAAAFy1JREFU70qxYum7KxpjjDHZUaxYMcLDw/Pktfbs2QNAnTp18uT1zNXB6pUpjKybYh5TVb7++r/cdtssnn76G44fj2P69B/Zvfu0z+MtEDPGGGOMMaZwsmAsD23b9ht33/2/3H//QnbuPJWyPylJee21tUEsmTHGGGOMMSavFZpgTESqi8g0EflVRC6KyAERmSQiFYKRj7fDh2MZNGgpUVGzWb36cLr0kiWLcN114SQn24BqY4wxxhhjrhaFYsyYiNQF1gMRwELgF6AFMAzoKiJtVPVUBlkENB9vr766hilTtnHxYpKP14M+fa7nb3+7lRo1bLphY4wxxhhjriaFIhgD3sEJoJ5W1cmenSLyP8AzwD+Ax/MwnxRvvvm9z/3t29fg739vS5MmEdnJzhhjjDHGGFNISEFfa0RE6gD7gANAXVVN9korBxwDBIhQ1bjcyicmJqZgv5HGGGOMMcYYypcvL3n1WoVhzJhnTvivvQMoAFU9C6wDSgOt8igfY4wxxhhjjMlUYQjGrnMfd/tJ3+M+NsijfIwxxhhjjDEmU4UhGCvvPsb4SffsD8ujfIwxxhhjjDEmU4UhGMuMp8/nlY7pClQ+xhhjjDHGGFMogjFPi1V5P+mhaY7L7XyMMcYYY4wxJlOFYWr7Xe6jv7Fc9d1Hf2PBApJPXs66YowxxhhjjCn4CsPU9nWBvWQ8JX0IUDmTqe0Dko8xxhhjjDHGZEWB76aoqvuAr4HawNA0yaOAMsDHngBKRIqJSKQbfOU4H2OMMcYYY4y5EgW+ZQxSWrXWAxHAQmAn0BLogNOtsLWqnnKPrQ38FzioqrVzmo8xxhhjjDHGXIlCEYwBiEgN4O9AV6AiTrfCL4BRqnra67ja+AnGspOPMcYYY4wxxlyJAt9N0UNVD6vqQFWtqqrFVbWWqg5LG0Cp6gFVFV+BmL98gPHABBH5VUQuisgBEZkkIhWyU0YRqS4i0640H1M4XGl9EJGKIvKoiHwuIntF5IKIxIjIWhF5REQKzd+3ybrc+D8jIn8SEXW3RwNZXlNwBLJuiUhbEVkgIsfcvI6JyNci0j03ym7yr0DVKxHp4dahI+7n4X4R+UxEbs2tspv8SUTuE5HJIrJGRGLdz66ZOcwr1+/dC03LWG7x0XXxF6AFTtfFXUCbrHRdDFQ+pnAIRH0QkceBd3Fab78FDgFVgHtwlmhYAPRW+yO/auTG/xm3t8CPQBGgLPCYqn4QyHKb/C+QdUtEXgJGAyeBRTj/wyoBNwHfqupfAn4BJl8K4D3WOOAvwCmc3kwngXrAXTgzhz+kqjm6GTcFj4hsA5oA54AjQCQwS1UfzGY+eXPvrqq2ZbABX+Es9PxUmv3/4+6fkpf52FY4tkDUB6AjcCcQkmb/NTiBmQL3Bvtabcu7LdD/Z3AWu/8G2IfTQ0CBR4N9nbbl/RbAz8Le7vHLgHI+0osF+1pty7stQJ+F1wBJwHEgIk1aBzef/cG+VtvybnN/7/Xdz7Aotw7MzEE+eXLvbi1jGRCROjg3IQfwP9294PzxZzRtfkDyMYVDXtQHEXkR+Afwlqo+dcWFNvlebtQrERkG/BPnw6wj8CrWMnbVCeBnYQjOEjJVgNqq+ntultvkbwGsVy2BjcCXqnq3j/RYnJ5g5QJ7BaYgEJEonN5D2WoZy8t7dxtTkrGO7uPX3r8EAFU9C6wDSgOt8igfUzjkRX1IcB8TryAPU7AEtF6JyPXAWOBNVV0dyIKaAidQdas18AdgCRDtjvF5QUSG2bieq1Kg6tUe4BLQQkQqeSeISDugHE4LvzHZkWf37haMZew693G3n/Q97mODPMrHFA65Wh9EpCjwkPt0aU7yMAVSwOqVW4c+wenu+uKVF80UcIGqW83dxxPADzjjxcYCk4D1IrJKRCpfSUFNgRKQeqXORG0v4LS4/iwi74vIGBGZh7N+7DJgcADKa64ueXbvXvRKMyjkyruPMX7SPfvD8igfUzjkdn0YCzQClqjqVznMwxQ8gaxXr+BMpnCbql640oKZAi9QdSvCfXwcZ4mZzsAmoBYwEbgD+AynW6wp/AL2P0tVJ4nIAWAa8JhX0l5guqr+ltNCmqtWnt27W8vYlRH38UoH3gUqH1M45Lg+iMjTwHM4M/78KZCFMgVeluqViLTAaQ2bqKobcr1UpjDI6v+sIl7H36eqy1X1nKr+BPTCmfWsvXVZNK4sfxaKyF+A+cB0oC5QBrgZ2A/MEpH/l0tlNFevgN27WzCWMU/UW95Pemia43I7H1M45Ep9EJGhwJvAz0AHtUXKrzZXXK+8uifuBl4OXNFMAReo/1nR7uN+Vd3uneC2wHpa8ltku4SmIApIvXInaBiHM4HHs6q6X1XPq+oPOEH+UeA5d0IGY7Iqz+7dLRjL2C730V9/0Pruo7/+pIHOxxQOAa8PIjIceAvYgROIHc958UwBFYh6VdY9/3og3muhZ8WZSRFgqrtv0hWX2BQUgf4sPOMn3ROslcpiuUzBFqh61dN9/DZtgqqeB77Dud+9KbsFNFe1PLt3tzFjGfP8YXcRkRAf01q2AS7gTKmaF/mYwiGg9UFEXsAZJ7YNuF1VTwa4vKZgCES9ugh86CetGc7NzFqcDynrwnj1CNT/rNU4M7zWF5HiqnopTXoj9/HAlRfZFACBqlcl3Ed/k7949qetb8ZkJM/u3a1lLAOqug9nJp7awNA0yaNw+iR/7FlfQESKiUiku2J3jvMxhVug6pWb9jJOIPY90MkCsatXIOqVql5Q1Ud9bcCX7mEz3H1zc/2iTL4QwM/Ck8BcnG4/r3inicjtOBN4xGCzwF4VAvhZuMZ9HCQi13oniEg3nJvmeGB9YK/AFAb54d7dFn3OhPvLWY8zC9RCYCfQEmd1791Aa1U95R5bG2eGqIOqWjun+ZjCLxD1SkQG4AxWTgIm47vf8gFVnZ47V2Hym0D9v/KT92vYos9XrQB+FkbgrM9TD+cm+juc2RR74QyE76eqn+X6BZl8IUCfhSE44w07A2eBz4HjON2te+JMtDBcVd/Mi2sywScifwT+6D69BueLnv1cDtxPquoI99jaBPveXVVty2QDagAf4ay2fQk4iDNRQnia42rjfJgcuJJ8bLs6tiutV8Br7v6MtpXBvk7bCla9yiBfT317NNjXaFtwtgB+FoYD/4NzA3QJOIVzo9Mq2NdoW95vgahXQDFgOE6XsVic7rC/4axl1yXY12hbntepzO6PDngdG/R7d2sZM8YYY4wxxpggsDFjxhhjjDHGGBMEFowZY4wxxhhjTBBYMGaMMcYYY4wxQWDBmDHGGGOMMcYEgQVjxhhjjDHGGBMEFowZY4wxxhhjTBBYMGaMMcYYY4wxQWDBmDHGGGOMMcYEgQVjxhhjjDHGGBMEFowZY4wxxhhjTBBYMGaMMcYYY4wxQWDBmDHGFGIi8rCIqIisDHZZCjr3fVQRqZ3D8w+450cFtGDGGGMKLAvGjDEmCERkutfNfUbb8GCXNS+IyEof154sImdE5DsReUVEwoNdTl9EpKmIvCYiDwe7LIHiXo+v+hgnIntEZIaItMil137Yff2muZG/McbkJ0WDXQBjjLnKJQCnM0iPy6uC5BPxQIz7cxGgEtDc3QaJSCdV3RWksnleNyHN/qbAq8AqYHoG5+/Dub7zAS9Z7kkGfvd6XhGo524PishzqjopwK/5MNAeOABsC3DexhiTr1gwZowxwbVeVaOCXYh8ZK6qPux5IiKhwJ+BscC1wKci0kxVNa8LpqqRV3h+p0CVJQ8dVtXaniciUgRoCbyNE4ROFJFvVHVHkMpnjDEFmnVTNMYYk2+paqzb8vIPd1dToFUQi3RVU9UkVV0P/BGnhTAEeDC4pTLGmILLgjFjjCkARKSRiLwsImtE5JCIXBSRU+5Yq0fdFovs5llcRIaJyHp3bFaCiJwQke0i8raI3JrBeU+6ZTntluWgiEwTkeuv/Gp9muP1881pylNFRCaKyC8icl5EYtxxZs+JSAl/GYrI3SKyxL3mBPdadonIHBHp4+P4dBN4iIgCH7lP2/sYYxXldWy6CTxE5AN33/yMLl5E/uoe94Of9DtFZKGIHBeRSyLym4j8n4jckVG+OaWqB4Hd7tMbfJSnuIj0EJGpbn06KSLxbj2ZJSI3+zjnYff9bO/u+ijNe3nAz+vkdV00xpiAsW6KxhhTMKzEGa8DkAScA8JxblzbA71E5G5VTcxKZiJSFPiayze+ijNWqyIQAdzo/rwhzXlVgX8DTdxdyTjj2moCA4G+ItJfVf83+5eYoaNeP4d6laeFWx7P5B5ngeJcHmf2JxHpoqq/pbmOfwAveu06C5QCGrhbB2BuFsp1wj0vFN/j/y5lcv5s4BGgh4iEqmqsn+P6eh2fQkSK4QSD/b12xwKVgZ5ATxEZr6p/yexCckDcR19fBHQB/s/r+XmcOlYT6AfcLyJ/VtVPvI65gPN+hgPFcK7jgle699i1YNZFY4wJGGsZM8aYgmE18BhQCyipqmFAWeBPwHGgO/BMNvLrhxOInXfzKK2qFYAS7ms8CWz3PsG98V+Ic/O7GmgHlFLVUOAaYCJQEvhEROrm7DL9qun18xm3PBWAL3Bu3n8EWrhlKQv0BqLdss5Kcx21gZHu0zFAZVUNVdVSQBXgPmBxVgqlqtcAw9yn61X1mjTb+kyyWAn8ivO+9fJ1gIg0BBrjBDOfpkn+fziB2AGc32k5VS0PlAMG4wQ0z4tIXwLIfQ/ru0/3+zjkHE6Q2AmopKpl3Pe3FjAJ58vg90Uk5feqqnPd99Pzng1L814293r9YNZFY4wJGAvGjDEmuFq7Xct8bZ7ub6jqPar6gaoe8rR+qWqcqs4E7ncPG5KN1/WMu/pYVWeqarybZ5L7Gm+r6pg05wzAaW3aDHRR1TWqesk974SqjgDeBUqTvcAwKx7z+nmT+/gkUBUnOOuiqpu9rmE+8IB7XGcR6eh1fgucz79fVPVFVT3pSVDV31R1gao+EuDy+6SqyVxugevn5zBPILVaVY94dopIfeBpnOvvpKpzVPWcm+85VX2fy+/b3wJRXhEp4nZf/Ryn9QpgZtrjVHWlqv5ZVVeo6imv/YdU9RlgGk6wNDCHRQlmXTTGmICxYMwYY4KrGE5rjK+tQlYyUNU1ODfktUWkWhZf19Mdrmo2yjrAfXxbVS/6OcbTje72bOTrk3vjX19ExgCe9dY2qOr37s/3uY8fqOrxtOer6tdc7mZ5v1eS59rLi0jpKy1nAHjes04iEuEj/YE0x3k8hPM5/oWq+mqdAvhf4CLQ0O3Wl101vL8gwOk2uB5nIhWA11R1k//T/fJ0YWyTg3Mhj+uiMcbkFhszZowxwbUqq1Pbi8h9ODPXNcMZE1TSx2HVcLq9ZebfwAvA3SLyJc76WKu8WzHSvHZRnBYlgP8RkXF+8vWMH6qRhTL4MkBEBvhJ24UbmIhIcaCRu//bDPJbAdyK8555bMIZ21UV2CAibwPLVPW/OSzzFVHVLSKyG2es2v3AW540EWkJ1MUZj5Z2ko/W7uN9ItItg5fwtGDVAI5ls3ghOF8MpBUP3KeqfrtzirNI91CgG3AdUJ7048uy+uWBd755VReNMSbXWTBmjDH5nHvzOY/UY4ouAidxJvMAJzgLAcpkJU9VXSUirwCvAHe6GyLyC854qfdUdY/XKeE4E2N4fs5MqayUwwfvRZ+TcSbW2OOWaYaqehZMDudy746j+Ofp1lfZs0NVo0XkTzhjyW4E3gNwW36+Bqap6qoclj+n5uAsHN0Xr2CMy10Ul6pq2slBPC1dZd0tMzlpBTzoWWfMHadVB2eM3BPAFBFpq6oH0p4kIjfgBMLegdxZnJY1xalLFchifU0jr+qiMcbkOuumaIwx+d9jOIHYeZwb4RqqWlJVK3smN+Bya5j4yyQtVR2N0xrzV+ArnO57kcBzwM8i8pDX4d6fF01UVTLbcnitc70mbKimqtepak9VfdcrEEvL7/T1/qjqEqA2MAgn0P0VZ+KHh4CVIvJ+DsufU55JRm71TJ0vIiFc7l6ZtosiXP6dDMvK70NVV15JAVU1QVV3qeoQYCpQHZjjljOtj3ACsR+ArjgTi4SqahW3vvZ2j8tJPcmrumiMMbnOgjFjjMn/PDeuo1X1X96TOIAztgqolJOMVfW/qjpWVbvitDJ0wJmdrijwjtcYplNcboVLt65UEJzGaTkDZ4Y+f6q7j7+nTVDVGFWdqqp9VPVaoCFOkAHwmIj0CFhpM+G2Qn6PE5x4xohF4bR+xQFf+jjthPsYjN/HCzgtmK1wZuNM4c6Q2AKnvtylql95Jhbx4qvrY1blt7pojDE5ZsGYMcbkf56AYquf9Db4Hj+WLe4shCtx1qdKwOlCdoublgBscQ+950pf60q5M+ftcJ92yOBQzyyKPhdLTpPnz6o6CNjo7mqf0fFePEHhlbbAeFq/PLMqeroofuGnVdAzOcmdbhfCPKOq0cDb7tPX3K60HikBsKr660LaOYPsM3w/81tdNMaYK2HBmDHG5H+eMVSN0ya4N8GvZzdDdwIMfy5xueXBuwvgdPfxXhHJKADyrAGW2zwTWjzsa6ZAEemCM3kHOF0RPfszuna4vNBwVrs/emZnDMvi8f58ihOINBaRm4B73f2+uigCzHCPr4bT1dSvXPp9/Atn7GJtnIllPDz1tYqv2SFFpDH+p/GHrL2f093H/FIXjTEmRywYM8aY/G+Z+/iyiNztdktERCJxpghvgdOVLTs+FpGPROQOESnn2emOV5qB09J2AVjjdc6HOK1GIcAiERnmzpjnOTdCRPqKyEouL4Scm97CmR2wFLBURG5xy1FERO7l8gLJ36jqCq/znhCRr0Skn3cQJyJhIvIiTvdAcMbRZcVP7uMN7uyHOaKqvwKeiUM+wJng4iTOpCK+jt+Js4AywCgReVtE6njSRaSsiNwuIp8An+W0XBmU9wTwifv0r15jx3biTJwiwFwRqeeWp5iI3INTn9N2W/TmeT/vEZHyfo7Jb3XRGGNyxIIxY4zJ/yYA+4BQ4AvggojE4Nz03g48jnPTnh0lgYeBpUCMiESLSBzwX6APTsvY4DQLIicAdwPrcGbmmwScFJHTInIWZwzTbJzufZqzS806t6vcH4FonFkRN4tILM6N/nycYOY/QP80pwrQBWfSjF9F5JyIRLv5/MNNf9+d5CMr5djD5XF2G0XklIgccLdWmZyelqcVzDMV/2fqLvLtx19wFjcGZ9HvfSIS615PLE4g9yDpp5QPlAk4rXMNcOqNZyHrp939UcAer9/LApzWtOG+MnN9gtM6extO/TrqvpdrPQfkt7pojDE5ZcGYMcbkc+6U5q1wbro9k3dcwAnM2qvq9BxkOxLnRn4psB9nqvAiOEHfR0AzVf0k7Umq+hvODW5/YAnwG8606gL8gtNi0R14IwdlyjZV/Q5nEod/Artx1tRKxBlT9DzQ0i2zt9k4M1TOxQloE3Cu4RjORBl3q+rgbBblHuAdnGC2LM6kIrXI/li++TjBindZ/XLH+Q3BCVxmAgdxfpelgEPA5zgLJP8xm+XIElXdxeXJRV4UEXH3f44zXm8ZzpT2xdyyTQBu4nI99pXnLzhfMizF6fJ4Dc57WT3NcfmqLhpjTE6Iqn1hZIwxxhhjjDF5zVrGjDHGGGOMMSYILBgzxhhjjDHGmCCwYMwYY4wxxhhjgsCCMWOMMcYYY4wJAgvGjDHGGGOMMSYILBgzxhhjjDHGmCCwYMwYY4wxxhhjgsCCMWOMMcYYY4wJAgvGjDHGGGOMMSYILBgzxhhjjDHGmCCwYMwYY4wxxhhjgsCCMWOMMcYYY4wJAgvGjDHGGGOMMSYILBgzxhhjjDHGmCCwYMwYY4wxxhhjgsCCMWOMMcYYY4wJAgvGjDHGGGOMMSYILBgzxhhjjDHGmCD4/yk9LRLfowgWAAAAAElFTkSuQmCC\n",
      "text/plain": [
       "<Figure size 432x288 with 1 Axes>"
      ]
     },
     "metadata": {
      "image/png": {
       "height": 277,
       "width": 433
      },
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "# Plot of a ROC curve for a specific class\n",
    "plt.figure()\n",
    "lw = 2\n",
    "plt.plot(fpr[1], tpr[1], color='darkorange',\n",
    "         lw=lw, label='ROC curve (area = %0.2f)' % roc_auc[1])\n",
    "plt.plot([0, 1], [0, 1], color='navy', lw=lw, linestyle='--')\n",
    "plt.xlim([0.0, 1.0])\n",
    "plt.ylim([0.0, 1.05])\n",
    "plt.xlabel('False Positive Rate')\n",
    "plt.ylabel('True Positive Rate')\n",
    "plt.title('Receiver Operating Characteristic (ROC) Curve')\n",
    "plt.legend(loc=\"lower right\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "We plot ROC curves for all the 9 classes."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 864x576 with 1 Axes>"
      ]
     },
     "metadata": {
      "image/png": {
       "height": 495,
       "width": 809
      },
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "# First aggregate all false positive rates\n",
    "all_fpr = np.unique(np.concatenate([fpr[i] for i in range(n_classes)]))\n",
    "\n",
    "# Then interpolate all ROC curves at this points\n",
    "mean_tpr = np.zeros_like(all_fpr)\n",
    "for i in range(n_classes):\n",
    "    mean_tpr += np.interp(all_fpr, fpr[i], tpr[i])\n",
    "\n",
    "# Finally average it and compute AUC\n",
    "mean_tpr /= n_classes\n",
    "\n",
    "fpr[\"macro\"] = all_fpr\n",
    "tpr[\"macro\"] = mean_tpr\n",
    "roc_auc[\"macro\"] = auc(fpr[\"macro\"], tpr[\"macro\"])\n",
    "\n",
    "# Plot all ROC curves\n",
    "plt.figure(figsize=(12,8))\n",
    "plt.plot(fpr[\"micro\"], tpr[\"micro\"],\n",
    "         label='micro-average ROC curve (area = {0:0.2f})'\n",
    "               ''.format(roc_auc[\"micro\"]),\n",
    "         color='deeppink', linestyle=':', linewidth=4)\n",
    "\n",
    "plt.plot(fpr[\"macro\"], tpr[\"macro\"],\n",
    "         label='macro-average ROC curve (area = {0:0.2f})'\n",
    "               ''.format(roc_auc[\"macro\"]),\n",
    "         color='navy', linestyle=':', linewidth=4)\n",
    "\n",
    "colors = cycle(['rosybrown', 'firebrick', 'sienna', 'olivedrab', 'darkgreen',\\\n",
    "                'lightseagreen', 'darkturquoise', 'b', 'darkorange'])\n",
    "for i, color in zip(range(n_classes), colors):\n",
    "    plt.plot(fpr[i], tpr[i], color=color, lw=lw,\n",
    "             label='ROC curve of class {0} (area = {1:0.2f})'\n",
    "             ''.format(i+1, roc_auc[i]))\n",
    "\n",
    "plt.plot([0, 1], [0, 1], 'k--', lw=lw)\n",
    "plt.xlim([0.0, 1.0])\n",
    "plt.ylim([0.0, 1.05])\n",
    "plt.xlabel('False Positive Rate')\n",
    "plt.ylabel('True Positive Rate')\n",
    "plt.title('ROC Curve for Multiple Classes')\n",
    "plt.legend(loc=\"lower right\")\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "We note from the AUC scores ('area' metric) in the plot above that class 7 (the most predominant class in the training dataset) has the highest AUC score, which is not surprising. The AUC score for class 8, however, is very low. "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "%%time\n",
    "y_prob = classifier.predict_proba(X_val)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "One-vs-One ROC AUC scores:\n",
      "0.802909 (macro),\n",
      "0.842938 (weighted by prevalence)\n",
      "One-vs-Rest ROC AUC scores:\n",
      "0.802909 (macro),\n",
      "0.842938 (weighted by prevalence)\n"
     ]
    }
   ],
   "source": [
    "macro_roc_auc_ovo = roc_auc_score(y_val_binarized, y_prob, multi_class=\"ovo\",\n",
    "                                  average=\"macro\")\n",
    "weighted_roc_auc_ovo = roc_auc_score(y_val_binarized, y_prob, multi_class=\"ovo\",\n",
    "                                     average=\"weighted\")\n",
    "macro_roc_auc_ovr = roc_auc_score(y_val_binarized, y_prob, multi_class=\"ovr\",\n",
    "                                  average=\"macro\")\n",
    "weighted_roc_auc_ovr = roc_auc_score(y_val_binarized, y_prob, multi_class=\"ovr\",\n",
    "                                     average=\"weighted\")\n",
    "print(\"One-vs-One ROC AUC scores:\\n{:.6f} (macro),\\n{:.6f} \"\n",
    "      \"(weighted by prevalence)\"\n",
    "      .format(macro_roc_auc_ovo, weighted_roc_auc_ovo))\n",
    "print(\"One-vs-Rest ROC AUC scores:\\n{:.6f} (macro),\\n{:.6f} \"\n",
    "      \"(weighted by prevalence)\"\n",
    "      .format(macro_roc_auc_ovr, weighted_roc_auc_ovr))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Generation of Predictions"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 137,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[Parallel(n_jobs=8)]: Using backend ThreadingBackend with 8 concurrent workers.\n",
      "[Parallel(n_jobs=8)]: Done  34 tasks      | elapsed:    0.0s\n",
      "[Parallel(n_jobs=8)]: Done 100 out of 100 | elapsed:    0.1s finished\n"
     ]
    }
   ],
   "source": [
    "# Generate predictions\n",
    "y_test_pred = etree_best.predict(X_test)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 173,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "((5668,), (5668, 10117))"
      ]
     },
     "execution_count": 173,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "y_test_pred.shape, X_test.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 178,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Restore the 'id' column since we need this for the Kaggle submission\n",
    "test_pred = pd.concat([test['id'], pd.DataFrame(y_test_pred, columns=['class'])], axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 179,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "7    3792\n",
       "4    1017\n",
       "2     393\n",
       "1     378\n",
       "5      37\n",
       "6      36\n",
       "9       8\n",
       "3       7\n",
       "Name: class, dtype: int64"
      ]
     },
     "execution_count": 179,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Verify that we have a mix of predictions for variation classes\n",
    "test_pred['class'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 180,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>class</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>3</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>4</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   id  class\n",
       "0   0      7\n",
       "1   1      4\n",
       "2   2      7\n",
       "3   3      7\n",
       "4   4      4"
      ]
     },
     "execution_count": 180,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "test_pred.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## Data Export"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [],
   "source": [
    "test_pred.to_csv(\"../assets/test_pred.csv\", index=False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
